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Thesis Abstract 
 
This thesis reports the development of Comparative Genomic Fingerprinting 
(CGF), a rapid genotyping method for Campylobacter jejuni that assesses the 
conservation status of 20 genes previously described as having high intraspecies 
variability based on comparative genomics studies. This novel method for genotyping C. 
jejuni, CGF was validated two-fold. First, by comparison to flaA restriction fragment 
length polymorphism analysis, and second a subset of isolates was validated using two 
higher resolution CGF assays assessing 35 and 119 genes. CGF was then tested in a 
molecular epidemiological study of C. jejuni isolated from environmental, animal and 
human clinical samples from southern Alberta. Reservoirs of infection, subtypes 
associated with higher incidence of human infection, and the persistence of prevalent 
subtypes in animal/environmental reservoirs were identified. This thesis demonstrates 
that CGF analysis is robust and can be used to rapidly assess genetic similarity of C. 
jejuni isolates and to detect epidemiologically relevant clonal groups. 
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 1 
Chapter 1 
 
1. Literature Review 
 
1.1 Epidemiology of Campylobacter 
 Campylobacter organisms have long been known as a veterinary pathogen 
attributed to infectious abortion in cattle and sheep under the name Vibro fetus since 
1909, but only in the recently decades become important as a cause of human illness 
(Blaser & Reller, 1981). To understand why Campylobacter may be seen as an emerging 
human pathogen (Altekruse, Stern, Fields, & Swerdlow, 1999) although studied since for 
nearly a century, first Campylobacter must be understood. 
 
1.1.1 Overview of Campylobacter and C. jejuni 
Campylobacter is a Gram-negative group of bacteria that is nearly ubiquitous in 
both animal, in particular mammalian, and water reservoirs (Koga et al., 2005; Mangen et 
al., 2005; Papworth and Olson, 2002). The bacterium has been isolated from water and 
animal sources including pigs, chicken, and cattle. Campylobacter is sensitive to many 
conditions including oxygen levels and prefers to grow under microaerobic conditions 
with low oxygen (3-15%), and high carbon dioxide levels (2-10%) (Snelling, Matsuda, 
Moore, & Dooley, 2005). These special growth requirements make it difficult to isolate 
some strains of Campylobacter in a laboratory setting. 
Members of the genus Campylobacter that are most commonly associated with 
human infection, also known as campylobacteriosis, are referred to as “thermophilic 
 2 
campylobacteria”. This classification is determined by growth at 42°C and 37°C, but not 
below 30°C. Members of this group include Campylobacter jejuni, Campylobacter coli, 
Campylobacter lari and Campylobacter upsaliensis. Campylobacter jejuni is the 
predominant cause of gastrointestinal disease of the genus Campylobacter and is isolated 
in 80% or more of clinical human cases (Skirrow, 1997; Thomas, Gibson, & Mabey, 
1999). The second most common is C. coli. Together C. coli and C. jejuni compose 95% 
of clinical isolates (Thomas et al., 1999). It has been suggested that the high frequency of 
these two species may be a reflection of the isolation methods resulting in an 
underestimation of other species that might be the cause of clinical illness (Bolton, 
Hutchison, & Parker, 1987). However, the consensus remains that C. jejuni is the most 
common Campylobacter species associated with human enteritis (Allos, 2001; Walker et 
al., 1986). 
 
1.1.2 Campylobacter as a human disease 
Campylobacter has long been associated with Traveler’s Diarrhea (TD) and 
incidence of enteric disease in developing countries. Up to 55% of travelers to developing 
countries will acquire TD (Yates & Stetz, 2006) and 45% of troops deployed in the 
middle-east have reported diarrhea resulting in decreased job performance for a median 
of three days (Sanders, Putnam, Riddle, & Tribble, 2004). Travelers have a high 
incidence of diarrheal disease (1 to 15 episodes per person per year) while residing in 
developing countries (Payment, 2001). Children in developing countries exhibit a peak 
incidence of diarrheal disease at 24 months of age before the incidence declines in 
adulthood (Payment, 2001), possibly due to the acquisition of protective immunity from 
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constant exposure (Thomas et al., 1999). These high childhood disease rates are thought 
to be one reason for the high child mortality rates in certain developing countries 
(Payment, 2001). In many locations, such as Thailand, Campylobacter infections are the 
leading cause of TD (Yates & Stetz, 2006). C. jejuni is responsible for nearly all cases of 
human campylobacteriosis acquired overseas (Schrotz-King, Prokhorova, Nielsen, 
Crawford, & Morsczeck, 2007).  
Infection by Campylobacter also is a leading cause of illness in many developed 
countries. Each year in the US, 2 to 2.5 million cases of gastroenteritis are attributed to 
Campylobacter (Gadewar & Fasano, 2005; Olsen et al., 2001; Poly & Guerry, 2008). If 
each case requires 2-3 sick days to be taken, 6 million work days could be lost annually. 
In the Netherlands, the cost associated with campylobacteriosis, including both health 
care costs and lost productivity, is an estimated 21 million Euros (Mangen, Havelaar, 
Bernsen, Koningsveld, & Wit, 2005). In Canada, there were 12,000 reported cases of 
campylobacteriosis during 2000. However, because of high rates of under reporting, it is 
thought that as many as 300,000 – 600,000 cases actually occurred in this year (Thomas 
et al., 2006). Even the cost of diagnosing watery or bloody diarrhea caused by 
Campylobacter can be high. In the US, the estimated cost of a positive test result for 
Campylobacter is can be as much as $900 to $1000 (Gadewar & Fasano, 2005). Although 
in developed countries, diarrheal disease is not traditionally considered to be life-
threatening, mortalities are also observed, primarily in infants, the elderly and previously 
ill patients (Altekruse, Stern, Fields, & Swerdlow, 1999). In the United States 
Campylobacter is estimated to be responsible for 124 deaths annually, 99 of which are 
food-borne acquired (Mead et al., 2000). This accounts for 5.5% of bacterial food-borne 
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deaths, second only to Listeria monocytogenes, and non-typhoidal Salmonella (Mead et 
al., 2000).  In developed countries young children (less than three years of age) and 
infants are also at risk of acquiring campylobacteriosis, in particular those in contact with 
puppies and pet chickens (Tenkate & Stafford, 2001) although contact with adult dogs 
does not appear to be a risk factor for disease in this age group (Kapperud, Skjerve, Bean, 
Ostroff, & Lassen, 1992). 
 
1.1.3 Overview of Campylobacter illness 
Campylobacter infection begins with consumption of the bacteria through 
ingestion of contaminated food or water (Figure 1). The infectious dose for 
Campylobacter is low and is estimated to be 500-800 cells (Skirrow, 1997; Young, 
Davis, & DiRita, 2007).  A correlation between ingested dose and infection rate exists 
where approximately 10% of individuals who ingest 800 or fewer cells will develop 
clinical symptoms of the disease (Thomas et al., 1999). Volunteer studies have shown 
that consumption of even 500 cells can cause an infection (Robinson, 1981). The normal 
incubation period prior to illness associated with C. jejuni averages 2 to 3 days (usually 
24-72 hours past ingestion of cells), but could be as short as one day or as long as a week. 
During this period the bacterium must survive passage through  the acidic environment of 
the stomach (Blaser & Engberg, 2008). Chemotactic motility towards amino acids which  
are found in high concentrations in mucus coated regions of the gastrointestinal tract 
(Young et al., 2007) may help direct the bacteria to the small intestine. Once in the small 
intestine the bacteria move through the mucus layer, aided by their spiral rod shape and 
motility, to colonize the jejunum and ileum (Blaser & Engberg, 2008). During 
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Figure 1: The route of infection of C. jejuni. 1) C. jejuni must enter the body, primarily 
by consumption of contaminated foods (for example, from a contaminated turkey) or by 
other means of ingestion. The normal incubation period before clinical symptoms appear 
is between 1 to 7 days, averaging between 2 or 3 days. 2) The bacterium must survive the 
acidic environment of the stomach. 3) After passing through the mucus layer coating the 
intestine, C. jejuni are able to colonize cells lining the jejunum and ileum of the small 
intestine. The spiral shape and motility of the bacterium aid in colonization. 4) The host 
begins a cell mediated immune response by production of interleukin-8 which begins a 
signaling cascade leading to production of other cytokines. 5) The first response by the 
host is fever, which is quickly followed by abdominal pain. 6) This stage of infection can 
be followed by acute and/or bloody diarrhea, especially in severe cases where the bacteria 
has been able to progress to the colon and rectum. 7) By the time diarrhea is observed, 
the host immune response is activated; macrophages, neutrophils and other cytokine 
growth factors can be found at the site of infection. 8) Approximately 5 days after onset 
of fever, antibodies can be found in the serum. These antibodies have little impact on the 
current infection but can offer some short-term protection against additional infections of 
a similar strain of Campylobacter. 9) In patients that have not been treated with 
antibiotics, C. jejuni can be shed in the feces for several weeks following infection. 
Relapses can occur, resulting in abdominal pain and diarrhea. Figure adapted from 
Skirrow (1997); Blaser and Engberg (2008). Images courtesy of Michael Maguire and 
Susan Ross. 
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colonization, the host’s immune system begins to respond by starting a cascade of 
molecular events beginning with production of interleukin-8, a cytokine which helps 
stimulate a cell mediated immune response (Blaser & Engberg, 2008). At this point the 
patient will begin to feel ill and will display physical signs of illness including 
development of a high fever (Skirrow, 1997), which may be accompanied by fear and 
anxiety (Goehler, Lyte, & Gaykema, 2007). These symptoms are followed by moderate 
to severe abdominal pain which typically leads to acute and in some cases bloody 
diarrhea (Skirrow, 1997).  
At this point the patient’s immune response is fully activated; macrophages, 
neutrophils and other cytokine growth factors can be found at the site of infection. Other 
symptoms of C. jejuni infection may include anorexia, headache, nausea, chills and 
sweats, myalgia, vomiting and gross blood in the stools (Peterson, 1994). In some cases, 
the symptoms may resemble a dysentery-like syndrome which mimics inflammatory 
bowel disease (Walker et al., 1986). Presence of blood in the stool usually signals a 
severe case of infection where the bacteria have been able to progress to the colon and 
rectum (Blaser & Engberg, 2008). Still, a majority of infections are self-limiting and can 
be treated by monitoring hydration and maintaining electrolyte balance; the ability to self 
treat most infections is likely responsible for the high number of unreported cases. Total 
duration of an infection is about 7 days where diarrheal symptoms are experienced and 
for most individuals, severe symptoms last about 3-5 days (Skirrow, 1997).  By the end 
of an infection, IgA, IgM and IgG antibodies can be found in the serum of infected 
individuals. The ability of patients previously infected with Campylobacter to produce 
these antibodies may aid in protection against a second infection by the same or similar 
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strains of C. jejuni (Skirrow, 1997). This type of protection has been suggested to occur 
in young captive Macaque monkeys; however, these young monkeys might also possess 
maternal antibodies capable of preventing clinical disease (Dassanayake et al., 2005). 
In severe cases of Campylobacter infection, antibiotic treatment with macrolides 
and fluoroquinolones are often prescribed by heath care professionals (Keller & Perreten, 
2006), although antibiotic therapy needs to be started as soon as symptoms appear in 
order to produce a dramatic reduction in the bacteria causing the disease to occur. 
Therapy is most important for individuals that are immune compromised; e.g., the elderly 
and the very young. Except in patients that have been treated with antibiotics, C. jejuni 
will continue to be shed in the feces for several weeks following an infection (Kapperud 
et al., 1992; Skirrow, 1997). Campylobacter cells shed in feces can contribute to human-
to-human transmission via a fecal-oral route. Presence of the bacteria in some patients for 
long periods following an infection can lead to a relapse accompanied by both abdominal 
pain and diarrhea. Occasionally, a relapse also can be triggered in patients who consume 
a large quantity of food very quickly after symptoms of an infection subside (Blaser & 
Engberg, 2008).  
 
1.1.3.1 Complications resulting from Campylobacter infections 
 While the majority of Campylobacter infections are considered to be self-limiting, 
and the host’s immune system is able to clear the bacteria from the body without the need 
for medical intervention, serious, life-long complications can occur. Irritable bowel 
syndrome is associated with gastroenteritis, in particular TD (Janda & Abbott, 2006). 
Acute myocarditis, which may lead to heart failure, also can develop after infection by C. 
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jejuni (Mera, Lopez, & Serralta, 2007). Although the mechanism for causing damage to 
the myoctyes is not known, it has been hypothesized to occur either by a direct bacterial / 
host interaction or as a consequence of circulating toxins (Mera et al., 2007).  
 Reiter’s syndrome, also known as Reactive Arthritis (ReA), is trigged by 
gastrointestinal or genitourinary infections, and campylobacteriosis is no exception. ReA 
occurs in about 7% of people after infection with Campylobacter (Yates & Stetz, 2006), 
and often is seen in patients who have had TD. Onset occurs about 1- 4 weeks after the 
triggering infection. The symptoms of ReA have been shown to be extremely long 
lasting; e.g., for up to 5 years in the majority of patients infected with Salmonella 
enterica serovar Typhimurium-triggered ReA (Yates & Stetz, 2006). This suggests that 
Campylobacter, the most common cause of TD, may be responsible for a significant 
proportion of ReA.  
 Campylobacter has been identified as a risk factor for post infection irritable 
bowel syndrome (PI-IBS) and inflammatory bowel disease. Up to 25% of patients who 
were diagnosed with Campylobacter enteritis will develop PI-IBS as gut changes persist 
long after infection (Spiller et el., 2000).  
Guillan-Barré Syndrome (GBS) and its variant, Miller Fisher Syndrome (MFS), 
both result from auto-immune responses which cause damage to nervous tissue, usually 
resulting in paralysis. Extreme cases of paralysis can compromise the function of 
respiratory muscles resulting in death (Sahin, Kobalka, & Zhang, 2003). The most 
commonly identified infectious agent associated with GBS is Campylobacter jejuni 
(Godschalk et al., 2006); up to 30% of GBS cases and 20% of MFS cases are preceded 
by C. jejuni infection (Jacobs et al., 1998; Koga et al., 2005; Rees, Soudain, Gregson, & 
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Hughes, 1995). An estimated one in one thousand cases of gastroenteritis will develop 
some form of GBS (Allos, 2001; Poly & Guerry, 2008). It is believed that molecular 
mimicry between lipo-oligosaccharides found on the cell surface of Campylobacter and 
gangliosides found in human nervous tissue may lead to a cross-reactive immune 
response resulting in a damaged nervous system (Godschalk et al., 2006; Poly & Guerry, 
2008). Genes including cgtA, neuA1, orf11, Cj1421c and cj1428c/fcl all appear to 
contribute to the pathogenesis in cases of GBS and MFS as they often appear conserved 
in strains obtained from clinical cases which involve neuropathic complications (Taboada 
et al., 2007).  Differences in host background may also play a significant role in the 
expression of either GBS or MFS following Campylobacter infection, since many of 
these genes are also shared by strains isolated from cases of enteritis without 
complications (Taboada et al., 2007). 
 
1.1.4 Campylobacter Outbreaks 
Despite a low infectious dose and its status as a common enteric pathogen, cases 
of Campylobacter infection are thought to be sporadic in nature (Pebody, Ryan, & Wall, 
1997), only resulting in rare outbreaks of disease conditions which can be traced to 
discrete sources of an individual bacterial contaminant. This may be due to the sensitivity 
of Campylobacter to desiccation, heat, ultra-violet radiation and salt (Wagenaar, Mevius, 
& Havelaar, 2006), all of which work to limit concentrations of bacteria in food and 
water sources that can be distributed to the public. Identified risk factors for sporadic 
infection include consumption of contaminated produce such as poultry, eating at 
barbeques, and contact with animals, in particular dogs (Kapperud et al., 1992). 
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In one outbreak of campylobacteriosis, individuals from New Zealand became ill 
when they drank spring water that appeared to be contaminated by runoff from adjacent 
farmland grazed by cattle and sheep following torrential rains (Centers for Disease 
Control and Prevention, 1991). Forty-four individuals developed symptoms of the 
disease, but after introduction of water chlorination no further cases were detected (Stehr-
Green, Nicholls, McEwan, Payne, & Mitchell, 1991). In another outbreak, a water 
holding tank at a boys’ school appeared to be contaminated by fecal material from birds 
(Palmer et al., 1983; Walker et al., 1986). Contamination of food by food handlers also 
has given rise to outbreaks, but these cases have been extremely rare (Olsen et al., 2001).  
In Canada our most notable outbreak occurred in 2000, when Escherichia coli 
O157:H7 and C. jejuni entered the public water supply for the community of Walkerton, 
Ontario, population 4800 (Hrudey, Payment, Huck, Gillham, & Hrudey, 2003). The 
pathogens likely entered a well used to supply the town with water through farm run-off 
which occurred immediately following a period of heavy rains. Many of the individuals 
who consumed the water became ill, resulting in approximately 2300 cases of infection, 
67 hospitalizations, 27 cases of haemolytic uraemic syndrome (a potentially fatal kidney 
ailment) and seven deaths (Auld, MacIver, & Klaassen, 2004; Clark et al., 2003).  
 
1.1.5 Transmission and Prevalence of C. jejuni 
Transmission of Campylobacter is multi-faceted with many potential routes 
(Figure 2). Poultry and bovine milk are well-established sources of human infectious C. 
jejuni cells, and provide a route for foodborne infection. Water also is thought to be an 
important source for the acquisition of Campylobacter, and may occasionally act as a  
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Figure 2: Campylobacter in the environment and routes of transmission. Dairy cattle have 
been associated with Campylobacter contamination and unpasteurized milk has been 
identified as a source of these infectious bacteria in humans (Levesque, Frost, Arbeit, & 
Michaud, 2008; Robinson, 1981). Livestock can act as carriers of Campylobacter and are 
known to shed it in feces (Açik & Çetinkaya, 2006; Inglis, Kalischuk, & Busz, 2004). 
Fecal material may enter water directly as run-off or may contaminate insects that spread 
the bacteria within the environment, possibly even to exposed food. Contaminated 
poultry, especially chickens can spread Campylobacter to humans as food. Migratory 
birds, such as geese can be contaminated by bacteria found in the water and then, can 
increase bacterial load in the environment via their own excretions (Aydin, Atabay, & 
Akan, 2001). Some birds may carry the bacteria into new geographical regions. 
Agriculture may contribute to the bacterial burden either through irrigation with 
contaminated water sources, or via use of improperly treated manure which can 
contaminate run-off. Consumption of raw or under-cooked contaminated meat products 
peaks during the barbeque season leading to an increase in human infections (Evans, 
Ribeiro, & Salmon, 2003; Kapperud et al., 1992). Consumption of contaminated surface 
and well water (Stehr-Green et al., 1991) also can result in campylobacteriosis. In 
addition, humans may impact the environment through improper hygienic practices and 
improper treatment of sewage. Images courtesy of Melissa Leece and Susan Ross.  Note: 
importance of sources not presented in scale. 
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vector. Migratory birds may act as vectors, transporting bacteria to new environments. 
Insects such as flies may also act as vectors carrying bacterial cells to new environments 
such as chicken coops or directly on to food.  
Use of contaminated water and manure in agriculture can increase the 
environmental bacterial load, leading to contamination of produce such as fruits and 
vegetables that generally are not cooked prior to human consumption. Farm animals and 
house hold pets, as well as large game animals found in the wild may become 
contaminated from naturally occurring bacteria in the environment and then act as  
carriers for Campylobacter. These animals can shed the bacteria in feces that can 
subsequently flow back into environmental reservoirs.  
Water is seen as a potential source for the transmission of Campylobacter because 
of its relatively low infectious dose. Fecal contamination of water most likely occurs as a 
result of a combination of problems, including improper wastewater discharge, use of 
improperly treated waste or run-off from agricultural activities, and by direct 
contamination of the environment by wild animals, including migratory birds (Gannon et 
al., 2005; Hyland et al., 2003; Johnson et al., 2003; Waldenstrom et al., 2002). There is 
also a seasonal cycle related to numbers of Campylobacter found in aquatic systems; i.e., 
bacterial contamination often rises to a peak in summer months after which levels tend to 
decline into the winter months (Thomas et al., 1999). Because of the cost and difficulty 
associated with isolation methods required for Campylobacter detection from clinical 
samples, it has been suggested that Campylobacter may be a contributor to many more 
waterborne cases of infection where the disease agent has not be identified (Thomas et 
al., 1999). 
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Mode of consumption is a key factor in the spread of Campylobacter to humans. 
Approximately 80% of Campylobacter related illnesses appear to be transferred through 
food (Logue, Sherwood, Elijah, Olah, & Dockter, 2003). C. jejuni is the most common 
Campylobacter isolated from clinical samples, with most of the remaining isolates being 
C. coli. Campylobacteriosis is usually attributed to improperly handled or undercooked 
poultry or livestock meat, unpasteurized milk, and contaminated water. An emerging 
source of foodborne illness is raw produce, as Campylobacter isolation rates range from 
68%-97% from produce, with the majority of isolates being C. jejuni (Chai et al., 2007).  
C. jejuni is able to survive for 2 to 5 weeks in bovine milk stored at 4°C (Walker 
et al., 1986) indicating the importance for use of pasteurization to process raw milk. Use 
of sterilization by hydrostatic pressure is already being used to preserve foods such as 
fruit juices (Martinez-Rodriguez & Mackey, 2005) and bacterial phage inactivation of 
meat contaminants prior to consumer purchase is being developed (Bigwood, Hudson, 
Billington, Carey-Smith, & Heinemann, 2008; Wagenaar, Van Bergen, Mueller, 
Wassenaar, & Carlton, 2005). In Iceland, freezing of chicken prior to consumer 
availability has limited case numbers of human infection (Reiersen et al., 2002; Stern et 
al., 2003). 
 
1.1.5.1 Campylobacter bacteria in poultry and other avian sources 
Campylobacter often is associated with poultry and consumption of contaminated 
poultry is deemed the main source of food borne illness, contributing to 20-40% of all 
cases of campylobacteriosis (Wagenaar et al., 2006). Attempts to eliminate 
Campylobacter contamination from chickens combined with an extensive educational 
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campaign was tested in Iceland after identification of an epidemic of campylobacteriosis 
(Reiersen et al., 2002; Stern et al., 2003). As expected, implementation of a surveillance 
program aimed at eliminating Campylobacter, resulted in a drop in the incidence of 
campylobacteriosis to levels seen in other European countries (Reiersen et al., 2002). 
Freezing of chickens prior to distribution also was implemented during peak periods of 
campylobacteriosis infection in Iceland; in combination with an educational program and 
enhanced on-farm biological security measures, these approaches appeared effective in 
reducing the number of domestic cases (Stern et al., 2003). During a four-week period 
where the sale of chicken meat was prohibited in Belgium, the incidence of 
campylobacteriosis dropped by 40% from expected values, but returned to normal after 
the ban was lifted (Vellinga & Van Loock, 2002). A decrease in incidence of 
campylobacteriosis also was observed in the Netherlands after a reduction in poultry 
consumption (Van Pelt, Wannet, van de Giessen, Mevius, & van Duynhoven, 2004; 
Wagenaar et al., 2006). 
Isolation rates of Campylobacter species depends on the manner in which 
chickens are raised (e.g., use of intensive or free-range rearing facilities) and the 
environment used for transport prior to arrival at the slaughter house. Prevalence of 
contamination is lowest in free-range chickens with approximately one-third of chickens 
carrying C. jejuni  (Avrain et al., 2003). A study in Quebec, Canada, found that chickens 
and turkeys raised on farms without rodent control, or with the flocks of birds located less 
than two hundred meters from a manure heap, were four to five times more likely to be 
colonized  (Arsenault, Letellier, Quessy, Normand, & Boulianne, 2007). Most birds in an 
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infected flock will carry the organisms until slaughter, allowing for transmission of the 
bacteria to other members of the flock (Avrain et al., 2003).  
It is currently unknown how poultry destined for food production are 
contaminated by C. jejuni. Vertical transmission to chicken eggs can occur in a primary 
fashion though the reproductive tract of the hen, by the negative pressure produced by 
egg cooling and contracting which draws the bacteria in though the eggshell, or 
alternatively through environmental contamination of chicks and adults by fecal shedding 
(Sahin et al., 2003), although this idea is controversial. Campylobacter is unlikely to 
penetrate the eggshell or remain viable within the open environment; a previous study 
done at a group of broiler farms has shown that Campylobacter cannot be isolated from 
eggs or chicks less than 2 days old, even though most hens were shedding the bacteria 
(Sahin et al., 2003). There has been little evidence to support the suggestion that there is 
linear transmission from hen to chick of Campylobacter, a possible hypothesis 
considering the almost ubiquitous colonization of Campylobacter bacteria in chickens 
(Callicott et al., 2006). 
Campylobacter colonizes the gut of avian species, and likely contaminates the 
skin of birds during slaughter and processing. In chickens, the cecum can be colonized by 
up to 1010 organisms per gram of cecal content without causing symptoms of disease, and 
is found on as many as 90% of raw chicken carcasses (Evans, 1997; Wassenaar, 
Geilhausen, & Newell, 1998). Colonization is not limited to the gut, and contamination of 
other organs such as the liver may occur by migration of the bacteria from the intestine 
through tubules such as the bile duct or into intestinal tissues through breaks in epithelial 
layers of the intestine (Whyte, Hudson, & Graham, 2006). Risk of Campylobacter 
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infection in chickens increases with age of the chicken before slaughter (Arsenault et al., 
2007; Barrios et al., 2006); these infections may occur independent of Campylobacter 
contamination acquired at the slaughter house. During transport to slaughter, shipping 
crates used to house the birds are not always thoroughly cleaned, leaving fecal 
contamination or debris from the feet and feathers (Hansson, Ederoth, Andersson, 
Vagsholm, & Olsson Engvall, 2005). A majority of crates (57%) that are washed and 
santized continue to test positive for the presence of thermophilic Campylobacter. This 
persistence may result in transmission of the bacteria to humans by consumption of 
contaminated meat when poor slaughter-house conditions and/or handling of the chicken 
meat has taken place.   
As well as being prevalent in chickens, Campylobacter can be isolated from a 
large portion of turkey carcasses prior to slaughter (Logue et al., 2003). In addition, C. 
jejuni has been isolated from migratory birds such as geese (Aydin et al., 2001). Mean 
prevalence of Campylobacter in migratory birds tested in Sweden was 21.6%, with the 
prevalence varying from 0% to 100% depending on the species examined (Waldenstrom 
et al., 2002).  Raptors, opportunistic feeders and ground-foraging birds were found more 
likely to be contaminated with Campylobacter (Waldenstrom et al., 2002).  
 
1.1.5.2 Campylobacter and swine  
Transmission of Campylobacter from pig to human is thought to occur mostly by 
contaminated pork products and has been associated with the consumption of products 
that may have been contaminated at slaughter. Two sources of contamination appear 
likely as a majority of bacteria are found on the skin surface and within the GI tract. 
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Additionally, animal organs may also contain Campylobacters including liver 
(Alexandrina & Botus, 2008). It is unclear if these organs are infected during the life time 
of the animal, or contamination from the skin surface or GI tract during slaughter as 
many Campylobacter species are isolated from fecal material. 
It is believed that C. coli is a commensal bacteria in the intestinal tract of pigs that 
can be pathogenic to humans (Alter et al., 2005). Although piglets are not born colonized 
with Campylobacter, acquisition is rapid. The majority of piglets are colonized with 
Campylobacter within hours after birth. The primary source of contamination is thought 
to be maternal in origin where transmission of Campylobacter is from mother to piglet 
(Alter et al., 2005). The majority of farm raised pigs test positive for C. coli in any age 
group. For piglets, a dramatic increase in number and strain diversity is found in herds 
both before and after transportation to a nursery. Because these piglets are no longer 
colonized with the maternal strain alternative sources of contamination must exist (Alter 
et al., 2005). This increase in acquired strain diversity may be related to age, as it has 
been suggested that after 3 weeks of age, new infections can increase by 50% per 
sampling period up until approximately 12 weeks of age (Alter et al., 2005). Typically, 
by the age of fattening, the Campylobacter genotype pool present in pigs has stabilized, 
and tends to remain constant until slaughter (Alter et al., 2005).   
Another study reported that 100% of organic piglets between 8 and 13 weeks of 
age excreted Campylobacter (Jensen, Dalsgarrd, Baggesen, & Nielson, 2006). However, 
there were temporal differences in the percentage of pigs that were C. jejuni positive; i.e., 
contamination rates ranged from 0%-78.6% in samples taken from April to September 
(Jensen et al., 2006). A high incidence in the number of contaminated young organic pigs 
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also was observed compared with conventionally raised pigs (Alter et al., 2005). C. jejuni 
also persisted longer in the organic pigs. This may have been due to greater 
environmental exposure and the challenge of maintaining hygienic practices within an 
outdoor paddock. As well as the potential of spread between pigs, additional 
contamination can result from environmental sources, which may introduce new strains 
into swine herds (Jensen et al., 2006).  
 Different porcine strains of Campylobacter have been shown to undergo genetic 
recombination. These recombinants were able to infect other species such as chickens 
(Ziprin, Hume, Young, & Harvey, 2002). Thus a pig-to-chicken species transfer 
represents a potential route for inter-species transfer of the bacteria. Such low host 
specificity would allow for potential contamination and spread of Campylobacter through 
environmental contact. 
 
1.1.5.3 Prevalence in cattle 
The possibility that cattle represent a significant reservoir for Campylobacter has 
been raised by work showing that adult cattle showed a consistent presence of 
Campylobacter; i.e.,  89.6% of the samples contained Campylobacter, and 66.1% shed 
the bacteria over all sampling times (Inglis et al., 2004). Excretion of Campylobacter has 
also been shown to increase in cattle after transport, and when the animal may be stress, 
such as before slaughter (Humphrey, O'Brien, & Madsen, 2007). Albeit some studies 
show the majority of cattle shed C. lanienae, C. jejuni has been attributed to 
contamination of milk (Levesque et al., 2008; Robinson, 1981). This requires the 
application of meat control later in the food processing system, including improved 
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hygiene during milking and slaughter, and the pasteurization of milk (Humphrey et al., 
2007).  Although associated with Campylobacter, cattle has largely been ignored as 
carrying potential human pathogens and little is known about the consequences of contact 
with these strains, although many have been isolated from healthy abattoir workers in 
Switzerland (Inglis et al., 2004). High prevalence of Campylobacter shedding in cattle 
and cattle-associated strains found in humans suggests that Campylobacter also may be 
spread from cattle to humans, and may be able to cause disease. 
 
1.1.5.4 Prevalence in other animals 
Campylobacter has been isolated from a large number of sheep (49.5%) that did 
not display clinical symptoms of a disease; isolation rates for Campylobacter were 
highest within the intestine suggesting that sheep may cause significant contamination to 
the environment, and are potential sources for introduction of the bacteria into the human 
food chain (Açik & Çetinkaya, 2006). Lambs can be colonized by the bacteria; this 
occurs most often where continuous breeding is being used, which allows fecal-oral 
spread of the bacteria to the young of various ages after accumulation of pathogens in the 
breeding/lambing pen (Andrés et al., 2007). This type of evidence suggests that 
Campylobacter strains that are able to colonize ovines could be more widely distributed 
in the environment than previously thought (Diker, Esendal, & Akan, 2000).  
Campylobacter has been found in farm and large game animals (Gill, 2007; 
Humphrey & Jorgensen, 2006). In addition, Campylobacter is often isolated from flies 
and household pets including cats and dogs (Chai et al., 2007; Evans et al., 2003; Gannon 
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et al., 2004; Humphrey et al., 2007; Johnson et al., 2003; Koene, Houwers, Dijikstra, 
Duim, & Wagenaar, 2008).  
C. jejuni has been isolated from a large number of zoological sources including 
primates, felids, red panda, hoofed animals, birds and reptile suggesting the ubiquitous 
nature of Campylobacter (Misawa et al., 2000). Transmission is suggested to occur by 
host-to-host, and fecal-to-oral contact or by ingestion of contaminated of water (Misawa 
et al., 2000). Many aspects of the epidemiology are not well understood and bacterial 
source tracking, identification of bacterial reservoirs, and identification of potential routes 
for human infection with C. jejuni and other Campylobacter spp. will require a 
significant effort to produce a complete picture of the molecular epidemiology of 
Campylobacter. 
 
1.2 Molecular Genetics, Typing Methods, and Campylobacter 
 
1.2.1 Introduction to molecular sub-typing  
Sub-species typing methods play an important role in the classification of strains, 
surveillance to identify trends in pathogen transmission which may incite disease, 
outbreak detection, and monitoring of prevention/control efforts. Campylobacter is no 
exception and significant efforts have been targeted at the development of sub-typing 
methods for use in molecular epidemiology.  
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1.2.2 Phenotypic sub-typing methods 
Although most Campylobacter isolation protocols require biochemical screening 
to confirm Campylobacter spp., species subtyping methods based on phenotypic traits are 
few. Among the more prominent and accepted phenotypic typing methods are the 
serotyping methods based on the Penner scheme of heat-stable antigens, and the Lior 
scheme of heat-labile antigens. The Penner serogrouping scheme recognizes 65 
serogroups, originally believed to be heat-stable lipopolysaccharide O antigens (Penner & 
Hennessy, 1980), but which have subsequently been found to be capsular polysaccharide 
antigens (Karlyshev, Linton, Gregson, Lastovica, & Wren, 2000). The Lior serotyping 
scheme is based on heat-labile surface and flagellar protein antigens (Lior, Woodward, 
Edgar, Laroche, & Gill, 1982) which rarely produce the cross-reactivity seen with the 
Penner sero-grouping scheme, thus reducing the difficulty of interpretation (Patton, M., 
Barrett, & Morris, 1985). Both of these methods have been used to track epidemiological 
trends and study species diversity (Skirrow, 1997; Woodward & Rodgers, 2002), and 
have provided an effective and practical early approach to the identification of pathogenic 
strains (Patton et al., 1991) before the development of DNA-based  typing methods. For 
additional typing resolution, both schemes can be combined (Patton et al., 1985), and 
when used together, have been successful in establishing epidemiological links after 
outbreaks have occurred (Patton et al., 1991; Woodward & Rodgers, 2002). 
 
1.2.3 Molecular-based Methods of subtyping strains beyond the Genus-Species level and 
application to Campylobacter jejuni 
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1.2.3.1 An introduction to molecular methods for subtyping Campylobacter 
Typing of Campylobacter is a dynamic field with older methods continually being 
advanced and new methodologies constantly being developed. These methods vary in 
through-put, cost, resolution, and ease of use/analysis. The optimal method depends on 
the purpose of the study; i.e., whether or not a test is being used for diagnostic 
confirmation, short-term epidemiological study, long- term epidemiological study, or 
determination of genotype/phenotype relationships. 
The general trend in the bacterial typing community has been to move away from 
phenotypic approaches towards DNA-based genotypic subtyping methods. Some 
problems associated with phenotypic typing methods include cost, large numbers of 
untypeable strains and instability of phenotypic markers under certain environmental and 
culture conditions (Farber, 1996). DNA-based typing methods are preferred as all 
bacterial isolates should give consistent results regardless of culture conditions (Farber, 
1996).  
In general, molecular typing methods require a combination of two elements: 
genetic loci that bear regions of high conservation within a specific group and that can be 
targeted in all isolates (i.e., several methods require a PCR amplification step, and this 
ensures that the genetic marker(s) can be amplified in all isolates) and loci that also 
encompass highly variable regions that will form the basis for differentiation among 
isolates. Methods of genotypic subtyping for Campylobacter include, but are not limited 
to, pulsed-field gel electrophoresis, ribotyping, random amplified polymorphic DNA 
analysis, flaA short variable region sequencing or restriction fragment length 
polymorphism, and multi-locus sequence typing (described in the sections below).  
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1.2.3.1.1 Pulsed-field gel electrophoresis 
Pulsed-field gel electrophoresis (PFGE)  is based on analysis of macro-restriction 
profiles obtained by digestion of genomic DNA with a rare-cutting endonuclease to 
produce distinct banding patterns of large fragments on gels that are resolved using a 
specialized electrophoresis unit capable of generating electrical fields that alternate in 
direction (Finney, 1993).  
PFGE has been used successfully in the identification of outbreaks associated 
with many bacterial pathogens (Fitzgerald et al., 2001; Olsen et al., 2001).  This method 
was used to discriminate between bacterial isolates obtained from a school outbreak of 
campylobacteriosis and those from sporadic community cases that occurred during the 
same time period. In combination with available epidemiological data, PFGE was able to 
provide the genetic evidence needed to confirm that strains of the pathogen isolated from 
the outbreak were related (Olsen et al., 2001). PFGE was also determined to be critical to 
understanding an outbreak that occurred in Kansas; it was shown to provide adequate 
discrimination between unrelated isolates of Campylobacter, greater than that of 
serotyping and flaA-SVR typing (Fitzgerald et al., 2001). However, differences in 
insertion sites of bacteriophages by acquisition, and loss or transposition can result in 
PFGE profiles which  obscure the true relationship among strains (Barton, Ng, Tyler, & 
Clark, 2007).  
One of the major challenges of PFGE has been the standardization of analytical 
protocols to enable inter-laboratory comparisons. Analysis of banding patterns typically 
requires the use of specialized software capable of comparing the macro-restriction 
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fingerprints. Online comparison between laboratories has been made possible with the 
development of the PulseNet system (Swaminathan, Barrett, Hunter, & Tauxe, 2001). 
This is one of the few database systems that provides both epidemiological data and 
typing data over widespread geographical regions (Maiden, 2006). Methods and 
protocols have been standardized, and the network has been successful at detecting 
disease outbreaks, particularly using PFGE (Swaminathan et al., 2001). However, this 
network has only been shown to be effective in bacterial populations where the PFGE 
patterns are relatively stable (Maiden, 2006), which appears to have been a problem in 
the case of C. jejuni (Barton et al., 2007; Clark et al., 2007) 
   
1.2.3.1.2 Ribotyping 
 The ribosomal genes for 5S, 16S and 23S rRNAs are located in several locations 
in the C. jejuni genome. These genes are highly conserved, but there can be significant 
variation in the surrounding regions. They thus represent suitable targets for use in 
subtyping.  
The traditional method of ribotyping begins with enzymatic digestion of genomic 
DNA with PstI, HaeIII, HindIII and PvuI in a single, double or triple digest followed by 
Southern blot hybridization with a probe specific derived from RNA genes (Cox, Stern, 
Hiett, & Berrang, 2002; Fayos, Owen, Desai, & Hernandez, 1992; Fitzgerald, Owen, & 
Stanley, 1996; Gibson, Fitzgerald, & Owen, 1995; Manfreda, De Cesare, Bondioli, & 
Franchini, 2003; Waldenstrom, On, Ottvall, Hasselquist, & Olsen, 2007; Ziprin, 
Sheffield, Hume, Drinnon, & Harvey, 2003). Digested DNA is run on an agarose gel, 
then hybridized to the rDNA probes by Southern blot hybridization followed by 
 25 
comparison of banding fragments. This method is effective for determining the species of 
Campylobacter (Denes, Lutze-Wallace, Cormier, & Manzano, 1995), but tends to lack 
the resolution needed to define specific subtypes of the organism (Kiehlbauch, Plikaytis, 
Swaminathan, Cameron, & Wachsmuth, 1991). The lack of consistency within a 
laboratory and difficulty in reproducing methods between laboratories, and conflicting 
evidence of distinguishing C. coli from C. jejuni suggests that this method is unsuitable 
for discrimination and subtyping of C. jejuni.  Automated systems have been designed for 
ribotyping but they are costly and of low throughput, factors which further limit the use 
of this typing method (Wassenaar & Newell, 2000). 
 
1.2.3.1.3 Random amplified polymorphic DNA 
Random amplified polymorphic DNA (RAPD) is based on PCR amplification of 
genomic DNA under low stringency conditions (i.e., low annealing temperatures) using 
arbitrarily assigned 10-mer primers. Strain RAPD banding patterns are then compared 
after gel electrophoresis (Açik & Çetinkaya, 2006; Ertas, Cetinkaya, Muz, & Ongor, 
2004; Fujimoto, Allos, Misawa, Patton, & Blaser, 1997; Ono, Kurazono, Niwa, & Itoh, 
2003; Payne, Lee, Dreesen, & Barnhart, 1999).  
The primers usually allow for some level of mismatch between primer and target, 
reducing the need to target identical, highly conserved DNA sequences. It is this 
allowance for mismatch that sometimes results in a combination of weak and faint bands, 
a common complication of the technique, which can lead to difficulties in reproducing 
results from run to run and between laboratories (Wassenaar & Newell, 2000). RAPD is 
less discriminatory than PFGE and  ribotyping (Eriksson et al., 2005) and  a high 
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percentage of strains must be categorized as untypeable.  These disadvantages negate the 
low cost, simplicity, and throughput of the method.  
A similar genotyping method is amplified fragment length polymorphism (AFLP) 
which is based on the selective amplification of small restriction fragments (50 to 500 bp) 
of chromosomal DNA to represent the entire genome (Duim, Wassenaar, Rigter, 
&Wagenaar, 1999). AFLP has been successfully applied to the differentiation of 
Campylobacter (Duim, Wassenaar, Rigter, &Wagenaar, 1999; Duim et al., 2001). 
Although this method is highly discriminatory, additional genotyping methods are 
required for optimal typing of Campylobacter jejuni (Boer et al., 2000) requiring 
additional expertise and expense for effective genotyping. 
 
1.2.3.1.4 Analysis of the flaA allele (also known as fla typing) 
C. jejuni contains two flagellin genes, flaA and flaB. The genes consist of both 
conserved and variable sequence regions. These genes are also found in other pathogens 
and may be valuable for typing of closely related pathogens (Wassenaar & Newell, 
2000). Generally the first of the two genes, flaA, has been targeted for C. jejuni fla 
typing.  
There are several competing protocols used in fla typing, which differ by DNA 
preparation method, primer design and PCR target location, PCR temperatures and time, 
restriction enzymes used, and the nomenclature used to describe the typing results 
(Wassenaar & Newell, 2000).  As of 2000, seven different fla typing procedures were 
available, however, the basis of procedure remains the same; i.e., extracted DNA is 
amplified by primers within (or flanking) the flaA allele, so that the PCR amplicon  
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(typically 0.7kb to 1.7kb) can be purified and digested with restriction enzymes, followed 
by gel electrophoresis. Differences in flaA alleles between strains result in restriction 
fragment length polymorphisms (RFLP) and, when fragments are visualized using gel 
electrophoresis, RFLP profiles can be compared and used to assess their similarity. 
Restriction enzymes that have been used in the literature include AluI, DdeI, HinfI, EcoRI 
and PstI (Duim, Wassenaar, Rigter, & Wagenaar, 1999; Wassenaar & Newell, 2000). 
A more detailed analysis of the flaA gene, flaA-short variable region (SVR) 
typing, can be obtained by sequence comparison of the flaA SVR, a segment of 321 bp 
corresponding to positions 283 to 603 of the flaA gene that is highly polymorphic (Dingle 
et al., 2001). The flaA gene is amplified by PCR, purified and sequenced. The sequences 
of the alleles from different strains can be compared and used to measure the relatedness 
of genes (and by extension strains) using standard phylogenetic analysis. However, fla 
typing relies on a single locus and is ideally suited for clonal bacteria, but may be 
problematic when applied to non-clonal or weakly clonal species such as C. jejuni  
(Terletski, Brenner, & Schwarz, 2004) since the flaA allele may not necessarily be related 
to gene content at other areas of the genome. Over-reliance on this locus for the 
comparative analysis of strains can result in a skewed picture of the “true”, whole 
genome, genetic relationship between strains.    
 
1.2.3.1.5 Multi-Locus Sequence Typing 
 Multi-Locus Sequence Typing (MLST) is the leading molecular typing method 
for Campylobacter at this time. MLST was proposed in 1998 as a universal and definitive 
method for characterizing bacterial populations (Dingle et al., 2001; Maiden, 2006) and 
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has been used as an established technique for characterization of C. jejuni for several 
years (Dingle et al., 2001).  
The typing scheme is based on PCR amplification of a 350-600 bp region of 
seven highly conserved house keeping genes (aspA, glnA, gltA, gylA, pgm, tkt and 
uncA), the sequencing of the fragments, followed by comparison of their nucleotide 
sequences using standard phylogenetic analysis (Maiden, 2006). A database of published 
MLST sequence types is available at http://pubmlst.org/campylobacter/ .  As typing data 
are nucleotide based, MLST can be easily compared between laboratories regardless of 
the methods used to generate the allelic sequence. Also, because MLST data can be 
exchanged freely over the internet, this allows for widespread comparison of MLST 
sequence types and can be used for population studies and evolutionary biology (Maiden, 
2006). 
 Outbreaks have been identified or confirmed using MLST, thus proving that it has 
practical use in some epidemiological applications (Sails, Swaminathan, & Fields, 2003). 
Some alleles have been identified that appear to be species-specific (Wagenaar et al., 
2006) which suggests that an application for source tracking may also be possible. MLST 
has been shown to be better correlated with epidemiological information than flaA-SVR 
(Clark et al., 2005) and its resolution is high allowing subtypes of C. jejuni to be 
differentiated (Parker, Miller, Horn, & Lastovica, 2007).  
Although more loci are evaluated than with other typing methods, recent work has 
shown that the seven loci used may not be sufficient to provide an accurate picture of  
gene content in all areas of the C. jejuni genome (Taboada et al., 2008). Additionally, 
MLST is unable to distinguish closely related strains in short-term outbreak 
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investigations and additional methods, such as fla typing, may be required in order to 
obtain sufficient resolution (Sails et al., 2003) increasing the cost and time to acquire 
results adequate for detailed molecular epidemiological analysis. 
 
1.2.3.2 Current challenges in subtyping of Campylobacter 
The general consensus is that phenotypic methods of subtyping Campylobacter  
lack adequate discrimination and reproducibility (Steele et al., 1998). Serotyping and 
biotyping only target specific and potentially transient phenotypic properties of an isolate. 
This is important for clinical purposes when a diagnosis is required for immediate 
treatment, but does not address the underlying genetic composition. Additionally, these 
methods require maintenance of a panel of costly antisera, and may give ambiguous 
results due to non-typable strains and cross-reactivity between antigens (Fitzgerald et al., 
2001). These challenges have led to a shift towards molecular and genotypic subtyping 
methods. 
Although band-based genotyping methods  (i.e., methods that rely on the 
comparison of electrophoretic fingerprints) such as PFGE, RFLP, RAPDs have proved to 
be useful in some contexts, analysis of fingerprint banding patterns are limited in their 
application to population studies and evolutionary studies as one of the prime analysis 
assumptions is that the multiple bands are unrelated (i.e., bands between different 
fingerprints that do not align within reason are not the same) which may not account for 
genetic rearrangement such as SNPs, or insertion/deletion events (Maiden, 2006). 
Additionally such methods can be difficult to reproduce accurately for each sample, such 
that large-scale application and inter-laboratory data comparisons require specialized and 
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expensive software for band analysis and fingerprint comparison (Maiden, 2006). MLST 
can remedy problems associated with reproducibility, data portability (Levesque et al., 
2008) but remains expensive and slow, even with the increasing speed and reduced cost 
of nucleotide sequencing (Maiden, 2006). Although MLST alone can generate relevant 
data for deciphering epidemiological relationships among isolates, it usually requires a 
secondary method, such as flaA-SVR, for optimal discrimination (Clark et al., 2005), 
adding to the cost and reducing throughput of the method. 
Among the major challenges with current genotyping methods for C. jejuni is that 
they do not adequately account for processes that result in genome plasticity. 
Campylobacter is naturally competent and can acquire genetic material “laterally” 
through uptake of DNA from the environment (Wang & Taylor, 1990). This process can 
contribute clinically relevant genetic material such as virulence genes or antimicrobial 
resistance genes to strains. Chromosomal rearrangements are also common in 
Campylobacter, which has limited the usefulness of PFGE as a typing method (Sails et 
al., 2003).  Most molecular typing methods are designed for use with clonal bacteria, 
however, their use with  non-clonal or weakly clonal species such as C. jejuni  is 
problematic  (Terletski et al., 2004). This genomic plasticity causes problems for 
methods that rely on the evaluation of one or a few loci, for example MLST and flaA 
typing, since whole-genome comparative genomic analysis has revealed that information 
on a small number of genetic loci does not necessarily allow for inferences to be made on 
the gene content at other areas of the genome (Taboada et al., 2008). For example, strains 
that are similar at specific typing loci may still harbor significant genomic differences 
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that could account for differences in pathogenicity. Conversely, strains that differ at the 
typing loci may have a similar complement of virulence factors.  
 
1.2.4 Development of next-generation molecular typing methods 
 
1.2.4.1 Evolution of bacterial genomes 
 A significant portion of genetic change in prokaryotes occurs via horizontal gene 
transfer (HGT). HGT, which may also be referred to as lateral gene transfer, leads to 
genetic exchange between members of the same species or between different bacterial 
species through DNA uptake and subsequent incorporation of the genetic material by a 
method such as homologous recombination (Hacker & Carniel, 2001). When HGT 
involves DNA encoding an entire operon, novel functions and metabolic abilities can be 
acquired in a single event (Lawrence, 1999). Such events can lead to an increase in 
metabolic diversity of recipient bacteria, or confer the ability to explore a greater variety 
of ecological niches (Marri, Hao, & Golding, 2007). Perhaps the most interesting aspect 
of HGT, at least from a clinical and epidemiological point of view, is the acquisition of 
virulence factors or antibiotic resistance genes as in the step-wise acquisition of virulence 
factors such as gene encoding shiga toxins in Escherichia coli (Boerlin, 1999).   
When HGT is combined with frequent point mutations, high recombination rates, 
high rearrangement rates, and gene silencing or gene loss, the speed at which bacterial 
genomes become diversified is rapidly increased. Because of this high rate of genome 
evolution, new challenges are presented in the analysis and interpretation of molecular 
typing and phylogenetic data due to the rapid erosion of genetic similarities or rapid 
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increase of differences between clonally related strains, reducing the extent to which such 
relationships can be firmly established with current technologies.  In particular, because 
of HGT, not all genes in an organism’s genome will share the same evolutionary history, 
which presents a challenge in phylogenetic analysis (Olsen & Woese, 1997). 
 
1.2.4.2 Genomics of C. jejuni 
 The first C. jejuni strain had its genome sequence published in 2000. C. jejuni 
NCTC 11168, a human clinical isolate, has a circular genome of 1,641,481 bp that is 
predicted to encode 1,654 proteins and 54 stable RNA species (Parkhill et al., 2000). In 
contrast to most other bacteria, there appear to be no phage-associated sequences, and 
few insertion sequences or repeat sequences (Parkhill et al., 2000).  
The genomes of three additional C. jejuni strains have been completely sequenced 
since the publication of the NCTC 11168 genome sequence; i.e., RM1221, CG8468 and 
81-176 (Fouts et al., 2005; Hofreuter et al., 2006; Poly et al., 2007). Strain RM1221, a 
strain isolated from a chicken carcass, has a slightly larger gene content than NCTC 
11168 (1,884 ORFs vs. 1,634 ORFs) and both strains have similar genome organization, 
although the RM1221 genome is interrupted by inserted prophage/genomic islands (Fouts 
et al., 2005). Strains CG8486 (Poly et al., 2007) and 81-176 (Hofreuter et al., 2006) were 
isolated from diarrheal patients and their genome sequences reveal that they are similar in 
size to NCTC 11168. The genomes have a similar organization to the other two genomes, 
with the bulk of genomic variability residing within hypervariable carbohydrate 
biosynthetic loci and a limited number of variable genes mapping outside these.  To date, 
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an additional eight strains have whole-genome shotgun sequencing data available at 
NCBI, with more expected to come in the very near future.  
 
1.2.5 Comparative genomics of C. jejuni 
Comparative genomics, the analysis of and comparison of two or more genomes, 
has not only served to uncover the large amount of within-species genomic diversity and 
the rapid pace of evolution of bacterial genomes, but it has also served to underscore 
some of the new challenges in bacterial genotyping and phylogenetic analysis.  
C. jejuni has approximately 1300 core genes, house-keeping genes that encode 
functions required for survival, as determined by comparative genomic sequencing (Fouts 
et al., 2005) and by microarray-based comparative genomic hybridization analysis 
(Dorrell et al., 2001; Pearson et al., 2003; Taboada et al., 2004). This accounts for about 
60-70% of the entire C. jejuni genome with the remaining genes forming part of an 
“accessory” pool of genes that are variably present or absent in different strains. As a 
result, genome content varies between strains of C. jejuni, with a select number of genetic 
regions in the C. jejuni genome being highly plastic (Pearson et al., 2003; Taboada et al., 
2004), leading to the suggestion that recombinogenic processes such as HGT play a 
dominant role in C. jejuni genome evolution.  
 
1.2.6 Comparative genomics in understanding pathogenicity  
It has been suggested that genomic differences exist between pathogenic and non-
pathogenic Campylobacter spp. (Humphrey et al., 2007). Comparative genomics can 
yield practical data for assessing genetic differences among strains that could account for 
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differences in their pathogenicity. For example, a large number of strains can be collected 
that are isolated from clinical samples (i.e., pathogenic strains) and compared at the 
whole genome level to strains isolated from food or environmental  sources to identify 
genes associated with pathogenic strains and which may help contribute to that 
organism’s ability to cause human illness.  
Comparative genomic sequencing of the clinical isolate 81-176 (Bacon et al., 
2000) has revealed some genomic elements that may contribute to virulence. Most strains 
of C. jejuni carry an ~35 kb plasmid, pVir, which is believed to contribute to virulence 
(Fouts et al., 2005). Some of the genes encoded by this plasmid appear to be similar to 
those of the cag pathway, which is located within a pathogenicity island found in 
Helicobacter pylori. Genes from the cag pathway are involved in type IV secretion, and 
are associated with virulence in H. pylori (Bacon et al., 2000). Although the exact 
mechanism is not known, the pVir plasmid has been shown to be associated with bloody 
stools and diarrhea (Tracz et al., 2005). As bloody stools serve as an indicator of severe 
invasive infection, it may suggest that the presence of pVir could be used as a predictor 
for virulence (Tracz et al., 2005). Similar in size to pVir, pTet carries tetO which encodes 
resistance to tetracycline (Bacon et al., 2000) and the plasmid may also play a role in 
pathogenicity.  In pVir, mutation of the comB3 operon encoded on this plasmid 
dramatically impairs the natural transformation ability of C. jejuni 81-176 suggesting that 
the encoded proteins enhance natural transformation, and promote DNA binding, perhaps 
through surface changes (Bacon et al., 2000).  This may be advantageous for pathogenic 
strains as they could acquire genes specific to host environmental conditions.  
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Analysis of strains 81-176 (Hofreuter et al., 2006) and CG8486 (Poly et al., 
2007), which induce inflammatory diarrhea in humans and have been shown to be 
virulent in tissue culture and in the ferret model, has been used to examine additional 
genomic features that may contribute to C. jejuni virulence. Both strains have a highly 
similar gene content and share genes that are absent from other sequenced C. jejuni 
strains. This suggests that the genes required for inflammatory diarrhea are shared by 
these strains. Subtle differences between the two strains in their ability to invade 
epithelial cells in vitro are likely to be due to changes in carbohydrate loci and/or more 
subtle changes in other genes, which may modulate virulence (Poly et al., 2007). 
Taboada et al. (2008) have recently shown that highly clonal bacterial isolates 
that would be indistinguishable by MLST nevertheless harbour significant genomic 
differences between them. This suggests that while the analysis of a small number of 
genetic loci could prove useful for establishing strain to strain relationships, MLST may 
fail to elucidate potential genetic differences between strains that could be of clinical 
importance. Analysis of strains by comparative genomics goes beyond current methods 
of strain comparison and also attempts to account for HGT in bacteria. Comparative 
genomic sequencing and microarray-based comparative genomic hybridization have been 
used in the analysis of diverse pathogenic and non-pathogenic strains. This has led to 
identification of putative virulence-associated markers that can be used in the analysis of 
additional strains in order to confirm such associations (Bolton, Hutchinson & Parker, 
1987; Fayos, Owen, Desai & Hernandez, 1992; Johnson et al., 2003; Olsen et al., 2001). 
Despite the usefulness of the comparative genomics approach and recent advances in 
high-throughput genomic sequencing, comparative genomic analysis remains slow, costly 
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and labour intensive. As a result, comparative genomic approaches have not found a use 
in routine bacterial typing and molecular epidemiology. 
 
1.2.7 Comparative genomic fingerprinting 
Comparative genomic fingerprinting (CGF) is a novel method of comparative 
genomics-based bacterial characterization developed by our research group.  It has been 
used in this study in an attempt to circumvent the main problems associated with genome 
sequencing and microarray-based comparative genomics; i.e., cost, ease and throughput.  
Microarray studies have demonstrated extensive genomic variability among C. 
jejuni strains and have led to the identification of a pool of accessory genes that are 
present in some but not all strains (Taboada et al., 2004; Taboada et al., 2008). CGF is 
based on the concept that differential carriage of these accessory genes can be used to 
generate unique genomic fingerprints for genotyping purposes. A CGF assay for the 
analysis of E. coli has recently been developed by our research group and shows great 
promise as a high-throughput comparative genomics-based method for genotyping that 
yields epidemiologically relevant information (Laing et al., 2008). As part of this thesis, 
we have developed a method of Comparative Genomic Fingerprinting (CGF) for C. 
jejuni, a rapid genotyping method that assesses the conservation status of a small number 
of genes previously described as having high intraspecies variability based on 
comparative genomics studies. 
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1.3 Overview of the thesis 
Campylobacteriosis is a common occurrence in the United States and Canada. In 
the US and Canada, incidence rates range between 13 and 20 cases per 100,000 
individuals (http://www.cdc.gov/nczved/dfbmd/disease_listing/campylobacter_gi.html, 
http://www.wrongdiagnosis.com/c/campylobacter_food_poisoning/prevalence.htm ) and 
affects millions of people each year. Southern Alberta represents a local ‘hot spot’ as 
incidence rates range between 30 and 45 cases per 100,000 (Population Health, 2007) 
with the highest rates in the Chinook Regional Health Authority, an area to the south of 
Calgary and bordering with Montana (Alberta Health and Wellness, 2005).   
As part of this thesis, 590 C. jejuni isolates were obtained from over 2000 
environmental, animal and human clinical samples collected in the region of southern 
Alberta during a 3-year study (2004-2006). These isolates were subsequently analyzed 
using CGF in a molecular epidemiological framework aimed at examining: the 
identification of reservoirs that are significant sources of human infection, the 
identification of subtypes that may be associated with higher incidence of human 
infection, and the examination of persistence of prevalent subtypes in 
animal/environmental reservoirs. 
 
1.3.1 Research Objectives 
This research for this thesis was focused on the development of CGF as a novel 
genotyping method, and the development of CGF for application to molecular 
epidemiological studies. Several smaller objectives were addressed to achieve this 
purpose: 
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1. A dataset of C. jejuni isolated from a common geographical region over 
several sampling years was obtained. The acquisition and confirmation of 
641 Campylobacter jejuni isolates obtained from water, animal fecal and 
human clinical samples was done for southern Alberta using methods of 
acquisition discussed in detail in Chapter 2. A list of isolates used for this 
study can be found in Appendix A.  
 
2. Three CGF assays targeting 20, 35, and 119 markers (i.e.,CGF-20, CGF-
35, and CGF-119) were developed and validated. These assays are 
introduced in Chapter 2, and validated in Chapter 3. The “functional 
equivalence” of the CGF-20 to CGF-35 and CGF-119 assays is 
demonstrated with Chapter 3. The results of assigning clusters based on 
the CGF-20 fingerprint is found in Appendix B. 
 
3. A “proof of concept” study using CGF-20 to demonstrate that this 
approach can be used effectively in molecular epidemiological studies. A 
discussion of the CGF-20 genotyping results in combination with 
available epidemiological data is described in Chapter 4.  
 
4. To further provide “proof of concept” of the effectiveness of the CGF-20 
genotyping method, the dataset of 641 C. jejuni isolates was typed using a 
flaA-RFLP genotyping method and the epidemiological relevance of the 
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clusters generated by both methods compared. The flaA-RFLP method is 
described in Chapter 2 with epidemiological evaluation of both methods 
in Chapter 4.  
 
5. Assessment of the use of additional molecular markers and 
advantages/disadvantages of using a high-throughput electrophoresis 
platform was compared to more traditional laboratory methods of data 
collection as described in Chapter 2 and evaluated in Chapter 3.  
 
6. Development of CGF and its practical application to problems in 
molecular epidemiology are discussed in Chapter 5. 
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Chapter 2 
 
2. Materials and Methods 
 
2.1 Isolation of Campylobacter spp. from water 
 Water reservoirs along the Little Bow River, part of the Old Man River Basin, 
were routinely tested for the presence of Campylobacter jejuni, Campylobacter coli, and 
other Campylobacter spp. The Oldman river passes through a portion of southern Alberta 
with a watershed of 22 641 km2 and a population of approximately 200 000 in rural 
farms, villages, and the city of Lethbridge. Additionally, the Oldman water basin contains 
the highest livestock density in southern Alberta (Hyland et al., 2003). Routine testing 
also took place within the Sumas watershed in southern British Columbia, South Nation 
watershed in southern Ontario and the Grand Falls watershed in New Brunswick. The 
Sumas and Grand Falls watersheds are relatively small with 343 km2 and 340 km2 
whereas the South Nation watershed is 3 900 km2. The Sumas watershed is among the 
most intensive areas for poultry farms in Canada, the South Nation watershed is 
intensively an intensively farmed area of cropland and dairy operations, and the Grand 
Falls watershed is used for agriculture, primarily potatoes. These external watersheds 
provide a basis of comparison between water samples from Albertan and foreign water 
samples, and to test the ability of the typing method to cluster geographically related 
samples more closely than unrelated. The majority of water samples were taken weekly 
or bi-weekly. All samples consisted of 500 mL to 1 L of liquid which was collected 
upstream into several 250 mL sterile bottles using a pole system placed 30 cm below the 
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surface of the water.  Samples were stored on ice for transport and shipped within coolers 
via ground transportation. After receipt they were vacuum filtered using a 0.22 µm sterile 
membrane filter. The filter was placed in Bolton’s Broth (Oxoid Inc., Nepean, Ontario) 
and incubated in a microaerobic environment (5% oxygen, 10% carbon dioxide, 85% 
nitrogen) for 24-48 h at 42°C ± 0.5°C. Bacterial cultures were then obtained by plating a 
loop-full of culture onto blood-free modified charcoal cefoperzone deoxycholate agar 
including CCDA selective supplement SR155 containing cefoperazone (32mg/L) and 
amphotericin B (10mg/L) (mCCDA) plates (20.0 mL/plate) and incubated again in a 
microaerobic environment for 24-72 h at 42°C ± 0.5°C. Colonies that grew on these 
plates were considered Campylobacter spp. “suspects”. Campylobacter spp. “suspects” 
were confirmed through biochemical analysis; i.e., if both oxidase and catalase tests 
(Oxoid Inc) were positive, the samples were still considered to be Campylobacter 
suspects. These biochemically confirmed Campylobacter suspects were transferred to an 
overnight culture in 5 mL of Bolton’s Broth and grown at 42°C ± 0.5°C under 
microaerophilic conditions. After 25 h, 800 µL of Bolton’s Broth was placed in an equal 
volume of 60% glycerol and stored at -80°C. An additional aliquot of Bolton’s Broth was 
taken and used for DNA extraction. Biochemically confirmed Campylobacter colonies 
finally were confirmed as Campylobacter bacterial isolates by PCR (described in Section 
2.5).  
  
2.2 Isolation of Campylobacter spp from animal fecal samples 
 Fecal samples were obtained from farmlands located within the Oldman River 
Basin of southern Alberta with permission of land owners and with the understanding 
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that exact sampling locations would be kept confidential. Fecal samples were obtained in 
sterile containers and stored on ice until arrival in the laboratory. Fecal samples were 
mixed with phosphate buffered saline (PBS) composed of 0.01M Phosphate, 0.027M 
Potassium chloride, and 0.137 Sodium chloride in a ratio of 1 g of fecal material to 10 
mL of PBS. Samples were thoroughly agitated to obtain liquid PBS-fecal slurry. For 
detection of Campylobacter, 1 mL of slurry was added to 9 mL of Bolton’s Broth and 
incubated microaerobically at 42°C ± 0.5°C for 24 hours. After incubation, one loopful of 
Bolton’s Broth was streak-plated on to modified charcoal cefoperazone deoxycholate 
agar including CCDA selective supplement SR155 containing cefoperazone (32mg/L) 
and amphotericin B (10mg/L) (mCCDA) plates and incubated at 42°C ± 0.5°C, 
microaerophilically for 24-72 hours. Following incubation, the presence of colonies 
dictated that samples were Campylobacter spp. “suspect”. Three Campylobacter spp. 
colonies were screened by biochemical analysis using oxidase and catalase tests (Oxoid 
Inc, Nepean, Ontario). Campylobacter “suspects” that were positive for both oxidase and 
catalase production were transferred to 5mL of Bolton’s Broth. Overnight cultures that 
were grown at 42°C ± 0.5°C under microaerophilic conditions were combined with an 
equal volume of 60% glycerol and stored at -80°C. An additional aliquot from each 
culture was taken, and used for DNA extraction. Confirmation of Campylobacter 
colonies was completed using the PCR methods described in section 2.5 
. 
2.3 Isolation of Campylobacter spp. from clinical isolates 
A total of 260 clinical isolates were obtained through collaboration with Clinical 
Laboratory Services (Calgary, Alberta) and the Calgary Health Region. These isolates 
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were obtained from fecal samples of individuals experiencing symptoms of enteritis that 
had been isolated by CLS and confirmed as Campylobacter spp. prior to arrival in 
Lethbridge, Alberta. 
 
2.4 Extraction of Campylobacter DNA 
 Blood particles found in Bolton’s Broth can interfere with PCR reactions. To 
avoid this, 1.8 mL of biochemically confirmed Campylobacter isolates were pelleted 
from solution by centrifugation in 2.0 mL microcentrifuge tubes in a conventional table 
top microcentrifuge at 8000 rpm for 10 min. The supernatant was removed and the pellet 
was resuspended in 200 µL sterile PBS or a “Q2” buffer supplied by the manufacturer 
(Qiagen Inc., Mississauga, Ontario). In cases where the amount of harvested cells was 
visibly less than that typically obtained, an additional 1.5 mL of Bolton’s Broth was 
pelleted in the same centrifuge tube after supernatant removal. Pelleted cells were 
resuspended in 200 µL sterile PBS or Q2 buffer (Qiagen). DNA was extracted manually 
from the resuspended cells using  a DNeasy tissue kit (Qiagen) according to the 
manufacturer’s instructions and eluted in 200 µL of  “elution buffer” or extracted 
mechanically using the Qiagen EZ1 BioRobot system, the EZ1 DNA Tissue Kit, and an 
EZ1 DNA blood card (Qiagen). The program included the optional ethanol wash, and a 
final elution volume of 100-200 µL. DNA was quantified using the programmed double-
stranded DNA quantification settings on a NanoDrop ND-1000 spectrophotometer 
(Thermo Scientific, Wilmington, DE, USA). 
In cases where samples were analyzed by ArrayTubeTM microarrays, large scale 
extraction was performed using a phenol/chloroform method (Taboada et al., 2004). In 
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this case, a bacterial lawn was grown overnight on mCCDA, Mueller Hilton, or blood 
agar dishes using microaerobic conditions. Cells were harvested from one-half to two-
thirds of the plate and resuspended in TE 100:10 (100 mM Tris (pH 8.0), 10 mM EDTA) 
containing 0.5 mg lysozyme and 0.5 µg of RNase A per reaction. After 10 min incubation 
at room temperature, 0.4 mg of Proteinase K were added, and the samples were incubated 
at 37°C for 1 h; 10% SDS was added to a final concentration of 0.1%, and mixed until 
the sample formed a clear lysate. The lysate was transferred to phase lock gel light 2 mL 
tubes (5 Prime Inc., Gaithersburg, MD), with an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1). Mixed samples were centrifuged at 3000 
rpm for 10 min. Samples were repeatedly extracted with phenol until the aqueous phase 
was clear. DNA was precipitated overnight by addition of 1/10 volume of sodium acetate 
(NaOAc, pH=7.0) and 0.6 volumes of isopropanol and collected by spooling. Spooled 
DNA was washed with 500 µL of 70% ethanol, and transferred to absolute ethanol. The 
absolute ethanol wash was decanted immediately and the DNA allowed to air dry. DNA 
was re-suspended in 200 µL of TE 10:1 (10 mM Tris (pH 8.0), 1 mM EDTA). 
 
2.5 Confirmation and species identification of C. jejuni and C. coli 
 The identity of C. jejuni and C. coli isolates was confirmed by PCR targeting 
three genes coding for 16S rDNA, mapA and ceuE (Linton, Lawson, Owen, & Stanley, 
1997). Nucleotide sequence of the primer sets used for gene amplifications are outlined in 
Table 1. Amplification reactions contained 2.0 units of Taq polymerase (Qiagen), with a 
final concentration of 1X Qiagen PCR buffer, 1.5 mM MgCl2, 0.1 µM of each of the 16S 
primers, and 0.2 µM each of the mapA and ceuE primer sets (Table 1). Each reaction  
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Table 1: Primer sequences used to confirm Campylobacter spp.*. Confirmation and 
specification was completed using a multiplex PCR. Isolates determined to be C. jejuni 
were further tested using the flaA-RFLP typing method. 
 
 
PCR Target
Gene / 
Fragment 
Size (bp)
Forward Primer Reverse Primer
Campylobacter  Species 16S rDNA / 857 ATCTAATGGCTTAACCATTAAAC GGACGGTAACTAGTTTAGTATT
Campylobacter jejuni map F / 589 CTATTTTATTTTTGAGTGCTTGTG GCTTTATTTGCCATTTGTTTTATT
Campylobacter coli ceu E /  462 ATTTGAAAATTGCTCCAACTATG TGATTTTATTATTTGTAGCAGCG
fla A Amplicon for RFLP fla A / 1700 GGATTTCGTATTAACACAAATGGTGC CTGTAGTAATCTTAAAACATTTTC
 
* Primers used for confirmation and specification of the Campylobacter isolates were as 
described in (Linton et al., 1997); the flaA protocol was as described in (Harrington, 
Moran, Ridley, Newell, & Madden, 2003). 
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mixture contained 2 µL of template DNA (~5 ng) which was brought up to a final volume 
of 50 µL with distilled deionized water. The amplification reactions were carried out 
using an Applied Biosystems thermocycler (Model 9700, Applied Biosystems, Foster 
City, CA). Amplifications were done using an initial denaturation step of 1 min at 95°C, 
followed by 30 amplification cycles consisting of a denaturation step at 95°C for 30 s, an 
annealing step at 59°C for 90 s and an elongation step at 72°C for 1 min. A final 
elongation step was done for an additional 5 min at 72°C. PCR products were maintained 
at 4°C until required. PCR amplicons were run on 1% agarose gel (Invitrogen Life 
Technologies, Carlsbad, CA) prepared with 1X Tris-borate-EDTA (TBE) buffer and 
containing 1 µg/ml of ethidium bromide. Gels were run at 110 V until 2 cm from the 
bottom edge of the gel, and visualized with ultra-violet (UV) light to confirm the 
presence of amplified DNA fragments 857 bp (Campylobacter genus), 589 bp (C. jejuni 
species) and 462 bp (C. coli species) long. All gels were photographed using a Syngene 
transilluminator and GeneSnap by Syngene software with an internal UV wavelength 
setting for ‘EtBr/UV’ gels (Synoptics Ltd., Cambridge, England). 
 
2.6 Sample Subsets / Strain composition 
 The complete southern Alberta Campylobacter jejuni data set consisted of 260 
(40.6%) clinical isolates, 241 (37.6%) animal fecal isolates, and 91 (14.2%) water 
isolates; the remaining 49 (7.6%) samples consisted of isolates previously evaluated in-
house by the Public Health Agency of Canada (PHAC), Laboratory for Foodborne 
Zoonosis (LFZ) in Guelph, Ontario, using selected typing methods and fulfilled the 
purpose of known reference strains. Data identifying source of the isolates used in this 
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study is presented in Appendix A; clinical cases were separated based on individuals who 
had traveled prior to onset of symptoms and those who had not; animal fecal isolates 
were separated based on the species of animal from which the isolate was obtained; water 
isolates were separated based on the watershed from which the original sample was 
obtained. All isolates were also identified by the month beginning in June 2002 (month 1) 
to August 2006 (month 43) in which a sample was isolated when the information was 
available.  
 Subsets of isolates used for Comparative Genomic Fingerprinting (CGF) each 
consisted of similar proportions of clinical isolates, animal fecal isolates, water isolates, 
and reference strains; i.e., subsets of Campylobacter isolates used to perform CGF with 
20 DNA probes (CGF-20), 35 DNA probes (CGF-35) and 119 DNA probes (CGF-119) 
all were chosen to contain the same % water, % clinical, % environmental, and  % 
reference strains relative to the larger sample set, in order to avoid introducing bias to the 
data but otherwise were selected at random.  
 
2.7 Subtyping of strains using flaA-RFLP: 
All Campylobacter strains were sub-typed using a flaA restriction fragment length 
polymorphism (RFLP) method. The methodology used to type C. jejuni isolates was a 
combination of previously described methods (Ertas et al., 2004; Nachamkin, Bohachick, 
& Patton, 1993) and modifications (Harrington et al., 2003).  PCR amplification of the 
flaA allele was performed on extracted DNA using an Applied Biosystems thermocycler 
(Model 9700). The PCR primers used are described in Table 1. Amplification began with 
an initial denaturation step for 1 min at 94°C followed by 35 amplification cycles each 
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consisting of a denaturation step at 94°C for 15 s, an annealing step at 45°C for 15 s, and 
an elongation step at 72°C for 105 s. The amplified DNA was extended at 72°C for 5 min 
and then maintained at 4°C until needed. Presence of a 1.7 kb band in the amplified 
samples was confirmed by electrophoresis of 2 µL of PCR product in 1% agarose (Ultra-
pure Agarose, electrophoresis grade, Invitrogen Life Technologies) made up in 1X Tris-
Borate-EDTA (TBE) buffer containing 1 µg/mL ethidium bromide. All gels were 
photographed using a Syngene transilluminator equipped with a GeneSnap camera and 
software with an internal UV light source set for use with ‘EtBr/UV’ gels (Synoptics 
Ltd.).  
  A single enzyme digest was used for restriction analysis of purified flaA 
amplicons. Each reaction consisted of 1 unit of Dde-I enzyme (New England Biolabs, 
Ispwich, MA), enzyme buffer to a final concentration of 1X, and 10 µL of the PCR 
product. Samples were digested at 37°C for 2 h and the products analyzed by 
electrophoresis in a 2% agarose gel (Ultra-pure Agarose, electrophoresis grade, 
Invitrogen Life Technologies) containing 1 µg/ml ethidium bromide. All gels were run 
with 10 µL of a 0.1 µg/µL 1 kb plus molecular weight ladder (Promega). Gels were run at 
110 V for 80 min and then visualized and photographed using a Syngene transilluminator 
(Synoptic Ltd Beacon House, Cambridge, England). Cluster analysis of Dde-I flaA 
profiles was performed using BioNumerics v4.2 software (Applied Maths, Austin, TX). 
 
2.8 Subtyping using Comparative Genome Fingerprinting with 20 genes (CGF-20)  
The presence/absence of the 20 genes used to produce a comparative genomic 
fingerprint in the CGF-20 assay was evaluated using four 5-plex PCR sets of primers  
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Figure 3: Development of the CGF-20 Assay. A) Primer sequences were designed in SNP 
free regions based on all available sequences. B) CGF-20 fingerprints were obtained from 
four multiplex PCRs, each targeting five genes. Sizing ladders are shown to the left and 
right of the four multiplex PCRs contains bands at 100bp, 200bp, 300bp, 400bp, 500bp, 
700bp, 1000bp and 1500bp C) Fingerprint clustering was performed using BioNumerics 
software to determine similarity of fingerprints. Similarity can be visualized using 
program generated dendrograms based on the presence and absence of 20 highly variable 
loci (the unique CGF-20 genetic fingerprint) and combined with strain information 
including name, flaA-RFLP type, and available epidemiological data including source 
and date of isolation. Part C can be found on the following page. 
 50 
 
 51 
with each gene discriminated by a signature amplicon, and each 5-plex capable of 
producing a unique five band fingerprint (Figure 3). Primers were designed using all 
available (eight) C. jejuni genome sequences 
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi, accessed March 2007) in order to 
avoid single nucleotide polymorphisms (SNPs). For each target gene, the corresponding 
DNA sequence was retrieved from each genome strain bearing the gene in order to 
construct a multiple sequence alignment using the program ClustalX (downloaded from 
http://bips.ustrasbg.fr/fr/Documentation/ClustalX/).  A consensus sequence was 
generated from each multiple sequence alignment, with SNP sites replaced by an 
unrecognizable place holder, thus, ensuring that the primers would be designed in SNP-
free regions. The altered sequence was used for primer design using Primer3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) with a desired length of 30 
nucleotides and a melting temperature of 60°C (PCR set 1-4, Table 2). These 20 genes 
were able to target 10 out of the 16 identified hyper-variable regions identified in 
Campylobacter spp. (Taboada et al., 2004) (Figure 4) and were estimated to produce a 
fair representation of the genetic diversity associated with the entire genome.  
PCR reactions for each of the 5-plex PCR sets were set up with final 
concentrations of 1X Qiagen buffer, 1.0 mM MgCl2 (Qiagen), 0.2 µM of each dNTP (i.e., 
dATP, dCTP, dGTP and dTTP), 0.5 µM of each primer, and 0.4 µl Taq DNA 
polymerase(Qiagen) per reaction. For the CGF-20, PCR primer sets 1-4 were used to 
generate amplicons (Table 2). Approximately 5 ng of template DNA was added to each 
reaction mixture. Distilled deionized water was added to bring the mixture to a final 
volume of 50 µL. PCR cycles were completed on a GeneAmp PCR Systems 9700  
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Table 2: Primer sequences for PCR sets 1-7 for CGF of Campylobacter jejuni. PCR sets 
1-4 were used for the CGF-20, whereas sets 1-7 were used for the enhanced CGF (CGF-
35) analysis. In order for PCR fragments to be amplified equally, PCR primer 
concentrations for the additional 15 genes used in the CGF-35 were altered as listed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
PCR Set Gene Forward Primer Reverse Primer Fragment Size
Final 
Concentration 
(pmol/uL)
cj0298c CTGTTTCTCGCGGAGCTAAA CAACGACGGGTATTCCTGAT 198 5
cj0728 AGCGATAAGCCTGATGGAGA TCTCTTTCTATGATGATGCCGTA 296 5
cj0570 CCAAACGATCACACCTATGC AAAAGATTTGCCTTGGACATT 405 5
cj0181 AGGAGCGGAATTTACTTCCAT GCTGCATAAGGGCAAGATTT 486 5
cj0483 CAGAATGCGGTGGAAGTGAT GCTCATCACGCACTTCTTCTT 612 5
cj0057 CAATCAAGAAAATTTAAAACCCTTA TTGGAATAGAACGCACTTCAGA 175 5
cj0860 ATAATGGGTTGGGCGAGTCT AAAAGCAAAAATATCAAGCAAGC 282 5
cj1431c GAAGGGATGATGGATTTGGA CACCCCCATTCTTTTTCGTA 307 5
cj0733 TGGCTTAAATTTTGTGTTGAAAAA CATCCATTTTTCATAATCTTTACCC 441 5
cj1427c GCTCCACTTTGTAAAAGAAATCC CTGGTTTCCAACCTGTAGCC 613 5
cj0297c GGCGTTGATATGGTTTTTATCC GCTTTTAGCTAAGCCATCTTCTTC 300 5
cj1727c GGGCTTTTGGAATTCCTGTT CCACGCCATGTTTAAAAGGT 369 5
cj0264c GCCTACACAGAAAATGGCAAA TGTGGCAAAGTTGAGAGTGC 406 5
cj0008 TGAAAGCAAGACAGCTTGGA CCGCTTTATCTGGATCTTGTTC 524 5
cj1585 TTGGAATTTAAGGCCTGTGC TGTGCCGTGTTCAGCTTTTA 630 5
cj1550c AGGCACTGCGTTTGAAAAGT TTTTAGTTGCACCACCAGAATG 188 5
cj1329 GGCTTAGGCTCTCGCTTAAAA GCTCGGTTAAAATGTCTGCAT 307 5
cj0177 TTTATGTTGAGCGCTTGTGC AAAAACCACATTGACAAATTGC 399 5
cj1334 TGCTTGTACATCGCCCTTTA GAAATTTTGGAAAATCAAAAGGT 462 5
cj0566 GTTTCCACAAGCCTTAGAAAAA TCCCCAAATCCTAGTAACTCCA 558 5
cj 0421c ATCCAAATTTTCTTCACTTTCTTGC TTTAGAATCCACCTTGAAAAACACG 100 10
cj 0033 AATTGGGATAAAAGGGGTGAGAAT TGAAGCCAAGTAAAACCAAAAACA 206 20
cj 0486 TGCATTGGTAGCTAATATGGGAAA AAAATAATAAGCACCTTGCGCATC 301 10
cj 0569 CTGATTGGTGTGGATCTAGTGGAG CAGAAAGGAAAACTACCGGATTTG 399 10
cj 0625 AGCGATCATGAATGATGAAAATGT CTATAGGACTTCTTGGCGTACAAGC 498 10
cj 0755 TGAGCTTACTTTAAAAGGCGGTGT GAAATCTGCCTTGGCCACTATAAC 101 10
cj 0763 GGATCTGTAGCTTTTGATGGTGAA CGATATTGGCTGAATCGATAAGAA 205 10
cj 0967 CCGAACAAGGACAAGCCTTAGATA TTTGAGAAAGATCGGTTGTGGTAA 301 10
cj 1141 GCCAAAAGAGCAGGAGCTAAGATA TGAAGCAAAACAAAAGGTATTTCA 413 20
cj 1136 TATCTCGTTTAGCTGGGGTGGTAT TGCCAAATTTTCCAAAGATCATAA 510 20
cj 1134 TACACGCTTGGATGAAATACCCTA TCTTCAACGCATTTATTGTCAAGC 152 10
cj 1552 GCCTGAAAGAACTTGCCATAATTT GAGCTTGAAAGTTGGTTGCATAAA 222 20
cj 1439 TCCCCCAAAATATACATTACTCTCG TGATTATCGATATGGAGCTTTGGA 307 10
cj 1721 AGCCGTAATTTGTTTGTCTTGGAT GCGGGTTATCGTTTTAATGATTTG 415 10
cj 1679 CAAGTTTTAATGGTCTTATGCTTGC TTGGCTTCTTGTAGTGATTGAAAAA 529 10
1
2
3
4
5
6
7
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Figure 4: Location of hyper-variable regions and the CGF targets within the C. jejuni 
genome. Hypervariable regions previously identified by Taboada et al. (2004) are defined 
by boxes while arrowheads indicate ORFs in the genome (the direction of the arrowheads 
indicates gene orientation). Grey arrows represent the CGF targets within the genome and 
are placed in the approximate genome location. 
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thermocycler (Applied Biosystems, Foster City, CA) with an initial denaturation step at 
94°C for 5 min, followed by 34 amplification cycles of denaturation at 94°C for 30 s, 
annealing at 55°C for 30 s and elongation at 72°C for 30 s. A final elongation step at 
72°C was done for 5 min before storing the sample at 4°C for short term storage, or at -
20°C for long term storage. 
PCR amplicons were viewed in 2.5% agarose gels (Ultra-pure Agarose, 
electrophoresis grade, Invitrogen Life Technologies) containing 1 µg/ml ethidium 
bromide. All gels were run with molecular weight markers to quantify band sizes. Gels 
were ran at 100 V until the loading dye reached a distance of 8 cm from the loading well. 
Gels were visualized using UV light (Figure 5) and photographed using Syngene 
transilluminator (Synoptic Ltd Beacon House, Cambridge, England). The presence or 
absence of each gene was scored as a “1” or “0” respectively, which generated unique 
binary fingerprint for each strain. Cluster analysis of gene fingerprints was 
performedusing BioNumerics v4.2 software (Applied Maths, Austin, TX) via the simple 
matching coefficient and UPGMA algorithm.  
 
2.9 Subtyping using Comparative Genome Fingerprinting with 35 genes (CGF-35)  
 A second comparative genomic fingerprint (CGF-35) was performed based on an 
extended fingerprint that includes all of the genes used for the CGF-20 assay plus 15 
additional genes (Table 2). These 15 genes provide additional discriminatory power by 
providing additional coverage of the hypervariable regions (Figure 4), and allow for 235 
or over 34 trillion unique fingerprints to be generated.   
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Figure 5: Visualization of CGF-20 targets using agarose gel electrophoresis. Lane 1 
contains positive control strain NCTC 11168, Lane 2 contains an representative sample 
strain, NZ_0346b obatined from an outbreak in New Zealand and used as a PCR control 
for the southern Alberta isolates, and lane 3 contains a PCR blank. GeneRuler 1kb DNA 
ladder plus (Fermentas, Burlington, ON) is in unmarked lanes. 
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The original four 5-plex PCR sets were completed as previously described above 
for the CGF-20 (Section 2.8). The additional genes were distributed into three additional 
5-plex PCR reaction sets with primers designed in SNP free regions. The reaction setup 
was identical to the PCR setup for the CGF-20 assay. Each of the additional PCR sets 
required optimization of primer concentrations for successful multiplexing (Table 2). 
Each PCR was done using a final concentration of 2.5 mM MgCl2, 0.2 µM of each dNTP, 
and 2.0 units of Taq DNA polymerase (Qiagen) per reaction in a 1X PCR Buffer 
(Qiagen).  
All PCR products for the CGF-35 assay were separated using a QIAxcel system 
(Qiagen) which consists of a QIAxcel capillary electrophoresis device and BioCalculator 
v3.0 (Qiagen) software for analysis. All PCR reactions were run once using the AM320 
method with a 20 second injection time. The 15 bp – 3000 bp alignment marker was used 
as the internal standard marker and band sizes were determined using the QX 100 bp to 3 
kb DNA size marker (Qiagen). The presence or absence of each gene was scored as a “1” 
or “0”, respectively, which generated a unique binary fingerprint for each strain. The 
QIAxcel was able to provide a visualization of bands with a size similar to what would 
been seen if the samples were run on a conventional agarose gel (Figure 6). Cluster 
analysis of gene fingerprints was performed using BioNumerics v4.2 software (Applied 
Maths). Both the 20 gene fingerprint obtained from PCR sets 1-4 and the 35 gene 
fingerprint from PCR sets 1-7 were evaluated using Bionumerics software (Applied 
Maths). 
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Figure 6: Visual representation of the CGF-35 images using the QIAxcel high-throughput 
capillary gel electrophoresis system. All seven multiplex PCRs of five genes are shown 
as images generated using the BioCalculator software (Qiagen, Mississauga, ON). Note 
that for each lane, the software adjusts band sizes using the 15 bp and 3000 bp alignment 
markers, which serve as internal controls. Based on the internal controls, estimated band 
sizes are given to the right of each set of three lanes as determined by the QIAxcel 
software, and lanes are normalized and aligned at 15 bp and 3000 bp. Bands were 
detected at concentrations as low as 0.1 ng/µL using the software, with a resolution as 
high as 3-5bp, allowing for identification of expected bands (shown by the green lines), 
and differentiation from amplification products resulting from non-specific binding. PCR 
Sets 3-7 can be found on the following three pages. 
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2.10 Subtyping using Comparative Genome Fingerprinting with 119 genes (CGF-119)  
A third, high resolution comparative genomic fingerprint (CGF-119) was obtained based 
on conservation of 119 variably absent or present genes in C. jejuni using the ArrayTube 
platform developed by CLONDIAG Chip Technologies (Jena, Germany) (Table 3). 
These genes represent roughly half of the variable genes in C. jejuni NCTC 11168 and 
targeted all of the hyper-variable regions in C. jejuni (Taboada et al., 2004). All 119 30-
mer probes were designed using the program, OligoArray 2.0 (Rouillard, Zuker, & 
Gulari, 2003),  and were designed to be SNP-free as in the CGF-20 and CGF-35 assays.  
Probes were produced and spotted in duplicate by CLONDIAG Chip Technologies (Jena, 
Germany) onto miniaturized microarrays, or ArrayTubes. 
Genomic DNA was extracted from Campylobacter strains using an EZ1 DNA 
Tissue Kit and BioRobot EZ1 (Qiagen) according to the manufacturer's instructions or by 
a phenol/chloroform method (Taboada et al., 2004) as described in Section 2.4 of the 
methods. DNA was quantified spectrophotometrically using a Nanodrop® ND-1000 
(Nanodrop Technologies, Inc.). Four µg of genomic DNA from each Campylobacter 
strain was biotinylated during individual random amplification procedures using a 
BioPrime® Array CGH Genomic Labeling System (Invitrogen) and Biotin-16-dUTP 
(Roche) according to the manufacturer’s Instructions. Labeled genomic DNA was 
purified using a purification module provided with the BioPrime® kit according to 
directions provided by the manufacturer, and quantified spectrophotometrically. 
Hybridizations were initially carried out using varying concentrations (2-8 µg) of C. 
jejuni NCTC 11168 and 81-176 genomic DNA to determine the optimal amount for 
detection using the ArrayTubes. In the optimized version of the protocol, 5 µg of labeled 
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Table 3: Oligonucleotide probe sequences for CGF-119. Each 30mer probe is shown with 
the corresponding NCTC 11168 gene name. Continued on next page. 
Gene  Probe Sequence Gene  Probe Sequence
Cj0008 CTTAATTCCTGATGTTGATTTATCTTTGGA Cj0483 GGTAAAAGCAGAGCTTAACGAGCAAAATGA
Cj0014c AGCTCCGAAAATACCCGCTAATATACCTAT Cj0484 ACTTATAGTGTTAGCATTGATAGCAATTTT
Cj0030 ACAGGAAGCATATAAAGGTATTAATGATAT Cj0485 TTTAGATAGAGCATTAAATTGGGATGAAAA
Cj0032 GATGAAATTTTAAAAGCCAAAGAACAAGAC Cj0486 TTGGTATGGCTTTATAGGCTCAAAAGTGAG
Cj0033 AGCTTTAGTTCTTTTCTCACTCCAAAAGAC Cj0487 GGGAGCAATTATCCAGTGGCAAAGATAACT
Cj0057 CCTGATAGCATATTTGGGATAAGCTTATGG Cj0488 TAAATATGGAAGAAGTATTTCACTTAGACT
Cj0058 CTAAAACCTTTTAAGTTAAACACTCCAAAA Cj0490 CCATGTGGTATATTTGCAGTATAATACTAA
Cj0100 GTTGCTTATCAAAATTTGGCGTATTCTATA Cj0555 GGCGATTTTAGCTACTATTATAATGAGTTT
Cj0122 TAATAAAATTCTTTCTCAAAACACTTCAGC Cj0566 GCAATGACAATCTTTCTTCGTCGGATTTAG
Cj0139 GCGAGAGAAGTATTTATAATATTGCTTCAT Cj0568 AGTTGGAAATCCTAAAGATAGCTATCTAGG
Cj0170 TGTGGAAATGGAGTGCATTCTAAGTATTTT Cj0569 GCTCATAATAAATCTAAGCCTTTTAAAGAA
Cj0171 GGAGCACTTTATTTATATAGGACAAAAGTA Cj0570 AATTTTAGGCATAGAAGGCGTAAGTTTGTT
Cj0177 AGCTATGGAGAAATAGATTTAAAAGACAGT Cj0617 TAGAACGATTTTGTTTGGAAATTCATATGG
Cj0178 CGGTCGTACTTTTATAGTAAGTTTTGAATA Cj0618 GTGTATACTTTCAAAGAAGAAAATCATCAA
Cj0179 TAGATGAGCTTGCAAATTTTGTCTATATAC Cj0628 TTTAATAATCAAGGTATCATAGGTAATGGT
Cj0180 CCTAGAAAATCTTTCAAGTGCTTTAGATAT Cj0629 TAATGGAATGTTTGATAAAGATGGCAATAC
Cj0181 CAGTTTTGTTATGCCTATTGATTACAATAT Cj0677 GCTTGGATACTTAGAATTTTAGGAGTGTGA
Cj0247c GCTTGATTTTATTTGTGCAAAGATTTTCTA Cj0727 AAAGCTAAACTTTTACCAAGTGAGCAATAC
Cj0259 GGCTGGAGAAATTTTGAAATTTCAATTAAA Cj0728 AGAGAACCTAATAAAACTGATGATAATGAA
Cj0263 GCTTTAAGTTTAAATTTGCTTGGGCAATAG Cj0730 GTTGTTACCTTTATAGCCAATTTCCTTTCT
Cj0283c ATCGACATCAGGACCAGCCATCTGAGTTTG Cj0731 ACTTTTATAGCTAGTTTGATTAAGGAGTGA
Cj0295 AAACAAGGTTATCAAAGAGGGACAAAATTT Cj0732 CAATCTTTCTTTAGCAAAAGAGTTAAAATG
Cj0299 GCTTTCGCGCTAAATTTAGATATTGATAAA Cj0733 TTAGCAAAGCCTTTGTATGTAATGGTGATG
Cj0334 AACCCTAAAGGCGTGGCTGAATATCTTGGC Cj0736 AAATTTTAGCTTTGAAGTTTCAGATGATGC
Cj0410 AGACAACTTGTCGCTCAAAGAAATAAATAA Cj0737 AAAATTGCTTCAACTGGTTATGATGCTTAG
Cj0422c ATGTCTAGTTCATATGCCATATCACGCTTG Cj0738 TAAGTATAGTAGCAAAGAAGGTTCTTATGT
Cj0423 TTGTTTGTTTAATATGGTCTTTTACGGGAA Cj0741 GACAAACCTTCTGTATTGCCGCCTGAAATT
Cj0427 GTGGAGCATTTGCCTACTCACCATGATTAA Cj0755 AGCACTTGGGTAAATACCTATAACCGTATA
Cj0480c ATTTAACACTCTAAGAGTGGGCTGATGCAT Cj0818 GCTTATCAAGAAGATAGAGCTATACCTTTA
Cj0481 AAACACTCGCTTTGATGAAGCAAAAGAGCT Cj0842 TCAGAAGATGTCGATACACAATATAATTAG
 
 
 
 
 63 
 
Gene  Probe Sequence Gene  Probe Sequence
Cj0859c GTTGACTTTAACATATTGACTTAAGCTATT Cj1322 GCTTGACTATAGAAAGCTTAAATGAAGATT
Cj0860 TATGATTGCCTCTATAGAGCCTGTAGCAGC Cj1323 GACACTATAGGCATAGAACTTTGTAATAAA
Cj0876c CCACATAACAACAAAGTTAAAACTATAGAA Cj1324 TCATAAGCTTGACAATAAATGCGTTGAAGA
Cj0913c AACTAATGAAATGAAATCTGCTTTAGTCAT Cj1325 TTAAAAGAAATTTGGGAGCAAAATATTAGC
Cj0967 TACGATGCTCCTATTAATATTTCTAGCTAG Cj1326 TCGGCACACCATTATATTTATATAGGTATT
Cj0970 TGTCATTCGTGGTCCTGCATCAAATACAAT Cj1327 TACAAAGAAGATGAGCTTATCCGTGAGTAA
Cj0971 ACAAAGGAAATTCTTTCTCAAAATTCCTAA Cj1328 ATCATTGATTCCGAAATCAACGATCTTGAT
Cj0972 GTGCAAACTATAAGCCAGTATCCATTATAA Cj1329 TTATTGGATTGACATTGGAAGGCCAGATGA
Cj0975 AGCTAGAGCTTTAAAGAAATATAAACTAGA Cj1330 TAAAAGTGCTTGAACTTTGTGATGAAGTAA
Cj1136 GGGTATTTTAGATAAAATCAACTTTGCAAA Cj1331 TGATAGCGAGCTTGATTTTAAAATCGTAGA
Cj1138 CCTTTGTGTATTAAAGAGAAATTGCAACTA Cj1332 CTTAGCGATGAGAGTAAATTTATCACAGGG
Cj1140 TTCCAAGTGACATAAAACACTACTTAAAGG Cj1333 AGAAAATTAGATAAATGGATGGAAAGGGTG
Cj1141 ATACAACTAACATGGGATGATTTTGAATGA Cj1334 GATATCTTGATACTCAAAACAAAACCATAG
Cj1142 GAAGCGATTTTAAATACTAGTAAATGCACT Cj1336 AGAAAATTAGATAAATGGATGGAAAGGGTG
Cj1143 TAGTTTGGATATAGATACAACAGAGGATTT Cj1337 ATTTTACCTTTGCTAGACTTCTTAGAAAAG
Cj1145c CAATACCTTTATAACCTCTAGGTGTATACC Cj1376 AGTGTCATATCTAAAGCTATGCTGTGGATG
Cj1158c TTGAGCATCTAAATTTCTAGCTTTAAACAT Cj1419c CTTGGTATAATCCCACACTTGTTCTACTAG
Cj1160c CTAACGATACAACGGTAAGCAAAATAATAA Cj1434c GGTACAACAATAGAAACTTTTGGAGTATTA
Cj1208 TAGTCGGACTCGGTATAGGATATTTAGTTG Cj1520 GGTAAAATCTACAAGAATGAGGATGATGAT
Cj1211 TTTATTCCCTTCATTATGATTGTGATTTAG Cj1521c AAGCACACGCATAAATTTATCTTCAATCAT
Cj1225 CTTAAAGATGGGGATTATCAAAAGGCAAGT Cj1553c TTTCCATAACGCATCTTCTAGTTTTATTTC
Cj1297 TTTGCCATATATGAAAAGCTTCTTTTATGA Cj1556 ATCTTTAGGCAATAGTTTAGAATCCATCTT
Cj1298 CAGGAGATCATATAAATATTTACAACGCTA Cj1560 TTATTTTAGGCGTGGCTATATCTTTTGGAA
Cj1300 ATCACTATGGCAGTAGTTTTAAATGCTTAA Cj1563c ATTCTATCCATTTTACCCATTCTATATCGC
Cj1306c ATCGATTTCAAAGCTTTGGTTTATGAGCAT Cj1602 TTGATGAAATTAAAAGCGATGAAGAAATGG
Cj1307 CGACAAATTTAAGCTTAATCAAAATGGTAA Cj1630 AATGGAGATTTAAGAATTACACTACCTATT
Cj1318 AGAAAATTAGATAAATGGATGGAAAGGGTG Cj1677 GTGGTTTTATTAGTGCAAATAAGGGTGTAG
Cj1319 GAGACAAAGCATAGAGTATTTTAAAGAAAA Cj1678 TAATGGAATGTTTGATAAAGATGGCAATAC
Cj1320 AATTTACCTAGTAGCGTTAGAATAGCAAAT Cj1679 GGCCAAAAGCAAAATGTTTTATCATAAAAG
Cj1321 ACTTAGAAGATAACTGCATAGTAAGCAGGT
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 genomic DNA from each sample was concentrated to a volume of 10 µl using a 
Speedvac centrifuge (Thermo-Savant SpeedVac Concentrator SPD111V, Holbrook, NY, 
USA). 
All probes were assessed using C. jejuni NCTC 11168 as a positive control strain.  
ArrayTubes were then validated using a set of 19 strains that were previously 
characterized by whole genome microarray analysis and MLST (Taboada et al., 2008). 
Once the Campylobacter ArrayTubes were validated, the 74 strains selected for 
additional analysis (Appendix A, as indicated) were assessed. C. jejuni NCTC 11168 was 
used as a positive control strain for all experimental analyses.   
The ArrayTubes were washed with 500 µl hybridization buffer (1M NaPOi, 20% 
SDS, 0.5M EDTA, 1X SSC, pH 7.2) for 5 min at 45°C while shaking at 550 rpm in a 
thermomixer (Eppendorf, Mississauga, ON). Ten µl of labeled Campylobacter genomic 
DNA (5 µg) was combined with 90 µl hybridization buffer, heat denatured for 5 min at 
95°C using a T Gradient thermocycler (Biometra, Montreal Biotech Inc., Montreal, QC) 
and added to the ArrayTubes for a 60 min hybridization at 45°C and 550 rpm.  The 
ArrayTubes were then washed with 500 µl 2X SSC (Invitrogen) 0.01% Triton X-100 
(BioRad, Mississauga, ON), then with 500 µl 2X SSC (Invitrogen), both for 5 min at 
40°C and 550 rpm, followed by a wash with 500 µl 0.2X SSC (Invitrogen) for 5 min at 
30°C and 550 rpm.  The ArrayTubes were blocked with 100 µl 6X SSPE 
(Invitrogen)/0.005% Triton X-100 (BioRad)/2% skim milk powder (Oxoid, Nepean, ON) 
for 15 min at 30°C and 550 rpm. Streptavidin-horseradish peroxidase conjugate (Sigma-
Aldrich Canada, Ltd, Oakville, ON) was diluted 1:2500 in 6X SSPE (Invitrogen)/0.005% 
Triton X-100 (Bio-Rad) and 100 µl of the diluted mixture was added to the ArrayTubes 
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for 15 min at 30°C and 550 rpm.  The ArrayTubes were then washed with 500 µl of 2X 
SSC (Invitrogen) 0.01% Triton X-100 (Bio-Rad) for 5 min at 30°C at 550 rpm, then 500 
µl 2X SSC (Invitrogen) and 0.2X SSC (Invitrogen) both for 5 min at 20°C and 550 rpm.  
One hundred microlitres of True Blue peroxidase substrate (Kirkegaard & Perry 
Laboratories, Gaithersburg, MD) was added to each ArrayTube for 5 min at 25°C to 
facilitate visualization.   
Signals were detected using the ATR01 ArrayTube reader (CLONDIAG) and 
extracted using IconoClust software, version 2.5 (CLONDIAG). A Microsoft Excel 
macro was used to calculate mean signal values for the duplicate spots for each probe.  
Spots flagged due to poor spot morphology were not included for further analysis.  Once 
individual reports were created for each Campylobacter sample, a metadata report was 
created to include all samples in the dataset. The data set was analyzed by calculating the 
“percent of positive” (PoP) for each probe compared to the average C. jejuni NCTC 
11168 positive control signal (i.e., average sample signal per average C. jejuni NCTC 
11168 signal in six replicates). Spots were considered conserved if the PoP was greater 
than 55%, divergent if the PoP was between 25-55%, and absent if the PoP was less than 
25%.   
 
2.11 Molecular epidemiological analysis 
Primary data analysis was completed using Microsoft Excel. Binary fingerprints 
were imported into Bionumerics (Applied Maths, and clustered as described in Section 
2.12. For ease of analysis, and to define a temporal cluster, isolate dates were recorded by 
month, and assigned a numerical digit starting from the earliest date in our data set, 
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which was assigned the first value. Two approaches were used to obtain information from 
the data. Initially isolates were screened according to primary composition (animal, 
water, clinical) or secondary composition (actual animal species or water source). 
Alternately, data summaries were produced using pivot tables in Microsoft Excel. 
 
2.12 Analysis of fingerprints using Bionumerics 
 Present/absent variable gene results were recorded into Microsoft Excel as a 
binary fingerprint before import into Bionumerics v5.1. Fingerprints were incorporated as 
an assay panel and each fingerprint type (CGF-20 or CGF-35) was analyzed separately. 
Clustering was performed using the simple matching coefficient using the UPGMA 
clustering algorithm. Cluster numbers were automatically assigned at 65%, 75%, 80%, 
85%, 90%, 93%, 95% and 100% identity using an add-on internet script available from 
within the Bionumerics program. Data was exported to Microsoft Excel for further 
analysis and evaluation. 
 
2.13 Statistical analysis of clustering results 
The discriminatory ability of the different typing methods, CGF-20 and flaA-
RFLP, were addressed using Simpson’s Index of Diversity (ID). The Simpson’s ID is 
used to determine the probability of any two strains randomly sampled from a population 
to belong to two different types (Simpson, 1949) and has been adapted for evaluating 
typing methods (Hunter & Gaston, 1988) and improved for objective assessment of 
identification of efficient and discriminatory methods (Grundmann, Hori, & Tanner, 
2001). The Simpson’s ID and Confidence Intervals (C.I.) were calculated online for flaA-
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RFLP, and CGF-20 using the Comparing Partitions website 
(http://comparingpartitions.info) (Carrillo et al., 2004). Additional analysis of clusters 
was performed using Microsoft Excel through the use of pivot Tables. Clusters were 
evaluated based on composition and sample types. 
Similarity between strains was defined using the CGF-119 fingerprint. One point 
was given for each identical match (i.e., for a gene scored as absent, present or divergent 
in the same way in both assays). One half point was given for each divergent to present, 
or present to divergent match identified when the two assays were compared. Points for 
each strain were totaled, and used to calculate a percentage of total possible matches; i.e., 
119 points, or 100%. 
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Chapter 3 
 
3. Development and validation of a comparative genomic fingerprint for Campylobacter 
jejuni 
 
3.1 Introduction 
Southern Alberta has nearly twice the incidence of campylobacteriosis compared 
to both northern Alberta and across Canada. Sub-species typing methods play an 
important role in the classification of strains, surveillance to identify trends in disease 
transmission, outbreak detection, and monitoring of prevention/control efforts. 
Campylobacter is no exception and significant efforts have been targeted at the 
development of sub-typing methods for use in molecular epidemiology. However, 
comparative genomics, the study of genetic similarity among organisms at the whole-
genome level, has yet to be developed and applied to exploring the molecular 
epidemiology of C. jejuni within southern Alberta. 
  Comparative genomic fingerprinting (CGF) of Campylobacter jejuni  is based on 
the selection of genes identified as highly variable after extensive whole genome 
microarray comparison of a dataset comprised of 150 C. jejuni strains (Taboada, personal 
communication). It has been used in this study in an attempt to circumvent the main 
problems associated with genome sequencing and microarray-based comparative 
genomics; i.e., cost, ease and throughput. Microarray studies have demonstrated 
extensive genomic variability among C. jejuni strains and have led to the identification of 
a pool of accessory genes that are present in some but not all strains (Taboada et al., 
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2004; Taboada et al., 2008). The concept that differential carriage of these accessory 
genes can be used to generate unique genomic fingerprints for genotyping purposes is the 
basis for CGF. 
Three variations of the CGF assays (CGF-20, CGF-35 and CGF-119) were 
developed (Sections 2.8, 2.9 and 2.10) based on the number of variable genes evaluated 
in each method. Additionally, a high-throughput alternative using capillary 
electrophoresis in place of traditional horizontal agarose gels for determining PCR 
product sizes to facilitate data analysis was also employed (Section 2.6). The CGF-20 
method was tested using a sample set of 641 C. jejuni isolates including isolates from 
water, animal fecal, human clinical samples and known reference strains that were 
previously evaluated using flaA-RFLP. This chapter addresses the results of CGF-20, 
adaptation of the CGF-20 to a high-throughput methodology, the reproducibility of CGF-
20 results, validation of the CGF-20 clustering results using both the CGF-35 and CGF-
119 assays, and the overall functionality of CGF to define clusters and discriminate 
among C. jejuni strains.  
  
3.2 Results 
 
3.2.1 Analysis and validation of the CGF-20 assay 
A total of 268 unique CGF-20 fingerprints or clusters were obtained by analysis 
of all 641 C. jejuni isolates in the collection (Figure 7). These clusters resolved to an 
average of 2.4 ± 3.8 members per cluster, with the largest cluster containing 29 isolates 
(4.5% of all isolates). A total of 184 clusters contained a single isolate (29% of all  
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Figure 7: Dendrogram of the CGF-20 data from the southern Alberta data set and 
includes a set of 49 reference strains. Binary fingerprints (shown to the right of the 
dendrogram), are visualized as black indicating gene presence, with white indicating gene 
absence, and were clustered in BioNumerics v 5.1 (Applied Maths) using the simple 
matching coefficient and UMPGA clustering algorithm. Each unique cluster (i.e., groups 
of strains with 100% fingerprint identity and each strain with no matching isolates – i.e., 
“singletons”) was assigned a CGF-20 cluster number. Clusters resolve to an average of 
2.4 ± 3.8 members per cluster with the largest cluster containing 29 isolates. A detailed 
version of the dendrogram which allows visualization of the CGF-20 fingerprints is 
available in Appendix B. 
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isolates) and were considered as ‘singletons’.  A more detailed epidemiological analysis 
of the CGF-20 clustering results is presented in Chapter 4. 
 
3.2.2 Development of a high-throughput CGF assay 
 Although traditional PCR-to-gel method has reasonably fast throughput (i.e., 96 
samples can be processed in 3-4 days), a method with enhanced throughput was 
developed and evaluated. To overcome the agarose gel electrophoresis ‘bottleneck’, an 
alternative method of visualizing PCR fragments was developed using the Qiagen 
QIAxcel capillary electrophoresis system. After PCR, samples in 96-well plates were 
loaded, separated and visualized directly by the instrument, eliminating the step-by-step 
process of manual pouring, loading, running and scoring agarose gels and reducing 
handling of toxic materials. Samples were sequentially analyzed and visualized after each 
12-sample lane was run, and immediately scored with the exact DNA fragment size 
estimated by the machine’s software. Initially, a subset of 96 samples had PCR results 
visualized by both traditional gel electrophoresis and capillary gel electrophoresis to 
determine the reproducibility of amplicon detection and size estimation by the two 
methods (i.e., the same PCR amplicons were run using both methods). The CGF-20 was 
then tested for assay reproducibility by repeating all multiplex PCRs using a subset 
composed of 93 isolates (i.e., using the same strains and comparing fingerprints 
generated on two separate occasions). 
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3.2.2.1 Analysis of reproducibility: A comparison of agarose gel electrophoresis vs. 
capillary gel electrophoresis  
The four multiplex PCR reactions used in the CGF-20 assay were initially 
resolved using agarose gel electrophoresis. These same multiplex PCR products were 
subsequently subjected to capillary electrophoresis using the QIAxcel (Qiagen, 
Mississauga, ON) to determine the technical reproducibility between both methods of 
amplicon visualization.  
A preliminary analysis of multiplex concordance was performed in order to 
identify whether any individual multiplex was more prone to variant results when 
comparing the original results to those obtained using capillary electrophoresis. A 
majority, 344 out of 384 (89.5%), of 5-plex PCR sets (i.e., four 5-plex PCR sets x 96 
samples) gave the same result using both methods (Figure 8), with each of the four 5-
plexes yielding similar levels of concordance, ranging from 88.5 to 90.6%.  Out of the 96 
samples analyzed 76 (79.2%) had identical CGF-20 fingerprints when replicated using 
capillary gel electrophoresis. When the 20 samples with variant fingerprints were 
examined for mismatches, the majority, 15 out of 20 (75.0%), had a single gene 
mismatch. Only 5 out of 20 samples had multiple gene mismatches (Figure 9). The 
overall concordance was therefore assessed by examining the number of genes that 
yielded identical data using both methods. A total of 1920 observations were performed 
(i.e., 96 samples x 4 multiplexes x 5 genes per multiplex) of which 1893 (98.6%) 
generated identical data.  
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Figure 8: A comparison of CGF-20 amplification products analyzed by capillary gel 
electrophoresis using the QIAxcel instrument with CGF-20 amplifications analyzed using 
agarose gel electrophoresis. Each multiplex PCR generated very similar results ~89% 
reproducibility (n=96) regardless of the method used for visualization of PCR amplicons. 
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Figure 9: Distribution of mismatches obtained for CGF-20 fingerprints when the 
amplicons were measured by capillary gel electrophoresis using a QIAxcel instrument. 
The number of mismatches (i.e., non-identical results for genes present or absent) 
between capillary gel electrophoresis and agarose gel electrophoresis was calculated. The 
majority of samples (94.8%, n=96) had identical fingerprints or only one mismatch. 
Overall, a total of 1893 out of 1920 (98.6%) individual gene observations yielded 
identical data using both methods. 
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3.2.2.2 Analysis of assay reproducibility using PCR replicates 
In order to determine the reproducibility of the CGF-20 assay, a subset of 93 
strains were re-evaluated by performing the assay a second time, and comparing the 
resulting CGF fingerprints to the original. 
A preliminary analysis of multiplex concordance was performed in order to 
identify whether any individual multiplex was more prone to variant results when 
comparing the results from both replicates. The majority, 345 out of 384 (89.8%), of 5-
plex PCR sets (i.e., four 5-plex PCR sets x 96 samples) gave the same result using either 
methods (Figure 10), with each of the four 5-plexes yielding similar levels of 
concordance, ranging from 86.0 to 93.5%.  Out of the 96 samples analyzed, 66 (68.8%) 
had identical CGF-20 fingerprints when replicated using capillary gel electrophoresis. 
When the 30 samples with variant fingerprints were examined for mismatches, the 
majority, 18 out of 30 (60.0%), had a single gene mismatch (i.e., an amplicon of the 
expected size would be present in the initial PCR, but not in the replicate or vice versa). 
Only 12 out of 30 samples had multiple gene mismatches (Figure 11). The overall 
concordance was therefore assessed by examining the number of genes that yielded 
identical data using both methods. A total of 1920 observations were performed (i.e., 96 
samples x 4 multiplexes x 5 genes per multiplex) of which 1849 (96.3%) generated 
identical data.  
 
3.2.3 Development of High Resolution CGF Assays: CGF-35 and CGF-119 
A second CGF assay (CGF-35) was developed based on an extended fingerprint 
that includes all of the genes used for the CGF-20 assay plus 15 additional genes. These 
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Figure 10: Reproducibility of CGF-20 fingerprints by PCR replication. CGF-20 
fingerprints were compared from two sets of PCRs to establish the reproducibility of 
method. Each PCR generated very similar results, with ~2/3 of all strains generating 
identical fingerprints at all 20 loci when replicated (n=93). Among the remaining strains, 
most were identical in three of four PCR sets. 
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Figure 11: Distribution of mismatches obtained for CGF-20 fingerprints between 
replications of PCR. The number of mismatches (i.e., non-identical results for genes 
present or absent) was calculated when the CGF-20 assay was replicated. The majority of 
isolates (87.1%, n=96) had identical fingerprints or only one mismatch. Overall, a total of 
1849 out of 1920 (96.3%) individual gene observations yielded identical data when the 
PCRs were replicated. 
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15 genes provide additional discriminatory power by providing additional coverage of the 
hypervariable regions in the C. jejuni genome. A subset of isolates was selected to 
evaluate this method. 
A third CGF assay, targeting 119 variably absent/present genes using the 
ArrayTube platform, was also developed. A subset of 74 isolates was evaluated using the 
CGF-119 assay in order to determine the concordance of clustering obtained with this 
assay and the CGF-20 assay, and to assess the extent to which the CGF-20 assay can be 
 used to predict overall genomic similarity.  
 
3.2.3.1 Validation of CGF-20 clusters using CGF-35 and CGF-119 
Nearly all CGF-20 clusters examined showed a strong propensity for high within-
cluster similarity at both the CGF-35 and CGF-119 levels (Figure 12). Strains displayed a 
high intra-cluster similarity (i.e., strains within a CGF-20 cluster) at the higher 
resolutions with an average similarity of 91.6% in CGF-35 fingerprints and 80.1% in 
CGF-119 fingerprints (Table 4). The overall average inter-cluster similarity (i.e., 
similarity to strains external to the CGF-20 cluster) was dramatically lower at 60.6% 
between CGF-35 fingerprints, and 54.7% between CGF-119 fingerprints (Table 4).  
 
3.4 Discussion 
Comparative genomic fingerprinting has been developed as a platform-
independent approach to genotyping based on selecting genes that are variably present or 
absent (VAP) in the genome as determined from whole-genome comparative genomic 
analysis. CGF builds on the genetic diversity of C. jejuni demonstrated in the literature  
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Figure 12: Detailed genomic analysis of select CGF-20 clusters using CGF-35 and CGF-
119 assays. CGF-20 clusters, shown with the calculated genetic similarity, are shown 
with the corresponding CGF-20, CGF-35 and CGF-119 fingerprints, and below the CGF-
20 cluster number. Black is used to indicate that a gene is present or divergent; white is 
used to indicate that the gene is absent. 
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Table 4: Average intra-cluster and inter-cluster genetic similarities identified for CGF-20 
clusters based on CGF-35 and CGF-119 data. Pair-wise similarities were computed for 
each isolate versus all other isolates within the CGF-20 cluster (intra-cluster) and all 
isolates outside of the CGF-20 cluster (inter-cluster) for the CGF-20, CGF-35 and CGF-
119 fingerprints is given with the standard deviation between all intra-cluster or inter-
cluster isolates. Matches for CGF-20 and CGF-35 fingerprints were calculated based on 
the simple matching coefficient (score of 1.0 per match, as a percentage of 20 or 35 
possible matches, respectively). Matches for CGF-119 were determined using the scoring 
scheme described in the methods section (score of 1.0 per match, 0.5 per 
divergent/present mismatches, as a percentage out of a total 119 possible matches). 
 
 
 
Cluster 
Number
# 
Members
CGF-20 
Average 
Similiarity
CGF-35 
Average 
Similiarity
CGF-119 
Average 
Similiarity
10 5 100.0% ± 0.0%
78.5% ±  
7.5%
85.4%  ± 
4.6%
37 3 100.0% ± 0.0%
96.2% ± 
1.5%
82.2% ± 
6.0%
42 4 100.0% ± 0.0%
94.3%  ± 
4.2%
82.0% ± 
4.1%
60 9 100.0% ± 0.0%
94.0% ± 
5.2%
86.8% ± 
6.7%
137 9 100.0% ± 0.0%
100.0% ± 
0.0%
91.3% ± 
3.3%
161 4 100.0% ± 0.0%
63.8% ± 
13.3%
71.4% ± 
8.0%
163 7 100.0% ± 0.0%
85.6% ± 
12.1%
72.3% ± 
24.4%
169 2 100.0% ± 0.0%
97.1% ± 
0.0%
42.9% ± 
0.0%
172 9 100.0% ± 0.0%
94.8% ± 
4.0%
81.3% ± 
7.5%
183 2 100.0% ± 0.0%
97.1% ± 
0.0%
84.5% ± 
0.0%
190 9 100.0% ± 0.0%
94.6% ± 
4.3%
83.9% ± 
9.1%
202 9 100.0% ± 0.0%
97.5% ± 
2,6%
91.1% ± 
5.1%
255 2
100.0% ± 
0.0%
97.1% ± 
0.0%
86.6% ± 
0.0%
100.0% 91.6% 80.1%Overall Average Similiarity
CGF-20 
Average 
Similiarity
CGF-35 
Average 
Similiarity
CGF-119 
Average 
Similiarity
56.1% ± 
9/3%
63.5% ± 
11.0%
58.2% ± 
8.7%
54.5% ± 
18.0%
61.2% ± 
16.8%
56.8% ± 
9.2%
58.7% ± 
12.7%
63.1% ± 
12.7%
59.1% ± 
8.9%
59.7% ± 
10.5%
62.2% ± 
10.8%
58.8% ± 
8.4%
32.9% ± 
16.9%
43.0% ± 
19.7%
40.8% ± 
15.7%
67.4% ± 
20.8%
62.8% ± 
14.9%
57.0% ± 
15.1%
64.8% ± 
23.1%
65.0% ± 
13.1%
59.2% ± 
15.6%
66.5% ± 
22.2%
65.3% ± 
18.2%
52.1% ± 
13.4%
59.4% ± 
21.2%
59.7% ± 
17.6%
54.8% ± 
15.9%
70.4% ± 
18.7%
66.5% ± 
14.1%
46.5% ± 
14.2%
59.1% ± 
22.5%
49.6% ± 
20.0%
51.5% ± 
17.1%
59.1% ± 
15.5%
61.9% ± 
9.2%
59.4% ± 
8.7%
53.2% ± 
12.1%
64.0% ± 
11.7%
56.7% ± 
10.4%
58.6% 60.6% 54.7%
Inter-Cluster Intra-Cluster 
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through analysis of whole-genome microarrays and whole-genome comparative genomic 
sequencing, which have provided insight into genome evolution, and the development of 
hypotheses related to virulence, pathogenicity, and host specificity (Dassanayake et al., 
2005; Dobrindt & Hacker, 2001; Dorrell et al., 2001; Pearson et al., 2003; Taboada et al., 
2004). Microarray-based comparative genomic hybridization remains labor intensive and 
expensive, and is not used to any significant extent in molecular typing and molecular 
epidemiology. CGF represents a possible alternative to microarray-based comparative 
genomic hybridization in the estimation of whole-genome similarity and in the 
assessment of genetic relatedness using comparative genomics-based genotyping.  
In this study, isolates have been analyzed using CGF-20, CGF-35, and CGF-119 
assays, which target 20, 35, and 119 VAP genes respectively, and have shown that the 
PCR-based CGF assays are flexible assays and can be easily modified by the addition of 
genes, with no more additional work than optimizing a PCR, while leaving the remaining 
fingerprinting information easily accessible for strain to strain or inter-laboratory 
comparison. Although the term ‘comparative genomic fingerprinting’ has not yet been 
universally applied, the importance of CGF as an emerging method for genotyping has 
been established through work carried out in our laboratory on vero-toxigenic 
Escherichia coli (Laing et al., 2008). 
In this thesis, the technical reproducibility of the CGF-20 assay was tested two-
fold: a) by comparing results using traditional agarose gel electrophoresis versus capillary 
electrophoresis and b) by comparing results of technical replicates for a subset of strains. 
Both comparisons showed that the PCR-based CGF assay is extremely robust, with 
greater than 97% of signal calls being identical in both tests (a: 1893/1920 calls, or 98.6% 
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concordance; b: 1881/1920 calls, or 97.9% concordance). The small discrepancies 
observed may be explained by the higher resolution (within 3-5 bp) and enhanced 
detection sensitivity (as low as 0.1 ng/µL of PCR product) of the QIAxcel instrument 
compared to traditional agarose gel electrophoresis and ethidium bromide/UV band 
detection. Although the gel-based CGF-20 can be completed relatively quickly in most 
laboratory settings (i.e., 96 samples in 4-5 days), the capillary electrophoresis system 
increases the accuracy of signal calls due to enhanced resolution and sensitivity, and 
greatly increases the throughput of the method (i.e., 96 samples in 1-2 days). 
A small difference between CGF-20 fingerprints between PCR replicates was 
observed. This difference was small (~3.7% of PCR amplicons) and is likely attributed to 
minute differences between PCR reactions including concentrations of PCR components 
including primers, and temperature depending on location in heat block. These variations 
between PCRs are unavoidable but may still lead to changes within the assay affecting 
the ability of primers to anneal, reduce extension or otherwise affect the overall yield of 
PCR product. As the majority of differences were in a single PCR, it is important to note 
that reduction of cluster stringency may compensate and still provide effective clustering 
of closely related strains. 
In this study, CGF assays targeting a larger number of loci that deliver increased 
sub-typing resolution have also been examined. These assays were used to assess the 
ability of the CGF-20 assay to rapidly cluster strains based on high levels of genetic 
similarity. The results of the study show that strains within the same CGF-20 cluster have 
much higher levels of genetic similarity, as determined by similarity in CGF-35 and 
CGF-119 fingerprints, compared to strains outside of the cluster. The data suggests that 
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the CGF-20 assay groups isolates with high genetic similarity and is highly correlated 
with additional genetic content. Interestingly, the high resolution also revealed genomic 
differences consistent with epidemiological information. For example, CGF-20 Cluster 
#202 contained 6 clinical isolates that show a high overall similarity (90.0%) in CGF-119 
fingerprints. Three of the clinical strains showed significant differences at 8 loci between 
cj1337 and cj1630. These strains were obtained between one-to-two months after the 
other clinical isolates in the cluster were sampled.  
Our analysis of genetic similarity using CGF-119 data demonstrates that the CGF-
20 method is able to reliably cluster isolates with high genetic similarity and is thus a 
useful typing method for Campylobacter jejuni. The CGF-20 assay was shown to 
generate functionally equivalent data to the CGF-119 assay in that strains that are similar 
using the CGF-20 assay also have extremely similar CGF-119 fingerprints. The CGF-119 
assay is based on targeting nearly half of all the variably absent/present genes in the C. 
jejuni genome identified by whole-genome comparative genomic hybridization using 
microarrays (Taboada et al., 2004) and has been designed to replicate whole-genome 
microarray data (E. Taboada, personal communication). Since there is high correlation 
between CGF-20 and CGF-119 data, it can be inferred that the CGF-20 assay can be used 
to rapidly assess whole genome genetic similarity between strains. Consequently, I will 
concentrate on epidemiological analysis of the CGF-20 data in subsequent sections of the 
thesis.  
An advantage to CGF compared to other methods and, in particular, to band-
based fingerprinting methods, is that analysis at reduced stringencies can retain 
biologically meaningful ‘inferred genetic relatedness’. Although CGF fingerprints can 
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only be used to estimate the genetic content of a strain, they appear to provide a relevant 
assessment of overall genetic relatedness. For example, strains with 90% matching CGF-
35 fingerprints are identical at 32 out of 35 loci and, by extrapolation, would also be 
expected to have an overall genetic similarity (i.e., at higher levels of resolution) on the 
order of 90%. By contrast, it is much more difficult to extrapolate the overall genetic 
similarity between strains that have 90% matching fingerprints based on the analysis of 
data from band-based methods such as PFGE and flaA-RFLP or based on methods that 
interrogate few loci, such as flaA-SVR, sequencing because of lower levels of genome 
sampling and the relatively low level of information content generated in those methods.  
The ability to analyze data at various stringencies of clustering while retaining 
biologically and genetically meaningful information may give CGF a wider range of 
applicability. 
CGF-20 can be performed at a fraction of the time and cost of other molecular 
typing methods, such as MLST and PFGE. CGF-20 fingerprints tend to be non-
ambiguous (i.e., the gene is present or absent) compared to other methods (i.e., restriction 
fragment-based fingerprints requiring less transparent algorithms to establish 
relationships). The reproducibility testing demonstrates that, not only are the results 
robust and easily reproducible, but that binary fingerprints based on presence/absence 
data could easily be compared among institutions.  
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Chapter 4 
 
4. Molecular epidemiology of Campylobacter jejuni in southern Alberta 
 
4.1 Introduction 
 Southern Alberta has nearly twice the incidence of campylobacteriosis compared 
to that found both in northern Alberta and across Canada. This region contains extensive 
livestock production which may contribute to the greater levels of infection with 
livestock-associated pathogens than in other regions. Cases of campylobacteriosis are 
thought to be generally sporadic, and of foodborne origin (Kapperud et al., 1992; Mead et 
al., 1999). To gain insight into the high incidence rate of campylobacteriosis in southern 
Alberta, 592 isolates of Campylobacter jejuni were obtained from water, animal fecal and 
clinical samples in the region over a three year period (2004-2006), and analyzed using a 
flaA-RFLP molecular typing assay and were also analyzed using the 20 gene comparative 
genomic fingerprinting assay (CGF-20) previously described and validated in Chapter 3. 
The purpose of this study was to evaluate the sample set by analyzing the genotyping 
data within an epidemiological framework to identify potential environmental reservoirs 
of C. jejuni, potential routes of transmission into the human population, and to identify 
prevalent or endemic genotypes (i.e., clones), if any, present within the region using 
CGF. This study aims to provide the proof-of-concept for the application of CGF in 
molecular epidemiological studies. 
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4.2 Results 
 
4.2.1 Evaluation of samples from southern Alberta 
 C. jejuni were isolated from water, animal fecal and clinical samples obtained in 
the southern Alberta; i.e., out of 834 water samples processed, 91 (10.9%) were culture 
positive for C. jejuni, as compared to the 30.0% isolated from animal fecal samples (241 
out of 803 samples). The combined data set also contained 260 clinical isolates from 
Clinical Laboratory Services (Calgary, Alberta). Due to confidentially issues, the exact 
date of isolation for some samples could not be obtained; i.e., isolation dates for 16 of the 
2005 clinical isolates and all 34 isolates from 2006 were not made available. In addition 
49 reference strains used in-house, most of which have been characterized by whole-
genome comparative genomic hybridization (Taboada et al., 2004; Taboada et al., 2008), 
were included in the final data set of 641 C. jejuni isolates as controls.   
 Isolation rates for C. jejuni varied between animal species (Table 5). Almost half 
(44%) of chicken fecal samples contained C. jejuni.  Most other animal species sampled 
also had similar isolation rates for C. jejuni. These included buffalo, pig, deer, duck, 
cattle and sheep with isolation rates of 57%, 46%, 45%, 45%, 37% and 33% respectively.  
Other avian sources, in addition to chicken, have been identified as significant 
contributors to Campylobacter infections. Surprisingly, Campylobacter isolates were 
obtained from only 20% of goose samples and 9% of other avian species including 
migratory birds such as seagulls and pelicans.   
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Table 5: Isolation rates of C. jejuni from animal fecal samples. Total numbers of fecal 
samples tested for each animal source are listed, as well as the number of C. jejuni 
isolates obtained, and the percentage of samples that were culture positive for C. jejuni. 
Only one C. jejuni isolate for each sample was used for CGF-20 genotyping although up 
to three C. jejuni suspect colonies were obtained during the isolation procedure until 
confirmation by PCR. 
 
Animal
Number 
of 
Samples
Number of 
C. jejuni 
Isolates
Percent of 
Samples 
Tested
Cattle 218 80 36.7%
Chicken 98 43 43.9%
Sheep 82 27 32.9%
Pig 59 28 47.5%
Duck 38 17 44.7%
Goose 81 17 21.0%
Horse 81 8 9.9%
Goat 33 5 15.2%
Deer 11 5 45.5%
Other 
Avian 45 4 8.9%
Buffalo 7 4 57.1%
Human 2 2 100.0%
Domestic 
Dog 34 1 2.9%
Domestic 
Cat 14 1 7.1%
Total 803 214 26.7%
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4.2.2 Epidemiological analysis of C. jejuni isolates using a CGF-20 assay 
A total of 268 unique 20 gene fingerprints or profiles were obtained by analysis of 
all 641 isolates of C. jejuni included in our collection (Figure 7 or Appendix B). Using a 
fingerprint similarity threshold of 100% for clustering (i.e., all 20 genes evaluated must 
be identical in conservation status), a total of 268 clusters were obtained. These clusters 
resolved to an average of 2.4 ± 3.8 members per cluster, with the largest cluster 
containing 29 isolates (4.5% of all isolates). Overall, 184 clusters contained a single 
isolate (29% of all isolates) and were identified as ‘singletons’. Of the 49 reference 
strains, 18 appeared as singletons, reducing the total number of unique fingerprints 
observed among the 592 southern Alberta isolates to 250. 
Of the total 268 clusters obtained for C. jejuni, 226 were exclusively composed of 
one or more isolates from the same source; i.e., clinical, animal and water sources. Each 
had 89, 87, and 50 respective clusters composed exclusively of that sample type (Figure 
13). Animal isolates shared profiles exclusively with clinical isolates in 28 clusters, and 
shared profiles exclusively with water isolates in four clusters. Water isolates shared 
profiles exclusively with clinical isolates in two clusters. A total of eight clusters were 
composed of isolates from all three sources (clinical, animal fecal and water).  
Many of the C. jejuni isolates from water (51.6%, n=91) had unique fingerprints 
(Figure 13). However, isolates from several clusters were isolated at a similar time and/or 
geographical region. Out of 8 clusters (containing 32/91 water isolates) that contain two 
or more isolates from multiple water samples, seven clusters (representing 30/91 isolates) 
contained isolates from the same location obtained within a two month period, or that had 
been isolated from the same location at the same time. The majority of isolates from  
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Figure 13: Analysis of CGF-20 cluster composition by source type. Strains from the three 
source types (Animal fecal, water or clinical sample) were sub-divided into 250 CGF-20 
clusters (including singletons). Clusters resolved to an average 2.4 ± 3.8 members per 
cluster, with the largest cluster containing 29 isolates (4.5% of all isolates). A total of 184 
clusters contained a single isolate (29% of all isolates) and were considered as 
‘singletons’. Among the 66 multi-strain clusters, 42 were composed of strains from more 
than one source, and eight clusters were composed of strains from all three sources. 
 91 
water grouped according to sampling site and date as would have been expected 
epidemiologically. 
 Several of the animal and water isolates appeared linked based upon similarities 
in their CGF-20 profiles. The water isolates were similar to geese (35.3%, n=17 isolates), 
and duck (35.3%, n=16 isolates) isolates in support of the idea that migratory birds 
contribute significantly to Campylobacter spp. contamination of the natural environment, 
and specifically bodies of water. In addition, water isolates were similar to isolates from 
cattle (25.0%, n=80), deer (40.0%, n=5), and horses (37.5%, n=8). Feces from these 
species may have entered water through run-off from pastures or feedlots following snow 
melt or precipitation. Other bird and animal species sharing CGF-20 profiles with water 
isolates in this study were isolates from chicken (16.3%, n=43 isolates), sheep (14.8%, 
n=27 isolates), and other avian species (25.0%, n=4). 
Isolates obtained from several animal sources had identical CGF-20 fingerprints 
to clinical isolates (Figure 14). Animal isolates with CGF-20 fingerprints identical to 
those from clinical specimens included those from chicken (58.1% of all chicken 
isolates), cattle (51.3% of all cattle isolates), sheep (59.3% of all sheep isolates), pig 
(44.0% of all pig isolates), goose (37.5% of all geese isolates) and ducks (35.3% of all 
duck isolates). Overall, 36.7% of cattle, 43.9% of chicken, 32.9% of sheep, 45.8% of pig, 
19.8% of goose, and 44.7% of duck fecal samples contained C. jejuni isolates with an 
identical CGF-20 fingerprint to a clinical isolate in this study.  
Several large clusters of clinical isolates also were detected based upon 
similarities in their CGF-20 profiles (Figure 15). Eight of these clusters contained 39.2%  
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Figure 14: C. jejuni isolates from animal sources with matching CGF-20 fingerprints to 
human clinical isolates. Nearly 50% of C. jejuni isolates from animal fecal samples share 
identical CGF profiles to human clinical isolates. 
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Figure 15: Proportion of clinical isolates by CGF-20 cluster represented as a percentage 
of all clinical isolates in the dataset (n=260).Eight CGF-20 clusters (CGF-20 Clusters 10, 
28, 169, 172, 186, 190, 202 and 255) contain 39.2% of total clinical isolates, while 19.2% 
of all the clinical isolates appeared as singletons. 
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(n=260) of all clinical isolates, while 19.2% (n=260) of all clinical isolates appeared as 
singletons. 
 
4.2.3 Epidemiological analysis of C. jejuni isolates using a flaA-RFLP assay 
 A total of 182 unique flaA-RFLP fingerprints were obtained by analysis of the 
641 isolates of C. jejuni in our collection. The largest cluster contained 66 members (10% 
of all isolates) with 122 clusters containing only a single member – i.e., “singletons” 
(19% of all isolates). On average, analysis of the flaA-RFLP data resulted in 
approximately 3.5 ± 7.2 members per cluster.  
Of the 182 flaA-RFLP clusters, 146 were composed exclusively of one sample 
type.  Animal, clinical and water sources each had 61, 46, and 39 respective clusters 
composed of that sample type (Figure 16). Animal isolates shared profiles exclusively 
with clinical isolates in 19 clusters, and shared profiles exclusively with water isolates in 
8 clusters. Water isolates shared profiles exclusively with clinical isolates in a single 
cluster. A total of eight clusters were composed of isolates from all three sources 
(clinical, animal fecal and water). 
Many of the C. jejuni isolates from water (38.5%, n=91) had unique fingerprints 
(Figure 16). However, several clusters were isolated at a similar time and/or geographical 
region. Out of 13 clusters of the bacteria obtained from multiple water samples, ten 
clusters (containing 45/91 isolates) contained C. jejuni isolated from the same location 
within a 2 month period, or that had been isolated from the same location at the same 
time. Seven clusters, representing seven of 91 isolates, contained a single water isolate 
that grouped with isolates from different sources and 35 water isolates had unique
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Figure 16: Analysis of flaA RFLP cluster composition by source type. Strains from the 
three source types (Animal fecal, water or clinical sample) were sub-divided into 182 
flaA-RFLP clusters (including singletons). Clusters resolve to average 3.5 ± 7.2 members 
per cluster, with a total of 146 clusters contain singletons. Among the remaining 60 
multi-strain clusters, thirty-six were composed of strains from more than one source, and 
eight clusters were composed of strains from all three sources. 
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 fingerprints. The majority of water isolates grouped according to site and sampling date. 
Several of the animal and water isolates appeared linked based upon similarities 
in their flaA-RFLP profiles. Host species with isolates most commonly similar flaA-
RFLP profile to water isolates were geese (64.7%, n=17 isolates) and ducks (50.0%, 
n=16 isolates). Similarly, cattle (26.3%, n=80 isolates) commonly matched flaA-RFLP 
profile to water isolates. As mentioned above (see 4.2.2) this may be related to water 
contamination with cattle manure following run-off associated with snow melting or 
precipitation. Other species sharing flaA-RFLP profiles with water isolates were chicken 
(14.0%, n=43 isolates), sheep (11.1%, n=27 isolates), pig (7.1%, n=28 isolates) and cat 
(100.0%, n=1 isolate) fecal samples. 
Isolates obtained from several animal fecal sources had identical flaA-RFLP 
fingerprints to clinical isolates (Figure 17). Animal isolates with flaA-RFLP fingerprints 
identical to those from clinical specimens included chicken (67.4% of all chicken 
isolates), cattle (56.3% of all cattle isolates), sheep (96.3% of all sheep isolates), pig 
(46.4% of all pig isolates), goose (29.4% of all geese isolates) and duck (29.4% of all 
duck isolates). Overall, 20.6% of cattle, 29.6% of chicken, 31.7% of sheep, 22.0% of pig, 
28.6% of buffalo, and 27.3% of deer fecal samples contained a C. jejuni isolate in the 
same flaA-RFLP cluster.  
 Several large clusters of clinical isolates also were detected based upon 
similarities in their flaA-RFLP profiles (Figure 18). Two of these clusters contained 
28.5% (n=260) of all the clinical isolates, and seven additional clusters contained 51.1% 
(n=260) of all the clinical isolates.  
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Figure 17: C. jejuni isolates from animal sources with matching flaA-RFLP fingerprints 
to human clinical isolates. Nearly 50% of C. jejuni isolates from animal fecal samples 
share identical CGF profiles to human clinical isolates. 
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Figure 18: Clinical isolates arranged by flaA-RFLP type. The majority of the 260 clinical 
isolates are found in nine flaA-RFLP types (57.0%) and ‘singletons’ (11.5%), isolates 
that do not cluster with any other isolates from the data set of 641 isolates including 
isolates from water and animal fecal samples in southern Alberta. The remaining isolates 
(31.5%) comprise a total of 29 flaA-RFLP types. 
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4.2.4 Comparison of CGF-20 and flaA-RFLP typing results 
 
4.2.4.1 Statistical comparison of CGF-20 and flaA-RFLP 
The Index of Diversity (ID), based on Simpson’s Index of Diversity is used for 
quantification of the biodiversity of a system, was calculated in order to provide an 
objective assessment of the level of diversity suggested by the CGF-20 and flaA-RFLP 
genotyping results. Both methods produced a high ID, indicating that on average, 
members were assigned to small clusters, with a high likelihood of genetic relatedness, 
while non-related isolates could be discriminated and allocated into separate clusters. 
Despite some differences in the average and largest cluster size, both the CGF-20 and 
flaA-RFLP methods had essentially indistinguishable IDs; i.e., the ID for CGF-20 was 
98.86 while that for flaA-RFLP was 97.31. 
In order to further compare the results obtained from the CGF-20 and flaA-RFLP 
genotyping methods, concordance was assessed by evaluating the corresponding flaA-
RFLP types for isolates within a particular CGF-20 cluster and vice-versa. Sixty flaA-
RFLP clusters consisted of more than one isolate. Of these, 9 (15.0%) were composed of 
isolates with a single CGF-profile. These nine clusters were very small and ranged from 2 
to 3 members averaging 2.2 members per cluster. When the reverse analysis was 
performed, 27 (32.1%) of the 84 multi-member CGF clusters in the dataset were 
composed of isolates with a single corresponding flaA-RFLP profile (Table 6). These 
twenty-seven CGF-20 clusters were also small, ranging from 2 to 9 members, and 
averaging 3.3 members per cluster. Thus, despite sharing similar discriminatory power,  
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Table 6: Distribution of flaA-RFLP types among CGF-20 clusters composed of a single 
flaA-RFLP type. Twenty-seven of eighty-four multi-member CGF-20 clusters were 
composed of isolates with a single flaA-RFLP type; five of these flaA-RFLP types appear 
in multiple CGF-20 clusters. 
 
flaA-RFLP Type CGF-20 Cluster(s)
7 5
9 255, 256, 260, 261, 262
11 102
12 3
13 6, 8
17 40
23 22
26 26
27 9, 248
30 221
37 171, 195
41 164
46 223
57 23
58 20, 74, 75, 81
59 237
70 70
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CGF-20 appeared to generate clusters that were more likely to be composed of isolates 
indistinguishable by a secondary typing method (i.e., flaA-RFLP). 
There were several CGF-20 clusters that were comprised of members sharing the 
same flaA-RFLP profile, but where the flaA type was also observed in other CGF-20 
These flaA-RFLP types (type 9, 13, 27, 37 and 58) demonstrate that, while some CGF-20 
clusters are homogenous for a single flaA allele, the alleles need not be exclusive to a 
given CGF-20 profile. Larger CGF-20 clusters, such as cluster #60, 70, 71, 202 and 250, 
were often composed of isolates sharing a dominant flaA allele, but which may also 
include isolates with secondary flaA-RFLP alleles (Table 7). These dominant flaA alleles 
also appear in several different CGF-20 clusters.  
Although certain CGF-20 clusters were composed of isolates with a single or a 
dominant flaA-RFLP allele, other CGF-20 clusters (i.e., CGF-20 cluster #10, 37, 42, and 
137) were composed of isolates with a variety of different flaA-RFLP alleles (Table 7). 
For example, CGF-20 cluster #10 contains 27 members with nine distinct flaA-RFLP 
types, CGF cluster # 37 contains four members, each with a distinct flaA-RFLP type, and 
CGF #137 contains 16 members, each with a distinct flaA-RFLP type that is unique in 
the dataset and appears as a singleton.  
Taken together, these findings suggest that while there is a significant association 
between flaA alleles and the genetic background as assessed by the CGF-20 profile, the 
same flaA allele can be found in isolates with very different genetic backgrounds and 
that, conversely, isolates with similar genetic backgrounds can have different flaA alleles. 
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Table 7: flaA-RFLP composition of multi-member CGF-20 clusters. Several large CGF-
20 clusters contained a dominant flaA-RFLP type as well as additional secondary flaA-
RFLP types that appear to be unrelated whereas other clusters were composed of several 
flaA-RFLP types, none of which appeared to be dominant. 
 
CGF 
Cluster
Number 
of 
isolates
Dominant 
fla A-RFLP 
type
Percent 
Dominant 
fla A-RFLP 
type
Additional 
fla A-RFLP 
Types
10 27 23 85.2%
14, 20, 23, 
25, 48, 49, 
50, 54, 102
37 4 47 25.0% 38, 47, 66, 96
42 14 38 28.6% 17, 23, 34, 37, 38, 47, 90
60 11 41 63.6% 22, 28, 67
70 9 70 100.0%
71 10 59 60.0% 58, 60
137 16 131 6.3%
131, 132, 
133, 134, 
135, 143, 
145, 146, 
147, 148, 
149, 150, 
151, 152, 
160, 161
202 16 2 87.5% 82, 136
250 7 15 71.4% 29, 77
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 4.2.5 Assessment of the ability of CGF-20 and flaA-RFLP assays to predict overall 
genetic similarity among C. jejuni isolates 
Overall genetic similarity among a subset of C. jejuni isolates was assessed using 
the CGF-119 fingerprinting method, which has been determined to provide an excellent 
picture of overall genome content of strains (E. Taboada, personal communication). 
Similarity in CGF-119 genetic profiles was calculated as a proportion of matches at the 
119 genes represented in the ArrayTube hybridization assay. In order to assess the ability 
of the CGF-20 and the flaA-RFLP assays to predict overall genetic similarity, the average 
CGF-119 similarity between members of the same cluster (intra-cluster similarity) was 
then compared to the average similarity versus all other strains in the dataset (inter-
cluster similarity) for groups of strains with the same flaA and/or CGF-20 type.  
The large multi-member flaA-RFLP clusters (flaA-RFLP types 2, 37, 41 and 52) 
had an overall intra-cluster similarity of 76.3%, with an inter-cluster similarity of 58.0% 
(Table 8). A similar low level of inter-cluster similarity (54.7%) was observed for strains 
analyzed by CGF-20 (Table 9). When examining the strains within the same CGF-20 
cluster an average intra-cluster similarity of 85% was observed. Taken together, this 
suggests that while strains of different CGF-20 or flaA-RFLP clusters tend to have a 
similarly low level of genetic similarity (i.e., ~ 60% identical CGF-119 profiles), strains 
within a given CGF-20 or flaA-RFLP cluster are likely to have much higher levels of 
genetic similarity (i.e., ~ 75-85% identical CGF-119 profiles), with strains within a CGF-
20 cluster having a marginally higher level of genetic similarity than strains within the 
same flaA-RFLP cluster.  
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Table 8: Average intra-cluster and inter-cluster genetic similarities for multi-member 
CGF-20 clusters. Pair-wise similarities in CGF-119 fingerprints were evaluated for intra-
cluster (comparisons made between isolates within a cluster) and inter-cluster 
(comparisons made between isolates external to the cluster).  Standard deviations are 
given as calculated using Microsoft Excel. 
 
 
Cluster 
Number
# 
Members
# Pair-
wise 
Matches
Average 
Matches
% 
Average 
Matches
# Pair-
wise 
Matches
Average 
Matches
% 
Average 
Matches
10 5 20 100.4 ± 5.8 84.4 345 66.8 ± 11.0 56.1
37 3 6 96.0 ± 7.8 80.6 213 64.8 ± 11.5 54.5
42 4 12 94.3 ± 6.7 79.2 280 66.7 ± 11.0 56.0
60 9 72 99.1 ± 12.0 83.2 585 66.4 ± 11.1 55.8
137 9 72 109.6 ± 4.0 92.1 585 48.8 ± 19.0 41.0
161 4 12 71.5 ± 16.2 60.0 280 61.3 ± 18.4 51.5
163 7 42 82.4 ± 28.5 69.2 469 68.4 ± 21.4 57.5
169 2 2 33.0 ± 0.0 27.7 145 100.0 ± 20.4 84.0
172 9 72 88.8 ± 6.4 74.5 585 60.1 ± 19.0 50.5
183 2 2 100 ± 0.0 84.0 145 48.7 ± 20.4 40.9
190 9 72 96.1 ± 16.1 80.7 585 57.1 ± 20.1 48.0
202 9 72 107.1 ± 8.1 90.0 585 67.9 ± 10.8 57.1
255 2 2 102.0 ± 0.0 85.7 145 63.9 ± 12.0 53.7
Inter-ClusterIntra-Cluster
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Table 9: Average intra-cluster and inter-cluster genetic similarities for multi-member 
flaA-RFLP clusters. Pair-wise similarities in CGF-119 fingerprints were evaluated for 
intra-cluster (comparisons made between isolates within a cluster) and inter-cluster 
(comparisons made between isolates external to the cluster). Standard deviations are 
given as calculated using Microsoft Excel. 
 
 
Cluster 
Number
# 
Members
# Pair-
wise 
Matches
Average 
Matches
% 
Average 
Matches
# Pair-
wise 
Matches
Average 
Matches
% 
Average 
Matches
2 7 42 107.5 ± 5.9 90.3 469 71.8 ± 11.9 60.3
9 2 2 103.0 ± 0.0 86.6 144 67.5 ± 12.3 56.7
17 2 2 105.5 ± 0.0 88.7 144 71.2 ± 11.3 59.9
21 2 2 98.0 ± 0.0 82.4 144 72.3 ± 15.3 60.7
23 2 2 65.0 ± 0.0 54.6 144 68.1 ± 15.3 57.2
26 4 12 71.3 ± 28.8 59.9 280 62.3 ± 19.6 52.4
28 2 2 84.5 ± 0.0 71.0 144 62.3 ± 19.6 63.0
32 2 2 107.0 ± 0.0 89.9 144 70.6 ± 22.8 59.3
37 10 90 87.6 ± 10.9 73.7 640 64.8 ± 20.5 54.4
38 3 6 86.8 ± 4.6 73.0 213 69.7 ± 11.3 58.6
41 10 90 93.1 ± 14.7 78.3 630 71.9 ± 13.7 60.4
52 6 30 65.8 ± 22.6 55.3 408 64.2 ± 18.6 53.9
56 2 2 105.5 ± 0.0 88.7 144 65.2 ± 23.9 54.8
Inter-ClusterIntra-Cluster
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Although the average intra-cluster similarities between strains of the same CGF-
20 or flaA-RFLP cluster are similar, the similarity distributions of all intra-cluster pair-
wise comparisons shows that there is a significant difference between both methods 
(Figure 19). The CGF-20 intra-cluster similarity distribution is skewed to the right, with 
most strains being distributed around a mean of ~ 90%. By contrast, the flaA-RFLP intra-
cluster similarity distribution appears to be bi-modal, with one peak at ~ 90% and an 
equally prominent peak at ~ 70%.  This secondary peak is due to a small number of cases 
in which strains that are quite genetically distinct (i.e., low CGF-119 similarity) share the 
same flaA-RFLP allele. Similarly, when the inter-cluster pair-wise similarity distributions 
were compared, it is possible to see that although both the CGF-20 and flaA-RFLP assays 
generate nearly identical distributions, both peaking at ~60% (Figure 20), the flaA-RFLP 
inter-cluster distribution had a slight right-handed tail. This tail could be due to a small 
number of cases in which strains with unrelated flaA-RFLP alleles share significant 
genetic similarity. 
 
4.2.6 Epidemiological comparison of the CGF-20 assay and flaA-RFLP assay 
An important consideration in molecular epidemiological studies is the concept of 
genotyping resolution because sufficient resolution is necessary in order to link 
epidemiologically related strains while excluding unrelated strains. Although the CGF-20 
assay and the flaA-RFLP assay both have similar levels of ID (Index of Diversity), the 
CGF-20 assay tends to yield more clusters of smaller size and thus, appears to have 
increased resolution. Consequently, it is important to determine if this increased level of 
resolution is useful within an epidemiological context.  
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Figure 19: Distribution of intra-cluster CGF-119 similarities for all pair-wise 
comparisons between the 74 isolates selected for CGF-119 analysis. The distribution of 
pair wise comparisons of the CGF-119 shows a higher frequency of high similarity 
matches which peaked at ~ 90% for the CGF-20 clusters. Although a similar peak was 
seen for the flaA-RFLP clusters, a secondary peak of low similarity matches was also 
seen at ~ 70%. 
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Figure 20: Distribution of inter-cluster CGF-119 similarities for all pair-wise 
comparisons between the 74 isolates selected for CGF-119 analysis. Although the 
distribution of percent similarity of pair wise comparisons between inter-cluster isolates 
was nearly identical for both CGF-20 and flaA-RFLP clusters, the right-hand of the 
distribution revealed a number of high-similarity matches between isolates of unrelated 
flaA-RFLP profiles (i.e., in different clusters). 
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An example where the CGF-20 resolution correlates with epidemiological data is 
the small six member flaA-RFLP cluster #15, containing five chicken isolates from 2004 
and one human clinical isolate from 2005 (Figure 21). Despite their unlikely 
epidemiological linkage, all of these isolates share the same flaA-RFLP allele and would 
be considered indistinguishable from each other. Based on their CGF-20 profiles 
however, the single clinical isolate (CJ339) differs from the chicken isolates at five of the 
20 loci (75% similarity), which all share the same CGF-20 fingerprint (cluster CGF-20 
#250). Given the underlying epidemiology of these isolates, the genetic differences 
observed between isolate CJ339 (cluster CGF-20 #181) and the chicken isolates would be 
best explained by lateral transfer of the flaA allele #16 into the CGF-20 #181 
background. Interestingly, six of the seven remaining CGF-20 #181 isolates in the dataset 
share the same flaA-RFLP fingerprint (flaA-RFLP #42). 
Evidence for lateral transfer, or flaA allelic transfer, is further supported by CGF-
119 data. In a specific example, two strains with flaA-RFLP type #23 but from different 
CGF-20 clusters (#10 and #172) were evaluated using the CGF-35 and CGF-119 assays 
(Figure 22). Based on flaA-RFLP assay results alone, one would predict that the isolates 
share high genetic similarity. However, examination of the CGF-119 data shows 
differences at 41 loci, demonstrating an example of isolates with identical flaA alleles but 
low CGF-119 similarity, suggesting that the flaA similarity is likely to have arisen from 
allelic transfer of flaA between unrelated isolates.  
Conversely, evidence can also be found of flaA allelic replacement between 
highly related C. jejuni strains (Figure 23). For example, CGF-20 cluster #202 is  
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CJ339 Clinical 28 181 15 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 0 0 1 1 0
CJ284 Chicken 20 250 15 0 1 1 1 0 1 1 1 0 1 1 1 0 1 1 0 0 0 1 1
CJ285 Chicken 20 250 15 0 1 1 1 0 1 1 1 0 1 1 1 0 1 1 0 0 0 1 1
CJ286 Chicken 20 250 15 0 1 1 1 0 1 1 1 0 1 1 1 0 1 1 0 0 0 1 1
CJ287 Chicken 20 250 15 0 1 1 1 0 1 1 1 0 1 1 1 0 1 1 0 0 0 1 1
CJ288 Chicken 20 250 15 0 1 1 1 0 1 1 1 0 1 1 1 0 1 1 0 0 0 1 1
CGF-20
 
Figure 21: CGF-20 relationships and fingerprints of the 6 isolates in flaA-RFLP cluster 
#15. Although these isolates have a common flaA-RFLP type, the CGF-20 fingerprints 
between the chicken isolate and the clinical isolate differ at 5 out of 20 loci resulting in 
assignment to different CGF-20 clusters. 
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Figure 22: Evidence of lateral transfer, or flaA allelic transfer, is observed when strains 
with very different CGF profiles share the same flaA-RFLP allele. In this example 
isolates CJ389 and CJ127, members of separate CGF-20 clusters (#172 and #10, 
respectively) and with very different CGF profiles, share the same flaA-RFLP allele. 
Genes present or conserved are indicated in black, and genes that are absent are indicated 
in white. 
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Figure 23: Evidence of flaA allelic replacement or exchange of flaA alleles between 
highly related C. jejuni isolates. CGF-20 cluster #202 was composed of isolates with 
three distinct flaA-RFLP alleles despite high similarity in CGF-20, CGF-35 and CGF-119 
profiles. Genes present or divergent are indicated in black, absent genes in white. 
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composed of nine isolates, seven of which had the same flaA-RFLP type (flaA-RFLP 
type #2), with two isolates from additional flaA-RFLP types (flaA-RFLP types #82 and 
136). Detailed genomic analysis using the CGF-119 assay shows very little variation in 
all nine isolates; i.e., 105 out of 119 loci (88%) had an identical gene conservation status 
in all nine isolates. As only 14 loci (12%) varied between all nine strains, the evidence 
strongly suggests that the flaA allele has been replaced in strains that otherwise (i.e., 
based on the majority of the hypervariable loci assayed by the CGF-119 assay) would 
appear to be highly related. Interestingly, three of the isolates (CJ266, CJ267, and CJ271) 
shared several additional polymorphisms not found in the other isolates.   
Although these examples represent only anecdotal evidence for the usefulness of 
the increased resolution provided by the CGF-20 assay, and to an even greater extent the 
CGF-119 assay, the importance of validating such findings with relevant datasets with 
more detailed epidemiological information cannot be overstated. 
 
4.2.7 Examination of highly prevalent CGF-20 genotypes among the southern Alberta 
data set 
Although 111 distinct CGF-20 fingerprints were found among the 260 clinical 
isolates in the dataset (i.e., the 260 clinical isolates segregate into 111 distinct CGF-20 
clusters), six CGF-20 clusters (#10, 169, 172, 190, 202 and 255) contained 31.3% (81 of 
260) of all clinical isolates in the dataset (Figure 24).  
Selected isolates from these six CGF-20 clusters were analyzed using the CGF-
119 assay in order to confirm genetic relationships and examine the genetic content of  
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CGF-10
CGF-169
CGF-172
CGF-190
CGF-202
CGF-255
Unique profiles (50)
All Other (52 profiles)
 
Figure 24: Proportion of clinical isolates by CGF-20 cluster represented as a percentage 
of all clinical isolates in the dataset (n=260). Approximately one-quarter of all strains 
appear as unique genotypes based on the CGF-20 fingerprint, while one third of the 
dataset is found within six fingerprints appearing over multiple time periods, which may 
suggest that these fingerprints could be persistent within the environment. 
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these isolates with a greater degree of resolution. CGF-119 data reveals that the isolates 
from a given CGF-20 cluster are more similar to one another than to isolates outside the 
cluster, suggesting that they represent genetically distinct clonal groups or strains of 
clinical importance in southern Alberta (Figure 25). The additional markers in the CGF-
119 assay, however, can further discriminate the isolates within a CGF-20 cluster into 
sub-types based on the presence/absence of certain genes. 
Interestingly, these six prominent “clinically-associated” CGF-20 clusters contain 
isolates from chicken, cattle, bison, and water. As these clinical isolates share CGF-20 
profiles with isolates from each of these sources and can share high levels of genetic 
similarity when examined with the CGF-119 assay, it is likely that these non-human 
isolates share phenotypic properties, including the ability to cause illness in humans, with 
the human clinical isolates. This strongly suggests these various sources represent 
possible reservoirs for C. jejuni strains of public health importance.  
Although all of the genotypes examined appear throughout the sampling period, 
several of the fingerprints (CGF-20 clusters #169, #172, #190, and #202) appeared to 
occur more often (Figure 26). For example, isolates belonging to CGF-20 cluster #10 
appeared most often and were isolated in 12 different months and across multiple 
sampling years.  It would appear that these clinical C. jejuni genotypes are at least 
persistent, if not endemic to the southern Alberta region. 
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CJ409
Chicken
 
 
 
21
172
37
DCDAADCDACDCCDDCDACCDCCCCCDCCAADCCCACCDADCCACCDDDCCCACDCCDDCAAADAAAAAAADDCDCDCDAACDDDDDDDACACAAACDCAAAAAAAAAAAAAAADCCDC
CJ419
H
um
an
 
 
 
 
 
29
190
37
ACCAACCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCACCCCCCCCCCCCACCAADCCCCCCAAAAAAAAACCCCCCCCCCCCCCCCCCCCACCCCCCAAAACAAACCCAAACCCCC
CJ420
H
um
an
 
 
 
 
 
29
190
37
ACCDACCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAADCCCCCCCCCCCCCAACCCCCCCCCDAAAACCACACDAACCCACAAACACCCCCAAACCCCC
CJ421
H
um
an
 
 
 
 
 
29
190
26
ACCDACCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAAACCCCCCCCCCCCCAACCCCCCCCCCCCCCCCACCCACACCCACCAACAACCCCCCCCCCCC
CJ422
H
um
an
 
 
 
 
 
29
190
26
ACCCACCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAACCCCCCCCCCCCCCAACCCCCCCCCCCCCCCCACCCACACCCCCCCACCCCCCCCCCCCCCC
CJ426
H
um
an
 
 
 
 
 
29
190
56
ACCAACCCDCCCCCCCCCCCCCCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAADCCCCCCCCCCCCCAACCCCCCCCCCCCCCCCACCCACACCCAAAAAAAAAAAAAAACCCCC
CJ427
H
um
an
 
 
 
 
 
29
190
56
ACCDACCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAADCCCCCCCCCCCCCAACCCCCCCCCCCCCCCCACCCACACCCCCCAACAACCCCCCCCCCCC
CJ433
H
um
an
 
 
 
 
 
27
.5
190
80
ACCCACCCCCCCCCCCCCCCACCCCCCCCCCCCCCCCACACCCCCCCCCCCCACCAADCCCCCCDCCCCCCADCCCCCCCCCCCCCCCCACCCACDCCCAACAACAACCCCAAACCCDC
CJ436
C
attle
 
 
 
 
17
190
37
ACDCACCCCCCCCCCCCCCCACCCCCCCCCCCCCCCCACADCCCCCCCCCCCACCAAACCCCCCCCCCCCCAACCCCCCCCCCCCCCCCCCCCACCCCCAAAAAAAAAAAAAAACCCCC
CJ442
Chicken
 
 
 
39
190
37
ACDDADDDDCDCDDDDADCCACCDCCDCCCCDCCCDCADADCCCCCADDCCCACDAAADCCCCAADDCCDDAACCCDCCCDCDCDDCDDADDDAAACDCAAAAAAAAAAAAAAACCCDC
CJ264
H
um
an
 
 
 
 
 
27
202
2
ACCCCCCACCCCCCCCCDCCCCAAAAAAAAAACCCCACCAACCCCCACCCCCAACAACCCCCCCDAAAAAAAACCCCCCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCCCC
CJ265
H
um
an
 
 
 
 
 
27
202
2
ACCCCCCACCCCCCCCCDCCCCAAAAAAAAAACCCCACCAACCCCCACCCCCAACAACCCCCCCAAAAAAAAACCCCCCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCCCD
CJ266
H
um
an
 
 
 
 
 
28
202
2
ACCCACCACCCCCCCCCACCACAAAAAAAAAACCDCACCAACCCCCDCCCCCAACAACCCCCCCAAAAAAAAACCCCCCDCAAAAAAAAAAAAAAAAAACCCAACAACCCCAAACCCCD
CJ267
H
um
an
 
 
 
 
 
28
202
2
ACDCADCADCCCDCDDCACCACAAAAAAAAAACCDCACDAACCDCDACCCDCAACAACCDCCCCCAAAAAAAACCCCCDACAAAAAAAAAAAAADAAAACCCAACAACCCCAAACCCCD
CJ271
H
um
an
 
 
 
 
 
29
202
2
ACDCACCACCCCCCCCCACCCCAAAAAAAAAACCCCACCAACCCCCACCCCCACCAACCCCCCCAAAAAAAAACCCCCCDCAAAAAAAAAAAAAAAAAAAACAACAACCCCAAACCCCD
CJ272
H
um
an
 
 
 
 
 
27
.5
202
82
ACCCACCACCCCCCCCCDCCCCAAAAAAAAAACCDCACCAACCCCCACCCCCAACADCCCCCCCAAAAAAAAACCCCCCCCAAAAAAAAAADAAAAAAAAAAAAAAAAAAAAAACCCCC
CJ277
W
ater
 
 
 
 
 
20
202
2
ACCCACCACCCCCCCCCDCCCCAAAAAAAAAACCCCACCAACCCCCACCCCCAACAACCCCCCCAAAAAAAAACCCCCCDCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCCCD
CJ278
C
attle
 
 
 
 
28
202
136
ACCCACCACCCCCCCCCDCCCCAAAAAAAAAACCCCACCAACCCCCDCCCCCAACAACCCCCCCDAAAAAAAACCCCCCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCCCD
CJ279
C
attle
 
 
 
 
40
202
2
ACCCACCACCCCCCCCCDCCACAAAAAAAAAACCCCACCAACCCCCDCCCDCAACAACCDCCCCDAAAAAAAACCCCCCDCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCCCD
CJ249
H
um
an
 
 
 
 
 
29
255
9
ACCCACDDCAACCCCCCCCCCCCCCCCCCACCCDCCCCCAACCDACCCCCDCAACCCCCCACCCAAAAAAAAACCCAAAACAAAAAAAAADAAAAAADAAAAAAAAAAAAAAAACCCCC
CJ250
H
um
an
 
 
 
 
 
29
255
9
ACCCACDDCAACCCCCCDCCDCCCCCCCCACCCACCCCCAACCDACCCCCDCAACCCCDCACCCAAAAAAAAACCCAAAACAAAAAAAAAADAAAAADAACCAACAACCCCCCCCCCDC
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Figure 25:  Detailed genomic analysis of suspected endemic clones in southern Alberta. 
A subset of clusters containing the six suspected endemic CGF-20 fingerprints were 
evaluated using the CGF-119 assay. Isolates with these six genotypes comprise ~31% of 
all clinical isolates in the dataset. While flaA-RFLP type usually correlates with CGF-20 
cluster, several CGF-20 cluster that have highly similar CGF-119 profiles have multiple 
flaA-RFLP types. Black is used to indicate genes that are conserved or divergent, and 
white to indicate genes that are absent. 
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Figure 26: Temporal distribution of the six CGF-20 clusters containing a high proportion 
of clinical isolates in the dataset. Several CGF-20 clusters (#10, 169, 172, 190, 202 and 
155) containing clinical isolates appeared at multiple times over the sampling period from 
September 2003 to August 2006. These profiles were not restricted to one particular 
source and were isolated from animal, environmental and clinical isolates (source of 
isolation not shown) suggesting that these profiles may be endemic to southern Alberta. 
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4.3 Discussion 
Comparison of CGF-20 and flaA-RFLP clustering results shows that although the 
CGF-20 method tends to generate more clusters with a smaller average cluster size, that 
both methods ultimately have a similar Simpson’s Index of Diversity. Therefore, it is 
important to examine the performance of the methods in an epidemiological context. 
Analysis of the overall genetic similarity between strains within flaA-RFLP and 
CGF-20 clusters (i.e., intra-cluster similarity) using CGF-119 data showed that strains 
with the same CGF-20 fingerprint tend to have a higher level of genetic similarity 
(~87%) compared to strains with the same flaA-RFLP fingerprint (~77%).   
Interestingly, when examining genetic similarity among strains outside flaA-
RFLP and CGF-20 clusters (i.e., inter-cluster similarity) both methods had a similar level 
of inter-cluster similarity (~66%). This level of similarity appears to represent the genetic 
relatedness expected for any two random C. jejuni strains when these strains are assessed 
using the CGF-119 assay. It is important to note, that the loci included in the CGF-119 
assay were selected from the ~20% of the genes that represent the most variable portions 
of the C. jejuni genome. As the assay is designed to uncover genetic variability and to 
provide enhanced typing resolution, it presents an over-estimation of genetic differences 
among strains because it does not include any of the C. jejuni genes that are conserved in 
all of the strains. Thus, the intra-cluster genetic similarity among strains within a CGF-20 
cluster, and to a lesser extent within a flaA-RFLP cluster, is underestimated by the CGF-
119 data. The assay, however, yields a comparable level of sub-typing resolution to 
whole-genome comparative genomic analysis (E. Taboada, personal communication) and 
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therefore represents a benchmark against which the CGF-20 and flaA-RFLP assays can 
be measured. 
While the rates of intra-cluster and inter-cluster CGF-119 similarity vary between 
different CGF-20 clusters, in 12 of 13 clusters examined the intra-cluster similarities 
were significantly higher than inter-cluster similarities (~ 90% vs. 60%). When the 
distributions of pair-wise intra-cluster similarities were compared, while a similar peak 
was observed at 90% for both methods, the flaA-RFLP intra-cluster had a prominent 
secondary peak at 70%. This suggests that while flaA-RFLP and CGF-20 clusters can be 
highly predictive of overall genetic similarity, in many instances flaA-RFLP can cluster 
isolates that share only marginally higher similarity (~ 10%) than the background ‘noise’ 
of genetic relatedness observed between isolates from different clusters. Interestingly, 
although the pair-wise inter-cluster CGF-119 similarity distributions for both methods 
had a nearly identical shape with a prominent peak at ~ 60%, the flaA-RFLP distribution 
differed from that of the CGF-20 by the presence of a small right-handed peak, which 
suggests that in a small number of cases, isolates can share significant overall genetic 
similarity despite having different flaA-RFLP alleles. Taken together, both of these 
observations (isolates of the same flaA-RFLP type with low CGF-119 similarity; isolates 
of different flaA-RFLP type with high CGF-119 similarity) are consistent with potential 
lateral transfer or allelic replacement of flaA alleles. The flaA gene is known to be a 
‘hotspot’ for recombination in the C. jejuni genome and is known to be subjected to high 
rates of lateral transfer (Mellmann et al., 2004). One effect of these high rates of 
recombination is a reduction in the accuracy of inferred strain to strain relationships due 
to the ‘uncoupling’ of the flaA locus from the rest of the genome: strains that are 
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genetically related can have different flaA alleles and strains that are genetically 
unrelated can have the same flaA allele. Consistent with this evidence, several prominent 
flaA-RFLP types which appear to be segregated into multiple CGF-20 clusters and 
prominent CGF-20 clusters comprised of strains with diverse flaA-RFLP types were 
observed.  The most parsimonious explanation for the flaA type composition in these 
clusters would be for allelic replacement of the flaA locus by recombination in strains 
that originally had the same flaA allele, and highlights problems with only using one or a 
small number of loci in the genome for predicting overall genetic content. 
Both the CGF-20 method and the flaA-RFLP typing method were able to uncover 
possible genotypic connections between isolates that were missed by the alternate 
method. One weakness of this dataset is that there is a lack of sufficiently detailed 
epidemiologic data (due in part to privacy restrictions of potentially personal information 
about the clinical isolates) to fully assess the likelihood of these connections in a 
quantitative manner. The CGF-119 data, however, can provide an appropriate context 
with which to examine the likelihood of clustering results obtained with either method 
because of its enhanced sub-typing resolution. If the typing method generates clusters of 
genetically related isolates, the intra-cluster CGF-119 similarities are expected to be 
high. Whereas the CGF-119 similarity data shows that ~22% (31 of 142) of flaA-RFLP 
intra-cluster pair-wise comparisons have low similarity levels (i.e.,  65%) that are no 
better than those obtained from isolates outside the cluster, for CGF-20 the proportion is 
significantly lower (~4%, or 9 of 229). Conversely, if the typing method is able to 
generate clusters that are genetically distinct from one another, the inter-cluster CGF-119 
similarities are expected to be low. Whereas the proportion of flaA-RFLP inter-cluster 
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pair-wise comparisons that have the high similarity levels (i.e.,  90%), i.e., that might be 
expected for isolates within a cluster is ~2.4% (62 of 2559), for CGF-20 it is considerably 
lower (~0.5%, or 12 of 2472). The analysis of CGF-119 data for flaA-RFLP and CGF-20 
clusters would suggest that more meaningful fingerprints were produced using the latter 
method, although a thorough analysis of “epidemiological fit” should be the focus of 
future studies. 
Although the flaA-RFLP and the CGF-20 typing methods generated different 
numbers of clusters, both methods produced approximately eight large clusters 
containing isolates obtained from each of the various sources sampled. A comparison of 
cluster composition, however, revealed that the eight flaA-RFLP clusters contain 216 
isolates compared to 87 isolates in the eight CGF-20 clusters, with only 50 isolates 
common to both sets of clusters. Although, based on the available epidemiological data, it 
is impossible to determine the likelihood that the isolates not identified by both typing 
methods truly represent clusters of genetically related organisms found in the various 
sources sampled. Our data suggests that the genotypes represented by the 50 overlapping 
isolates are likely to be common in this geographical region, can circulate between the 
various reservoirs, and are of public health significance since they are able to cause 
illness in humans.  
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Chapter 5  
 
5. Review of Thesis 
Campylobacter jejuni has a highly variable “accessory” pool of genes consisting 
of 30-40% of the genome. As a result, genome content varies among strains of C. jejuni, 
with a select number of genetic regions in the C. jejuni genome being highly plastic 
(Pearson et al., 2003; Taboada et al., 2004). Whole genome comparative genomic 
methods (i.e., sequencing, comparative genomic hybridization) therefore represent the 
most appropriate approach to fully address the genetic relatedness of two strains. 
However, comparative genomic analyses remain slow, costly and labor intensive and 
have yet to find a use in routine bacterial typing and molecular epidemiology. 
In response to these challenges, our group has developed an advanced genotyping 
method, comparative genomic fingerprinting or CGF, based on the theoretical foundation 
of comparative genomics but utilizing conventional molecular biology methods available 
to most laboratories. CGF is based on assessing the gene conservation profile of genes 
known to be variably absent or present (VAP) in the species of interest and utilizing this 
information as a genetic fingerprint for genotyping purposes. The resulting fingerprints 
can be compared and used to assess the degree of genetic relatedness of strains based on 
the percentage of conserved loci shared. An advantage of comparative genomic 
fingerprinting compared to other methods and, in particular, to band-based fingerprinting 
methods, is that analysis at reduced stringencies may retain biologically meaningful 
‘inferred genetic relatedness’. Although CGF fingerprints can only be used to estimate 
the genetic content of a strain, they appear to provide a relevant assessment of overall 
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genetic relatedness. Comparative genomic fingerprinting at 20 VAP loci (CGF-20) can be 
performed at a fraction of the time and cost of other molecular typing methods, including 
MLST and PFGE. As demonstrated in Chapter 3, CGF-20 fingerprints are non-
ambiguous, robust and easily reproducible, which make them amenable to inter-
laboratory comparison.  
Possible applications of the CGF-20 assay could be to provide a basis for rapid 
and low-cost identification of prominent lineages that could then be verified with the 
slower but higher resolution CGF-35 or CGF-119 assays. Although it may be intuitive to 
assume that the highest levels of resolution are always preferable, because of the 
significant level of correlation between the CGF-20 and CGF-119 data, clustering 
obtained with the CGF-20 assay could be used to rapidly identify lineages that may 
represent groups that have a shared epidemiology, that share certain biological 
characteristics, or that may have become adapted to a particular environmental niche. 
Conversely, the increased resolution provided through the addition of supplementary loci 
in the CGF-35 and, to a greater extent, CGF-119 assays could refine the clusters to 
provide an enhanced ability to discriminate between strains for which differences in 
underlying geographical, temporal or source parameters may be associated with the 
acquisition of additional genetic differences, thus enabling confirmation of 
genetic/epidemiological links with a higher confidence. 
In this thesis, a dataset comprised of 641 C. jejuni isolates from human clinical, 
animal, and environmental sources was analyzed using the CGF-20 assay in order to 
address basic questions about the molecular epidemiology of C. jejuni in southern 
Alberta. The data indicates that in addition to the traditionally recognized reservoirs of 
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infectious C. jejuni (i.e. commercial poultry), several common farm animals and wild 
animals native to southern Alberta can also harbor humanpathogenic C. jejuni. The 
reoccurrence of highly related CGF-20 fingerprints among species over time may 
indicate that not only are campylobacters being shed into the environment; but that they 
persist while acquiring subtle genetic differences over time. That several species of 
animals harbor and shed campylobacters that share identical CGF-20 profiles to human 
clinical isolates represents a public health concern. These matching profiles do not appear 
to be due to random chance, as validation using CGF-119 data identified several groups 
of strains from animal and human sources that were nearly identical as assessed by the 
CGF-119 assay. Since this assay was designed to “amplify” genetic differences between 
strains by targeting the most variable loci in the C. jejuni genome, it therefore appears 
that these animal species may shed C. jejuni, some of which appear to have pathogenic 
capabilities. Interestingly, four animal species often shared CGF profiles with clinical 
isolates: chicken, cattle, sheep and pigs. As many of the bacterial isolates were of cattle 
and sheep origin, two animals not commonly investigated for Campylobacter spp. 
carriage, they must be considered as potential links in the chain leading to human 
infection. Current campylobacteriosis rates in southern Alberta are double the rates found 
in other regions of Canada. New Zealand also has been facing rates of campylobacteriosis 
with epidemic proportions (Baker et al., 2006). It is interesting to note that both southern 
Alberta and New Zealand are known for both sheep and cattle production. Our data also 
suggest that bison also require more investigation as a potential reservoir of pathogenic 
campylobacters in southern Alberta and elsewhere. Although bison ranches are rare, 
several are located in southern Alberta. Out of seven bison fecal samples obtained in this 
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study, four were positive for C. jejuni, and each of these matched with at least one 
clinical isolate in our dataset using both flaA-RFLP typing and CGF typing. Although 
bison meat has been tested for other microbes, association of campylobacters with this 
meat has not been established (Gill, 2007).  
Several instances where animal, water and clinical isolates shared profiles were 
found which suggests that a chain of transmission between all three reservoirs is possible. 
This supports the concept that agriculture, including livestock production and spreading 
of manure on crops leads to an increase in fecal coliforms in surface waters (Johnson et 
al., 2003), making it likely that campylobacters from animal manure enter the southern 
Alberta waterways. The most common manure spread in southern Alberta is from cattle, 
seconded by swine, and use of composted manure as a carbon credit is likely to increase 
in the future with pending carbon emission legislation (Coulter, 2008; Papworth & Olson, 
2002). In addition, cattle are estimated to produce 4.9 to 5.4 kg of manure per head each 
day (Ormann, 2005) and Alberta has both a beef cattle population of over 5.5 million and 
possesses an extensive feedlot production system with 2.36 million head of finished cattle 
processed in 2002 (http://www.growingalberta.com/features/default.asp?id=93). This 
suggests that at least 26.9 to 29.7 million kg of manure are produced from beef cattle in 
Alberta daily. These and other animal sources of fecal matter are likely important sources 
of Campylobacter spp., and other bacterial pathogens, into the natural waters of southern 
Alberta. Another route of transmission that will require investigation in southern Alberta 
and that has been recently suggested based on ongoing work on campylobacters in 
Iceland, could be from insects such as flies acting as vectors to transmit campylobacters 
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from manure directly to food or into the food production environments at various points 
along the farm to fork continuum (Guerin et al., 2007). 
An important finding from this study is the detection of a small number of 
genotypic lineages comprising a significant proportion of clinical isolates in our dataset. 
This suggests that some strains of C. jejuni with increased virulence may be endemic to 
the region, and may be maintained in asymptomatic animal hosts as isolates with 
identical profiles were obtained from human clinical and animal fecal samples. For 
example, among the 4 isolates obtained from buffalo in the study, the first two isolates 
obtained were identical to clinical isolates obtained several months later, whereas the 
later two samples obtained near the end of the study were identical to clinical samples 
that were obtained early, but persisted over several months; these isolates also were 
observed months later in chickens. Although it appears that some of these genotypes and 
relevant clusters are present in the environment and are of clinical concern during certain 
months, this is likely to be an artifact due to seasonal sampling bias as water samples 
were not collected when water surfaces were frozen and fecal sample collection declined 
during poor weather conditions. The temporal distribution of some of these genotypes is 
such that they appear in isolates obtained over several different sampling years and 
consequently, may be endemic to southern Alberta. The high prevalence of six genotypes 
among the clinical isolates in our dataset (~31%) suggests that they represent genotypes 
with an increased risk to human health that should be investigated further in order to 
identify possible genetic commonalities that could be targeted for diagnostic purposes.  
 Due to the plasticity seen in the genome of C. jejuni, genetically related strains 
identified on the basis of estimating whole genome genetic content should define more 
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complete and useable genetic relationships for multiple applications rather than methods 
based on one or a limited number of genes. The CGF-20 and CGF-35 assays were 
validated with the CGF-119 assay, which additional ongoing work in our laboratory has 
shown it to be a robust predictor of overall genome similarity between strains (E. 
Taboada, personal communication). CGF methods allow for rapid visualization of genes 
present throughout the entire genome allowing for patterns of gene transfer, loss and 
acquisition to be observed and analyzed in the context of underlying epidemiology and 
phenotype. The methodology also enables a comparison of the genetic relatedness of 
strains to be assessed with an unprecedented level of resolution, even for strains that have 
similar genotypes. This is in contrast to band-based methods such as flaA-RFLP or 
PFGE, which can be used to infer genetic similarity in the case of identical or highly 
related banding patterns, but in which increasing levels of fingerprint divergence can 
quickly translate into an inability to assess genetic relatedness with any level of accuracy.  
Although multi-locus sequence typing (MLST) has been shown to predict overall genetic 
similarity among strains (Taboada et al., 2008), it would not be able to predict the pattern 
of conservation within the hyper-variable regions of the genome, which could result in a 
change to the phenotype between strains of the same MLST type. Natural competence 
and high rates of lateral gene transfer in C. jejuni pose an additional challenge in inferring 
genetic relatedness of strains since these events occur readily and genetic divergence can 
therefore arise rapidly. By evaluating 20 different loci interspersed across the genome 
and targeting most of the hyper-variable loci in the C. jejuni genome, the CGF-20 assay 
is better able to compensate for these effects by providing sufficient data at many loci, 
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hopefully identifying changes that might not have been observed if only one locus is 
studied.  
A number of issues limited our ability to identify and validate epidemiological 
linkages among matching isolates obtained from clinical, animal and environmental 
sources. For instance, although the majority of water and animal samples were obtained 
from within the Oldman River Basin in the Chinook Health Region, during this study, I 
was unable to obtain clinical samples from the same corresponding region. The clinical 
samples, which were from the Calgary Health Region, lacked exact diagnoses and 
isolation dates due to privacy restrictions. For animal and water sources, sampling was 
not done year round, since water collection did not occur during the winter months, and 
animal fecal collection occurred sporadically throughout the Oldman River watershed. 
Despite these concerns, the strong connections observed based on the genotyping data 
and the available epidemiological data suggest that many C. jejuni isolates from animals 
and contaminated water in this region represent a public health risk. 
 
5.1 Thesis Conclusions 
A method of comparative genomic fingerprinting (CGF) for genotyping 
Campylobacter jejuni based on the presence or absence of 20 highly variable genes 
(CGF-20) located throughout the C. jejuni genome has been presented in the analysis of 
641 isolates of human, animal, and environmental origin obtained in southern Alberta. 
The CGF-20 data was validated two-fold: all isolates were also genotyped using flaA-
RFLP, and a subset of these isolates was also analyzed using higher genetic resolution 
CGF-35 and CGF-119 assays, which are based on 35 and 119 highly variable genes in the 
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C. jejuni genome, respectively. Based on the work presented in this thesis, the following 
conclusions can be reached: 
 
1. The CGF-20 assay was shown to be a highly robust assay based on validation 
using the CGF-35 assay using a subset of isolates from the dataset, since ~98% of 
all loci queried yielded matching data when the assay was repeated. 
 
2. The QIAxcel-based assay presents a high-throughput CGF assay capable of high-
resolution genotyping (i.e., using the CGF-35 assay) of 96 samples per day at a 
cost of ~ $10 CAD per sample; the lower resolution CGF-20 assay can achieve 
twice the throughput of the CGF-35 assay at half the cost. This is in contrast with 
MLST, the current gold standard for C. jejuni genotyping, which anecdotal 
evidence from research collaborators shows to have a throughput of 96 samples in 
4 weeks or more at a cost of ~$50-75 per sample. 
 
3. The CGF-20 assay was found to be functionally equivalent to the CGF-119 assay 
since isolates with a given CGF-20 cluster shared high levels of similarity in 
CGF-119 fingerprints. The CGF-119 assay is highly predictive of whole-genome 
genetic similarity among strains as it incorporates more than half of known 
variably absent/present genes while targeting all the highly variable regions in the 
C. jejuni genome. The CGF-20 assay thus represents a rapid and inexpensive 
method for genotyping C. jejuni that can be used to rapidly establish groups or 
clusters of strains with high levels of whole-genome genetic similarity. In 
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addition, for the majority of purposes, the resolution of 35 and 119 gene 
fingerprints would be too high when analyzed at the level of 100% identity, and 
may need to be evaluated using a lower level of stringency to increase the 
possibility of finding matches between closely related although not identical 
strains. This is particularly important for an organism such as C. jejuni, which is 
known to undergo rapid genetic change. 
 
4. The CGF-20 assay, when applied to a molecular epidemiological study of C. 
jejuni isolates from southern Alberta was able to generate epidemiologically 
relevant clusters. CGF-20 results were also compared to flaA-RFLP data. Both 
methods were shown to yield similar results by generating clusters comprised of 
isolates with high genetic similarity while excluding unrelated isolates. The CGF-
20 assay, however, produced smaller clusters with a higher within-cluster, or 
intra-cluster, similarity when compared to flaA-RFLP.  
 
5. The data presents strong evidence for two types of lateral transfer of the flaA 
allele. The first type, flaA allelic replacement, was observed when strains deemed 
to be highly similar based on CGF-119 profiles had unrelated flaA-RFLP profiles. 
The second type, flaA allelic transfer, occurred in cases where two strains 
appeared to be vastly different based on CGF-119 profiles but nevertheless shared 
the same flaA alleles. Since the CGF-119 fingerprints are based on data on a large 
number of loci spread across the genome (in contrast to the flaA-RFLP data, 
which is based on a single locus known to be undergoing constant 
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recombination), the most parsimonious explanation would suggest that in these 
cases the flaA allele was transferred between unrelated strains or replaced 
between related strains. CGF provides a better assessment of whole-genomic 
similarity as numerous genes from hypervariable areas of the genome are 
evaluated.  
 
6. Our data indicates that in addition to the currently recognized reservoir of poultry, 
other livestock such as cattle, sheep, and pigs can harbour C. jejuni strains with 
genotypes that match those from human clinical cases. As there were found 
several instances where animal, water and clinical isolates shared genotypic 
profiles, this would suggest that transmission can occur between all three 
reservoirs. Determining the mechanism of transmission is an extremely important 
subject for subsequent investigations so that it is possible to determine how to 
best implement control measures (i.e., changes to the manufacturing, handling or 
consumption of meat, treatment of water, or treatment of manure) so as to reduce 
campylobacteriosis in southern Alberta. 
 
7. At least six ‘endemic’ clinically-associated CGF-20 genotypes were identified. 
The high prevalence of these six genotypes among the clinical isolates in our 
dataset (~31%) would suggest that they represent genotypes with an increased 
risk to human health and should be investigated further. Whole genomic analysis 
of strains with these genotypes could be useful in identifying genes that may 
important in virulence and are worthwhile targets for additional investigation.  
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8. This study establishes the C. jejuni CGF-20 as a high-throughput molecular 
typing method is able to predict genetic similarity, yield epidemiologically 
relevant clusters, and be suitable for phylogenetic and molecular epidemiological 
applications. The methodology is robust and can enable rapid and inexpensive 
molecular epidemiological analysis, and straightforward collaboration between 
members of the national or international public health and research laboratory 
communities.  
 
9. A combined approach using CGF assays of varying resolution (i.e., using a 
different number of variably present/absent genes) coupled with detailed 
epidemiological information could prove useful in future genomics-based 
molecular epidemiological studies of C. jejuni. Although for the majority of 
purposes the 20 gene fingerprint has enough resolution to allow for rapid 
determination of important genotypic clusters, the increased resolution of the 35 
and 119 gene fingerprints may be useful for further refining genotypic clusters in 
the context of epidemiological investigations. This is particularly important for an 
organism such as C. jejuni, which is known to undergo rapid genetic change. 
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Appendix A: Table of 641 isolates that compose the southern Alberta C. jejuni data set. 
As well as the sample type, the source, 2-digit representation for the month of isolation, 
location of travel if travel occurred prior to clinical symptoms for strains isolated from 
patients. Month of isolation begins with month 1 set as June, 2002 and month 43 as 
August, 2006. The 74 isolates selected for further genetic analysis by CGF-35 and CGF-
119 are indicated with an asterisk (*). Due to privacy concerns, several clinical isolates 
were only provided with year of isolation. This isolates were treated as month “27.5” to 
allow for identification and exclusion from concurrent month calculations. Similarly, not 
all water locations could be released and are listed as “water” under source. Isolates 
previously evaluated in-house in Guelph, Ontario using several typing methods and 
fulfilled the purpose of known reference strains, and are labeled as “reference” to 
separate these from isolates obtained in Alberta. Continued on the following pages. 
Key  Sample Type Source Travel Month CGF-35/119
CJ001 Animal Pig 29
CJ002 Animal Pig 29
CJ003 Water Water 27 *
CJ004 Water Water 27 *
CJ005 Water Water 27 *
CJ006 Water Water 27
CJ007 Water Water 27
CJ008 Water Water 29 *
CJ009 Water Water 29
CJ010 Water Water 29 *
CJ011 Animal Cattle 29 *
CJ012 Animal Cattle 29 *
CJ013 Animal Sheep 29 *
CJ014 Animal Cattle 29
CJ015 Animal Cattle 29
CJ016 Animal Cattle 29
CJ017 Animal Horse 31 *
CJ018 Animal Horse 31
CJ019 Water LB4W2 20
CJ020 Water LB4-14 20
CJ021 Animal Cattle 31
CJ022 Animal Horse 31
CJ023 Animal Pig 41
CJ024 Animal Pig 41
CJ025 Clinical Human 29
CJ026 Clinical Human 30
CJ027 Reference Chicken 18
CJ028 Reference Chicken 18
CJ029 Clinical Human 29
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Key  Sample Type Source Travel Month CGF-35/119
CJ030 Clinical Human 29
CJ031 Clinical Human 29
CJ032 Clinical Human 30
CJ033 Clinical Human 30
CJ034 Reference Human 17
CJ035 Animal Cattle 18
CJ036 Reference Chicken N/A
CJ037 Clinical Human 27.5 *
CJ038 Water Water 15 *
CJ039 Water Grand Falls 20
CJ040 Animal Goose 41 *
CJ041 Clinical Human 28
CJ042 Clinical Human 27.5
CJ043 Animal Goose 42
CJ044 Animal Duck 42
CJ045 Water LB4W3 20
CJ046 Animal Cattle 31
CJ047 Animal Duck 19
CJ048 Water B7 19
CJ049 Reference Wild avian 17
CJ050 Water SU-53 42
CJ051 Clinical Human 30
CJ052 Clinical Human 30
CJ053 Clinical Human 30
CJ054 Water B5 19
CJ055 Water LB4W 19
CJ056 Clinical Human 30
CJ057 Animal Sheep 16
CJ058 Animal Cattle 17
CJ059 Animal Cattle 17
CJ060 Animal Sheep 40
CJ061 Animal Cattle 33
CJ062 Clinical Human 29
CJ063 Clinical Human 29
CJ064 Reference Reference 19
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Key  Sample Type Source Travel Month CGF-35/119
CJ065 Animal Duck 42
CJ066 Clinical Human 27.5
CJ067 Water Water 1
CJ068 Water Water 15
CJ069 Water Water 16
CJ070 Animal Goose 19 *
CJ071 Animal Goose 19
CJ072 Animal Goose 19
CJ073 Water LB4W 19
CJ074 Water LB4 20 *
CJ075 Animal Duck 20
CJ076 Animal Duck 41
CJ077 Animal Duck 41 *
CJ078 Animal Goose 42 *
CJ079 Animal Duck 41
CJ080 Animal Sheep 31
CJ081 Animal Sheep 33
CJ082 Animal Sheep 33
CJ083 Clinical Human 29
CJ084 Clinical Human 30
CJ085 Clinical Human 30
CJ086 Clinical Human 22
CJ087 Water Water 40
CJ088 Water SU-52 42
CJ089 Reference Human 8
CJ090 Reference Human 9
CJ091 Water B4 19
CJ092 Clinical Human 30
CJ093 Clinical Human 30
CJ094 Clinical Human 30
CJ095 Clinical Human 30
CJ096 Clinical Human 30
CJ097 Clinical Human 29
CJ098 Water LB4W 20
CJ099 Water LB4W2 20
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Key  Sample Type Source Travel Month CGF-35/119
CJ100 Reference Chicken 17
CJ101 Animal Sheep 31
CJ102 Animal Sheep 31
CJ103 Clinical Human 27
CJ104 Clinical Human 27
CJ105 Clinical Human 27
CJ106 Animal Sheep 31
CJ107 Water B7 19
CJ108 Water B5 19
CJ109 Clinical Human 27.5
CJ110 Clinical Human 28 *
CJ111 Clinical Human 16 *
CJ112 Clinical Human 29 *
CJ113 Animal Cattle 17 *
CJ114 Animal Cattle 17 *
CJ115 Animal Sheep 29 *
CJ116 Animal Sheep 29 *
CJ117 Animal Sheep 33 *
CJ118 Animal Goat 33 *
CJ119 Animal Cattle 43 *
CJ120 Clinical Human 27.5
CJ121 Animal Cattle 17
CJ122 Animal Cattle 17
CJ123 Animal Cattle 30
CJ124 Animal Cattle 17
CJ125 Clinical Human 27
CJ126 Clinical Human 27 *
CJ127 Clinical Human 29 *
CJ128 Clinical Human 29 *
CJ129 Clinical Human 29
CJ130 Clinical Human 29
CJ131 Clinical Human 29
CJ132 Clinical Human 29
CJ133 Clinical Human 29
CJ134 Clinical Human 29
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Key  Sample Type Source Travel Month CGF-35/119
CJ135 Clinical Human 29
CJ136 Clinical Human 29
CJ137 Clinical Human 29
CJ138 Clinical Human 29
CJ139 Clinical Human 30
CJ140 Clinical Human 30
CJ141 Clinical Human 27.5
CJ142 Animal Chicken 18 *
CJ143 Animal Chicken 18
CJ144 Animal Chicken 18
CJ145 Water Pine Creek 29 *
CJ146 Animal Goose 41
CJ147 Animal Pelican 41
CJ148 Animal Duck 42
CJ149 Animal Chicken 42
CJ150 Animal Chicken 42
CJ151 Animal Chicken 42
CJ152 Reference Reference N/A
CJ153 Reference Human 9
CJ154 Animal Pig 41
CJ155 Animal Pig 41
CJ156 Animal Chicken 20
CJ157 Animal Chicken 20
CJ158 Clinical Human 27.5
CJ159 Clinical Human 15.5
CJ160 Animal Pig 18
CJ161 Animal Pig 18
CJ162 Animal Cattle 18
CJ163 Animal Sheep 29
CJ164 Clinical Human 30
CJ165 Clinical Human 30
CJ166 Clinical Human 30
CJ167 Water Water 18
CJ168 Animal Sheep 16
CJ169 Animal Sheep 16
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Key  Sample Type Source Travel Month CGF-35/119
CJ170 Animal Cattle 29
CJ171 Animal Chicken 41
CJ172 Clinical Human 29
CJ173 Reference Human 9
CJ174 Animal Cattle 17
CJ175 Animal Cattle 18
CJ176 Animal Cattle 33
CJ177 Animal Cattle 33
CJ178 Animal Cattle 33
CJ179 Animal Cattle 33
CJ180 Animal Cattle 33
CJ181 Animal Chicken 41
CJ182 Animal Cattle 41
CJ183 Clinical Human 27
CJ184 Clinical Human 29
CJ185 Animal Cattle 17
CJ186 Animal Cattle 40
CJ187 Animal Cattle 40
CJ188 Animal Cattle 40
CJ189 Clinical Human 27
CJ190 Clinical Human 27
CJ191 Clinical Human 29
CJ192 Clinical Human 29
CJ193 Clinical Human 29
CJ194 Animal Cattle 18
CJ195 Reference Human 17
CJ196 Reference Human 18
CJ197 Animal Cattle 30
CJ198 Animal Cattle 17
CJ199 Animal Cattle 17
CJ200 Animal Cattle 17
CJ201 Clinical Human 29
CJ202 Clinical Human 29
CJ203 Water Water 18
CJ204 Reference Pig N/A
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Key  Sample Type Source Travel Month CGF-35/119
CJ205 Clinical Human 27.5
CJ206 Animal Pig 1
CJ207 Animal Pig 1
CJ208 Animal Turkey 18
CJ209 Animal Pig 18
CJ210 Animal Pig 18
CJ211 Animal Pig 17
CJ212 Animal Chicken 39
CJ213 Animal Chicken 39
CJ214 Animal Chicken 39
CJ215 Animal Chicken 39
CJ216 Animal Chicken 39
CJ217 Animal Chicken 39
CJ218 Animal Chicken 39
CJ219 Animal Pig 41 *
CJ220 Animal Chicken 41
CJ221 Animal Pig 41 *
CJ222 Animal Pig 41
CJ223 Animal Pig 41
CJ224 Animal Pig 41
CJ225 Animal Pig 41
CJ226 Animal Pig 41
CJ227 Clinical Human 27
CJ228 Clinical Human 28
CJ229 Clinical Human 29
CJ230 Clinical Human 29
CJ231 Water Water 1
CJ232 Animal Cattle 31
CJ233 Clinical Human 29
CJ234 Clinical Human 29
CJ235 Clinical Human 29
CJ236 Animal Cattle 29
CJ237 Animal Cattle 29
CJ238 Clinical Human 27.5
CJ239 Clinical Human 15.5
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Key  Sample Type Source Travel Month CGF-35/119
CJ240 Clinical Human 29
CJ241 Clinical Human 29
CJ242 Clinical Human 29
CJ243 Clinical Human 29
CJ244 Clinical Human 29
CJ245 Clinical Human 29
CJ246 Clinical Human 29
CJ247 Clinical Human 29
CJ248 Clinical Human 29
CJ249 Clinical Human 29 *
CJ250 Clinical Human 29 *
CJ251 Clinical Human 29
CJ252 Clinical Human 29
CJ253 Clinical Human 30
CJ254 Clinical Human 30
CJ255 Clinical Human 30
CJ256 Clinical Human 27
CJ257 Clinical Human 29
CJ258 Clinical Human 30
CJ259 Clinical Human 30
CJ260 Clinical Human 15.5
CJ261 Water Casselman 20
CJ262 Water B5 20
CJ263 Water Water 29
CJ264 Clinical Human 27 *
CJ265 Clinical Human 27 *
CJ266 Clinical Human 28 *
CJ267 Clinical Human 28 *
CJ268 Clinical Human 28
CJ269 Clinical Human 28
CJ270 Clinical Human 28
CJ271 Clinical Human 29 *
CJ272 Clinical Human 27.5 *
CJ273 Water Water 18
CJ274 Water Water 18
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Key  Sample Type Source Travel Month CGF-35/119
CJ275 Water B4 19
CJ276 Water B4 19
CJ277 Water B4 20 *
CJ278 Animal Cattle 28 *
CJ279 Animal Cattle 40 *
CJ280 Animal Chicken 18
CJ281 Animal Chicken 18
CJ282 Clinical Human 28
CJ283 Clinical Human 31
CJ284 Animal Chicken 20
CJ285 Animal Chicken 20
CJ286 Animal Chicken 20
CJ287 Animal Chicken 20
CJ288 Animal Chicken 20
CJ289 Clinical Human 27
CJ290 Clinical Human 28
CJ291 Clinical Human 27.5
CJ292 Clinical Human Mexico 27
CJ293 Clinical Human 27.5
CJ294 Clinical Human Mexico 27
CJ295 Clinical Human 28
CJ296 Clinical Human 28
CJ297 Clinical Human 28
CJ298 Clinical Human 28
CJ299 Reference Chicken 18
CJ300 Animal Chicken 18
CJ301 Animal Chicken 18
CJ302 Clinical Human 30
CJ303 Animal Cattle 18
CJ304 Animal Cattle 18
CJ305 Clinical Human 30
CJ306 Clinical Human 15.5
CJ307 Clinical Human 27.5
CJ308 Clinical Human 27.5
CJ309 Clinical Human 29
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Key  Sample Type Source Travel Month CGF-35/119
CJ310 Clinical Human 15.5 *
CJ311 Animal Cattle 18 *
CJ312 Animal Sheep 30
CJ313 Animal Sheep 30
CJ314 Animal Sheep 30
CJ315 Animal Sheep 30
CJ316 Animal Sheep 31
CJ317 Clinical Human 27.5
CJ318 Clinical Human 29 *
CJ319 Clinical Human 30 *
CJ320 Animal Buffalo 17 *
CJ321 Animal Buffalo 17 *
CJ322 Animal Horse 19 *
CJ323 Animal Cattle 30 *
CJ324 Animal Turkey 31 *
CJ325 Clinical Human 27
CJ326 Clinical Human 27
CJ327 Clinical Human 28
CJ328 Clinical Human 27.5
CJ329 Clinical Human 29
CJ330 Clinical Human 27.5
CJ331 Clinical Human 15.5
CJ332 Reference Human 8
CJ333 Reference Human 9
CJ334 Reference Reference 17
CJ335 Reference Human 17
CJ336 Reference Human 17
CJ337 Reference Human 17
CJ338 Reference Reference 19
CJ339 Clinical Human 28
CJ340 Water Water 1
CJ341 Animal Cattle 16
CJ342 Animal Cattle 16
CJ343 Water LB4 20
CJ344 Water LB4W 20
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Key  Sample Type Source Travel Month CGF-35/119
CJ345 Water LB4W3 20
CJ346 Water LB4-14 20
CJ347 Clinical Human 28
CJ348 Clinical Human 28
CJ349 Clinical Human 28
CJ350 Clinical Human 29
CJ351 Clinical Human 29
CJ352 Clinical Human 29
CJ353 Clinical Human 15.5
CJ354 Clinical Human 15.5
CJ355 Clinical Human 27.5 *
CJ356 Reference Human 8
CJ357 Reference Dog 18 *
CJ358 Reference Chicken 18
CJ359 Clinical Human 27
CJ360 Clinical Human 28
CJ361 Clinical Human 30
CJ362 Animal Cattle 16
CJ363 Reference Reference 17
CJ364 Animal Sheep 18
CJ365 Animal Cattle 31
CJ366 Animal Cattle 31
CJ367 Animal Cattle 31
CJ368 Animal Cattle 31
CJ369 Animal Horse 31
CJ370 Animal Cattle 33
CJ371 Animal Cattle 33
CJ372 Clinical Human 28
CJ373 Clinical Human 30 *
CJ374 Clinical Human 15.5 *
CJ375 Animal Cattle 30 *
CJ376 Animal Cattle 30 *
CJ377 Clinical Human 29
CJ378 Clinical Human 29
CJ379 Clinical Human 29
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Key  Sample Type Source Travel Month CGF-35/119
CJ380 Reference Reference 17
CJ381 Animal Sheep 19
CJ382 Animal Sheep 19
CJ383 Clinical Human 27.5
CJ384 Animal Cattle 17
CJ385 Clinical Human 27
CJ386 Clinical Human 30
CJ387 Animal Cattle 17
CJ388 Animal Deer 19
CJ389 Clinical Human Mexico 28 *
CJ390 Clinical Human 28 *
CJ391 Clinical Human 28 *
CJ392 Clinical Human 28
CJ393 Clinical Human 29 *
CJ394 Clinical Human 29 *
CJ395 Clinical Human 29
CJ396 Clinical Human 29 *
CJ397 Clinical Human 29
CJ398 Clinical Human 29
CJ399 Clinical Human 29
CJ400 Clinical Human 29
CJ401 Clinical Human 30 *
CJ402 Clinical Human 30 *
CJ403 Clinical Human 30
CJ404 Clinical Human 30
CJ405 Clinical Human 30
CJ406 Clinical Human 15.5
CJ407 Clinical Human 15.5
CJ408 Reference Human 18
CJ409 Animal Chicken 21 *
CJ410 Clinical Human Philippines 28
CJ411 Clinical Human ???
CJ412 Animal Chicken 21
CJ413 Animal Chicken 21
CJ414 Clinical Human 30
 
 162 
Key  Sample Type Source Travel Month CGF-35/119
CJ415 Clinical Human 30
CJ416 Clinical Human 30
CJ417 Clinical Human 27.5
CJ418 Clinical Human 28
CJ419 Clinical Human 29 *
CJ420 Clinical Human 29 *
CJ421 Clinical Human 29 *
CJ422 Clinical Human 29 *
CJ423 Clinical Human 29
CJ424 Clinical Human 29
CJ425 Clinical Human 29
CJ426 Clinical Human 29 *
CJ427 Clinical Human 29 *
CJ428 Clinical Human 29
CJ429 Clinical Human 30
CJ430 Clinical Human 30
CJ431 Clinical Human 30
CJ432 Clinical Human 30
CJ433 Clinical Human 27.5 *
CJ434 Clinical Human 27.5
CJ435 Clinical Human 27.5
CJ436 Animal Cattle 17 *
CJ437 Reference Reference 17
CJ438 Reference Reference 17
CJ439 Animal Cattle 30
CJ440 Animal Buffalo 33
CJ441 Animal Buffalo 33
CJ442 Animal Chicken 39 *
CJ443 Animal Chicken 41
CJ444 Animal Chicken 41
CJ445 Animal Chicken 41
CJ446 Clinical Human 30
CJ447 Reference Chicken 18
CJ448 Reference Human 18
CJ449 Reference Human 18
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Key  Sample Type Source Travel Month CGF-35/119
CJ450 Clinical Human 30
CJ451 Clinical Human 30
CJ452 Clinical Human 30
CJ453 Clinical Human 27
CJ454 Clinical Human
 Costa Rica 28
CJ455 Clinical Human 29
CJ456 Water Water 16
CJ457 Animal Deer 18
CJ458 Animal Deer 19
CJ459 Reference Sheep 17
CJ460 Reference Human N/A
CJ461 Clinical Human 15
CJ462 Clinical Human 15
CJ463 Water Sewage 1
CJ464 Animal Cattle 31
CJ465 Water Water 16
CJ466 Animal Cattle 31
CJ467 Animal Sea Gull 19
CJ468 Animal Cattle 17
CJ469 Water Grand Falls 19
CJ470 Animal Sheep 31
CJ471 Clinical Human 28
CJ472 Clinical Human 15.5
CJ473 Clinical Human 29
CJ474 Animal Cattle 40
CJ475 Clinical Human 18
CJ476 Animal Human 31
CJ477 Water LB4-14 19
CJ478 Water B7 20
CJ479 Water LB4W3 19
CJ480 Animal Horse 29
CJ481 Water B6 20
CJ482 Clinical Human 29
CJ483 Reference Human 18
CJ484 Water Grand Falls 20
 
 164 
Key  Sample Type Source Travel Month CGF-35/119
CJ485 Animal Human 31
CJ486 Animal Cattle 40
CJ487 Animal Goose 19
CJ488 Reference Wild avian 18
CJ489 Water Water 18
CJ490 Animal Duck 42
CJ491 Animal Pelican 31
CJ492 Water Water 29
CJ493 Water SU-54 42
CJ494 Animal Goose 30
CJ495 Animal Chicken 20
CJ496 Water Water 17
CJ497 Animal Duck 19
CJ498 Animal Chicken 41
CJ499 Water B4 20
CJ500 Animal Cattle 18
CJ501 Animal Duck 19
CJ502 Animal Duck 19
CJ503 Water LB4W 19
CJ504 Water Water 20
CJ505 Animal Goose 42
CJ506 Clinical Human 27.5
CJ507 Water Water 16
CJ508 Water Water Treatment 21
CJ509 Animal Goose 30
CJ510 Water Water 18
CJ511 Animal Goose 19
CJ512 Animal Goat 33
CJ513 Animal Duck 20
CJ514 Animal Goose 20
CJ515 Water LB-4 1
CJ516 Water LB4-14 20
CJ517 Animal Sheep 40
CJ518 Animal Deer 18
CJ519 Animal Chicken 18
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Key  Sample Type Source Travel Month CGF-35/119
CJ520 Clinical Human Mexico 27
CJ521 Reference Human 9
CJ522 Reference Reference 19
CJ523 Animal Cattle 29
CJ524 Animal Cattle 29
CJ525 Animal Sheep 29
CJ526 Animal Deer 22
CJ527 Animal Pig 41
CJ528 Animal Horse 29
CJ529 Animal Goat 41
CJ530 Animal Pig 1
CJ531 Water B5 19
CJ532 Animal Horse 29
CJ533 Animal Cattle 18
CJ534 Animal Duck 41
CJ535 Animal Cattle 17
CJ536 Water Water 42
CJ537 Water B4 19
CJ538 Animal Goose 42
CJ539 Animal Goose 41
CJ540 Clinical Human 27.5
CJ541 Water LB4W2 20
CJ542 Clinical Human 29
CJ543 Clinical Human 30
CJ544 Animal Pig 17
CJ545 Clinical Human 27
CJ546 Water Sewage 21
CJ547 Animal Duck 42
CJ548 Water Grand Falls 19
CJ549 Animal Duck 42
CJ550 Clinical Human 27.5
CJ551 Animal Goose 42
CJ552 Reference Human 18
CJ553 Clinical Human 27
CJ554 Water LB-4 19
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Key  Sample Type Source Travel Month CGF-35/119
CJ555 Clinical Human 27.5
CJ556 Clinical Human 15.5
CJ557 Clinical Human 28
CJ558 Animal Chicken 20
CJ559 Clinical Human 29
CJ560 Reference Human 17
CJ561 Water LB4W2 19
CJ562 Clinical Human 28
CJ563 Clinical Human 27.5
CJ564 Clinical Human 30
CJ565 Animal Cat 19
CJ566 Animal Cattle 41
CJ567 Animal Cattle 18
CJ568 Animal Cattle 42
CJ569 Animal Cattle 18
CJ570 Animal Goat 41
CJ571 Water Water 17
CJ572 Water LB4W2 19
CJ573 Water B6 19
CJ574 Water B5 20
CJ575 Animal Chicken 39
CJ576 Animal Pig 19
CJ577 Water SU-51 42
CJ578 Animal Pig 41
CJ579 Reference Human 9
CJ580 Animal Goose 41
CJ581 Clinical Human Guatemala 28
CJ582 Clinical Human 27.5
CJ583 Animal Pig 1
CJ584 Animal Pig 41
CJ585 Animal Pig 17
CJ586 Clinical Human 29
CJ587 Clinical Human 15.5
CJ588 Animal Cattle 18
CJ589 Animal Goat 18
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Key  Sample Type Source Travel Month CGF-35/119
CJ590 Animal Cattle 40
CJ591 Reference Cattle 17
CJ592 Reference Human 8
CJ593 Clinical Human Mexico 28
CJ594 Clinical Human Mexico 27
CJ595 Clinical Human 30
CJ596 Clinical Human Costa Rica 27
CJ597 Clinical Human
CJ598 Water B6 20
CJ599 Clinical Human 27.5
CJ600 Clinical Human 27
CJ601 Clinical Human 27
CJ602 Clinical Human 30
CJ603 Clinical Human 30
CJ604 Clinical Human 27.5
CJ605 Animal Chicken 39
CJ606 Clinical Human 27.5
CJ607 Clinical Human 15.5
CJ608 Clinical Human 28
CJ609 Clinical Human 15.5
CJ610 Water B5 19
CJ611 Water Water 18
CJ612 Water Water 18
CJ613 Water Water 1
CJ614 Clinical Human 29
CJ615 Water B5 20
CJ616 Water B5 19
CJ617 Water Water 16
CJ618 Water LB4-14 19
CJ619 Clinical Human 28
CJ620 Animal Sheep 31
CJ621 Clinical Human 27
CJ622 Animal Chicken 20
CJ623 Clinical Human 29
CJ624 Animal Cattle 29
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Key  Sample Type Source Travel Month CGF-35/119
CJ625 Reference Dog 17
CJ626 Animal Chicken 21
CJ627 Clinical Human 29
CJ628 Clinical Human 29
CJ629 Water Water 18
CJ630 Clinical Human 27.5
CJ631 Clinical Human 27.5
CJ632 Clinical Human 29
CJ633 Reference Human 8
CJ634 Water LB4W2 20
CJ635 Animal Chicken 21
CJ636 Reference Reference 17
CJ637 Animal Cattle 43
CJ638 Reference Human 18
CJ639 Animal Cattle 17
CJ640 Clinical Human 30
CJ641 Clinical Human 30
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Appendix B: Detailed Clustering of the southern Alberta Data Set using Bionumerics 
v5.0 (Applied Maths, Austin, TX). Fingerprint clustering was performed using 
BioNumerics software to determine and present similarity of fingerprints using program 
generated dendrograms based on the unique CGF-20 genetic fingerprint. This data was 
then combined with available information and epidemiological data such as name, flaA-
RFLP type, and source of sample and date of isolation. Continued on the following 
pages. 
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